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Abstract
The Bcl-2 family of proteins regulates the mitochondrial apoptotic pathway and consists 
of both pro- and anti-apoptotic members. Bax-a is present in the cytosol of healthy 
cells. Apoptotic stimuli induce the translocation of Bax-a to the mitochondria leading 
to the permeabilisation of the outer mitochondrial membrane (OMM) and the release of 
downstream pro-apoptotic proteins from the intermembrane space (IMS). The 
mechanism by which Bax permeabilises the OMM remains unclear. Recent evidence 
suggests Bax alone might be sufficient to permeabilise the OMM. However, other 
models indicate the involvement of the mitochondrial permeability transition pore 
complex or the voltage-dependent anion channel (VDAC) present in the OMM. In this 
study Bax and C-terminally truncated Bax were expressed as GST-fusion proteins and 
were immobilised on agarose-GSH. The binding of mitochondrial membrane proteins 
that might be involved in the Bax mediated release of proteins from the IMS was 
investigated. The results showed that VDAC and the adenine nucleotide translocase 
(ANT) were retained by GST-Bax. Exogenous cyclophilin D (Cyp D) was added in the 
presence of VDAC and ANT and was also retained indicating that Bax interacts with 
the components of the permeability transition pore complex. The anti-apoptotic Bcl-2 
protein Bcl-XL was expressed with a hexahistidine tag at its N-terminus. This was used 
to investigate its effects on Bax interaction with VDAC and ANT. The ANT ligands 
atractyloside and bongkrekic acid which promote and inhibit apoptosis respectively 
were shown to change the relative amounts of VDAC and ANT that bind GST-Bax. 
Apoptotic cell death has been identified in cardiomyocytes subjected to ischaemia. In 
this investigation cardiomyocytes transfected with GFP-Bax were treated with cyanide 
to simulate ischaemia and GFP-Bax translocation was observed using fluorescence 
microscopy. GFP-Bax co-immunoprecipitated with VDAC and ANT after translocation 
to mitochondria but not with Cyp D. The implications of these findings are discussed in 
this thesis.
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Chapter 1: Introduction
Chapter 1: Introduction
[1.1] Background
Apoptosis is an evolutionarily conserved cell suicide program that is essential for 
development and maintenance of tissue homeostasis in multicellular organisms. This 
form of cell death differs from necrosis which is considered to be accidental and is the 
result of lethal cell injury. Apoptotic cell death has many important physiological 
functions including the termination of immune responses and eliminating viral-infected 
cells. In addition, defects in the pathways leading to apoptosis have been implicated in 
the pathology of various diseases such as neurological disorders, heart disease and 
cancer. The identification of pro-apoptotic proteins within the IMS has established the 
important role mitochondria play in the apoptotic process. For example, the release of 
cytochrome c from the IMS leads to apoptosome formation and activation of pro- 
caspase 9 which in turn activates downstream pro-caspases leading to the cleavage of 
structural cellular proteins and chromatin. SMAC/Diablo, also present in the IMS, 
deregulates the inhibitor of apoptosis proteins (IAPs). Pro- and anti-apoptotic Bcl-2 
proteins regulate the permeabilisation of the OMM. However, the mechanism 
responsible for the release of proteins from the IMS remains unclear.
This introduction focuses on the main events that occur during apoptosis, in particular 
how mitochondria are recruited by the Bcl-2 proteins into apoptotic pathways and how 
they are involved in bringing about the destruction of the cell.
15
Chapter 1: Introduction
[1.2] Apoptosis
In 1972, Kerr and co-workers (Kerr et al., 1972) coined the term “apoptosis” to 
describe cell death during which cells shared the same morphological features such as 
shrinkage of the cell away from its neighbours, plasma membrane blebbing, 
cytoplasmic and nuclear condensation and preservation of the structure of organelles 
including mitochondria until the last stages of programmed cell death (PCD). Different 
types of cells undergoing PCD share these changes suggesting a common conserved 
pathway. These features were distinct from those observed when cells underwent 
necrotic cell death, where cells swell and chromatin appears diffuse or finely clumped. 
Apoptotic cells are gradually phagocytosed by neighbouring cells or macrophages 
whilst necrotic cells lyse, releasing their contents into the extracellular space and thus 
eliciting an inflammatory response by the tissue (Wyllie et al., 1980).
[1.3] The Apoptotic cascade
The pathways leading to apoptotic cell death are intricate and precisely ordered. 
Apoptosis is initiated by intracellular or extracellular signals followed by the activation 
of a cascade of proteolytic enzymes, in particular a group of cysteine proteases known 
as caspases (cysteine-dependent aspartate-directed proteascs) (Wolf & Green, 1999, 
Wang & Lenardo, 2000) are involved in apoptosis. These enzymes initiate the process, 
propagate or amplify the signal, or attack cellular structures to cause their collapse as a 
result of activation of different apoptotic pathways. The extrinsic pathway is activated
16
Chapter 1: Introduction
by the ligation of death receptors leading to the rapid activation of upstream (initiator) 
and downstream (effector) caspases, and the mitochondria are initially bypassed (Lui et 
al., 1997, Scaffidi et al., 1998, Scaffidi et al., 1999) allowing cells to respond directly to 
the immediate environment. The death receptors belong to the TNF receptor (TNFR) 
superfamily and are single transmembrane spanning proteins with cysteine-rich 
domains in the extracellular region (Hofmann et al., 1999, Locksley et al., 2001). An 
example of this type of receptor is the Fas receptor (CD95) (Huang et al., 1996), which 
is triggered by the Fas ligand and signals through the Fas-associated DD adaptor 
protein (FADD). The intrinsic pathway of PCD is driven by organelles, particularly the 
mitochondria, which detect and respond to unfavourable changes in the internal 
environment. Organelles other than mitochondria may initiate apoptosis (Ferri & 
Kroemer, 2001). Nuclear damage may be sufficient to induce cell death, Golgi 
dysfunction may activate caspase-2 and caspase-12 can be selectively activated in 
response to ER stress which can be the result of accumulation of unfolded proteins in 
the ER or inhibition of the ER-Golgi transport (Oyadomari et al., 2002). Figure [1.1] 
outlines the control of apoptosis through the extrinsic and intrinsic pathways. 
Activation of these pathways leads to the activation of downstream effector caspases 
which are required to dismantle cellular components. Cross-talk between the extrinsic 
and intrinsic pathways does occur for example, the release of cytochrome c from 
mitochondria can occur when either of these pathways is activated in mammalian cells 
(Goldstein et al., 2000) and death-receptor mediated activation of caspase-8 can lead to 
cleavage of the Bcl-2 protein Bid which is involved in the mitochondrial pathway 
(Kuwana et al., 1998).
17
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Apoptotic Control Pathways
Extrinsic
Death Receptor 
Activation
Death ■  
Receptor 
Ligands
Intrinsic
Intracellular Damage & 
Endoplasmic Reticulum Stress
Mitochondria
Downstream Caspase Activation
-Cl
Apoptosis
Figure [1.1] Control of apoptotic pathways. There are two principal pathways that 
lead to caspase activation and cell death. The extrinsic pathway is triggered by ligation 
of the cell surface death receptors and allows the cell to respond directly to the 
immediate environment. Cell death can also occur via the intrinsic pathway driven by 
organelles particularly the mitochondria or in response to ER stress (P. Lovat, personal 
communication).
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[1.4] Mitochondria and Apoptosis
Mitochondria are often referred to as the “powerhouses” of cells; their function is to 
produce ATP, which is necessary for various essential physiological processes. 
However, mitochondria also have a role in cell death. The first indication that 
mitochondria play an active role in apoptosis came in 1994 with the observation that 
induction of nuclear apoptotic changes (chromatin condensation, nuclear 
fragmentation) in extracts of Xenopus eggs required the presence of mitochondria 
(Newmeyer et al., 1994). This finding lead to a rapid advance in the understanding of 
mitochondrial function. Apoptosis is executed by caspases that are responsible for the 
distinct morphological features of apoptosis described by Kerr et al (Kerr et al., 1972). 
For example, cleavage of the nuclear lamins is required for nuclear shrinkage and 
budding (Rao et al., 1996 and Buendia et al., 1999). Caspases are expressed 
constitutively as inactive proenzymes and are activated by proteolytic cleavage to 
generate large (p20) and small (plO) subunits. These enzymes can be grouped 
structurally and functionally into two classes (Eamshaw et al., 1999). Class I are the 
initiator caspases that contain long prodomains with either a caspase recruitment 
domain (CARD) or a death effector domain (DED) and are mutually cleaved after 
aggregation into complexes, a process mediated by adaptor proteins. These caspases 
then cleave and activate class II, the effector caspases, which have short prodomains. 
Caspases-2, -9, -8 and -10 are apoptosis initiators and cleave and activate apoptosis 
effectors caspases-3, -6 and -7. The domain structures of the principal caspases are 
shown in figure [1.2].
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Initiator caspases
Caspase-2 O -i 1—1 1
Caspase-9 2
CARD p20 plO
Caspase-10 u n
Caspase-8 CTm i H— 1___ 1
DED DED p20 plO
Effector caspases
Ca.tpa.te-)
Caspase-6
p20 plO
Figure [1.2] Caspases are the executioners of the apoptotic response. The domain 
structure of the principal caspases involved in apoptosis. Caspases are activated by 
cleavage to generate a large (p20) and small (plO) subunit. Initiator caspases contain a 
long prodomain with either a CARD (pink) or DED (green) domain. These domains 
interact with complementary domains on adaptor proteins that serve to cluster the 
initiator caspases and facilitate autoproteolysis.
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Apoptosis in response to ligation of the death receptors leads to assembly of upstream 
caspases (e.g. caspase-8) and adaptor proteins at the plasma membrane receptor, 
forming a death-inducing signalling complex (DISC). It is thought that the low 
intrinsic activity of procaspase-8 is enough to allow some of the proenzymes to be 
cleaved (Muzio et al., 1998). The upstream caspases are processed to their active forms 
leading in turn to the activation of downstream caspases. Studies indicate that caspase 
cascades are highly ordered, such that caspase-8 and -9 cleave and activate caspase-3 
and -7 and caspase-3 activates caspase-6 (Hirata et al., 1998, Takahashi et al., 1999, 
Slee et al., 1999). When activated effector caspases can activate remaining initiator 
caspases, producing a positive feedback loop. Therefore caspase-3 activates caspase-2 
and caspase-6 activates caspases-8 and -10 (Slee et al., 1999). Caspase-3 is a key 
effector in the apoptotic pathway. It can amplify the signal from upstream caspases 
(e.g. by cleaving procaspase-8) and can cleave caspase-activated DNase (CAD) (Enari 
et al., 1998) which is responsible for the chromatin degradation in apoptotic cells and 
can be detected as a 180bp nucleosomal ladder on agarose gels. This DNase exists in 
non-apoptotic cells as an inactive complex with an inhibitory subunit and is known as 
ICAD (Nagata, 2000, Lui et al., 1997). Other caspase substrates include structural 
proteins, such as fodrin and vimentin which are cleaved by caspase-3 (Janicke et al., 
1998, Slee et al., 2001) and nuclear lamins A and B which are cleaved by caspase-6 
(Slee et al., 2001). Mitochondria can be recruited into the apoptotic pathway by 
caspase-8 (Luo et al., 1998, Li et al., 1998). Figure [1.3] shows that caspase-8 cleaves 
the Bcl-2 family protein Bid to a produce a 15 kDa carboxyl-terminal truncated Bid
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fragment (tBid) that translocates from the cytosol to mitochondria (see section [1.5] for 
the Bcl-2 family proteins).
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Figure [1.3] Mitochondria are recruited into the apoptotic pathway by the Bcl-2 
family proteins Bax and Bid. Proteins Bax and Bid translocate from the cytosol to the 
mitochondrial outer membrane when cells receive an apoptotic stimulus. Bid is 
processed by caspase-8 to a truncated form (t-Bid) before translocation to the outer 
mitochondrial membrane where it can process Bax. The activated Bax then causes the 
release of apoptosis-inducing factor (AIF), procaspase-9, cytochrome c, and other 
intermembrane space proteins into the cytosol.
Bid is thought to have two functions. One in promoting conformational changes in Bax, 
a Bcl-2 pro-apoptotic protein that also translocates from the cytosol to mitochondria
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during apoptosis. These Bid-induced conformational changes in Bax are required for 
the membrane insertion of its hydrophobic C-terminal domain anchor and 
oligomerisation (Desagher et al., 1999, Wei et al., 2001). The other function of Bid is 
to bring about mitochondrial membrane restructuring to ease the egress of pro- 
apoptototic proteins from the IMS by inducing permeability transition pore (MPT-pore) 
mediated opening of the cristal structure (Scorrano et al., 2002) (see section [1.8.3] for 
the MPT-pore). Wei and co-workers (Wei et al., 2001) showed that caspase-activated 
Bid triggers the homo-oligomerisation of Bax and another pro-apoptotic Bcl-2 protein 
Bak. This results in the release of apoptotic proteins from the IMS. It was found that 
cells lacking both Bax and Bak, but not cells lacking only one of these proteins, were 
completely resistant to multiple apoptotic stimuli that act through the mitochondrial 
pathway e.g. staurosporine, uv radiation, growth factor withdrawal, and the 
endoplasmic reticulum stress stimulus thapsigargin. Therefore, it was concluded that 
Bax or Bak are essential for the mitochondrial intrinsic pathway involvement in 
apoptosis.
[1.5] The Bd-2 family of proteins
The Bcl-2 proteins are key regulators of apoptosis. Bcl-2 was the first discovered as a 
proto-oncogene found at breakpoints of t (14; 18) chromosomal translocations in B-cell 
lymphomas (Tsujimoto et al., 1985). In this condition neoplastic cell expansion can be 
attributed primarily to failed PCD rather than rapid cell division. Gene transfection 
studies showed that overexpression of Bcl-2 significantly prolongs cell survival in the
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presence of classical apoptotic stimuli such as lymphokine deprivation from 
haematopoietic cells and glucocorticoid treatment of thymocytes. Conversely, 
antisense mediated suppression of Bcl-2 expression was demonstrated to induce or 
accelerate cell death (Reed, 1990). Since then other proteins belonging to this family 
have been found. Some are anti-apoptotic such as Bc1-Xl while others for example, 
Bax are pro-apoptotic. The precise functions of most of the Bcl-2 proteins have not 
been elucidated. A principal site of action of the Bcl-2 family proteins is the 
mitochondrion where they regulate the release of apoptogenic, proteins for example, 
cytochrome c from the IMS (section [1.7.3]). The proteins can be classified into three 
functional groups (Adams & Cory, 1998). Members of the first group, such as Bcl-2 
and Bc1-Xl, are characterised by four short conserved Bcl-2 homology (BH) domains 
(BH1-4). They also possess a C-terminal hydrophobic tail, which localises the proteins 
to the outer surface of mitochondria, the ER and the nuclear membranes (Krajewski et 
al., 1993, Gonzalez-Garcia et al., 1994, Lithgow et al., 1994). All members of this 
group possess anti-apoptotic activity. Group II consists of proteins with pro-apoptotic 
activities for example, Bax and Bak. Their overall structure is similar to group I 
proteins containing the hydrophobic tail but not the BH4 domain at the N-terminus. 
The third group of Bcl-2 family members which, consists of a large and diverse group 
of proteins whose only common feature is the presence of the 12-16 amino acid BH3 
domain (Figure [1.4] and Table [1.1]).
One characteristic of the Bcl-2 family of proteins is that they are capable of forming 
homo- and heterodimers. In a landmark study by Oltvai and co-workers (Oltvai et al.,
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1993) it was shown that Bax co-immunoprecipitates with Bcl-2 from RL7 cells (human 
B-cell line which produces high levels of Bcl-2). Their work also showed that Bax 
forms homodimers and heterodimers in vivo. Another important finding from this 
study was that the intracellular ratio of Bax to Bcl-2 is an important indicator of 
whether or not a cell will live or die. If Bcl-2 predominates the cells survive whereas if 
Bax is more abundant cell death occurs (Oltvai et al., 1993).
BH4
Group I 
Group II
BH3 BH1 BH2 TM
M U Bcl-2
Bax
Group III
Bid
B ik
Figure [1.4] The Bcl-2 family of proteins can be classified into 3 functional groups.
Members of group I have four short, conserved Bcl-2 homology (BH) domains (BH1- 
4). They also possess a C-terminal hydrophobic domain (TM). These proteins include 
Bcl-2 and BcI-Xl- Group II proteins have a similar structure to group I except for the 
N-terminal BH4 domain. The group members are pro-apoptotic such as Bax and Bak. 
Group III proteins contain the BH3 domain. These proteins may share little sequence 
similarity to the other two groups except for this BH3 domain. Members of this group 
can be either pro- or anti-apoptotic. (Diagram taken from Hengartner, 2000).
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Anti-apoptotic Pro-apoptotic
BH3 domain-only Multi-domain
Bcl-2f Bid Bax
Bc1-Xl Bad Bak
Bcl-w Bik/Nbk Bok
Mcl-1 Hrk Bcl-Xs
Al/Bfl Bim/Bod
Boo/Diva Bnip3
Nrll3 Nix
Noxa
Puma
Bmf
Table [1.1] Bcl-2 family proteins either inhibit (anti-apoptotic) or promote (pro- 
apoptotic) apoptosis. Most of the anti-apoptotic proteins contain all four BH domains. 
The pro-apoptotic proteins can be divided into two groups: the BH3 domain-only 
proteins which share little sequence similarity except for their BH3 domains and the 
multi-domain proteins which contain BH 1,2 and 3 domains.
[1.6] Bd-XL-an anti-apoptotic protein
Boise and co-workers found the gene encoding Bc1-Xl (Boise et al., 1993). They 
showed that Bcl-XL could function as a Bcl-2-independent regulator of programmed 
cell death. Alternative splicing results in two distinct Bcl-X mRNAs. The protein
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product of the larger mRNA (Bc1-Xl) was similar in size and structure to Bcl-2 (Bcl-XL 
is 27 kDa and Bcl-2 is 26 kDa). When stably transfected into an interleukin-3 (IL-3)- 
dependent cell line, it inhibited cell death upon growth factor withdrawal to the same 
degree as Bcl-2. The smaller mRNA (Bcl-Xs) encodes a protein that inhibits the ability 
of Bcl-2 to enhance the survival of growth factor-deprived cells. In vivo, Bcl-Xs is 
expressed in cells that undergo a high rate of turnover, such as developing lymphocytes. 
In contrast, Bc1-Xl is present in tissues that contain long-lived post-mitotic cells, for 
example the adult brain.
Bc1-Xl functions antagonistically to pro-apoptotic Bcl-2 proteins, for example Bax 
(section [1.7.3]). Studies have shown that Bc1-Xl prevents the loss of OMM integrity 
by preventing hyperpolarisation of the OMM and mitochondrial swelling in response to 
apoptotic stimuli such as staurosporine and IL-3 withdrawal (Vander Heiden et al.,
1997). The same study also showed that overexpression of Bc1-Xl in Jurket T cells 
undergoing apoptosis prevents cell death.
[1.7] Bax a pro-apoptotic protein
Oltvai and co-workers first identified Bax as a protein that could form heterodimers 
with Bcl-2 (Oltvai et al., 1993). Their findings suggested a model for the control of 
programmed cell death in which the ratio of Bcl-2 to Bax determined cell survival or 
death following an apoptotic stimulus. In situ hybridisation was used to map the human
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bax gene to chromosome 19q 13.3-13.4 (Apte et al., 1995). Oltvai and co-workers 
(Oltvai et al., 1993) described six different bax mRNA transcripts produced by 
alternative splicing. Bax-a is a 579 bp transcript that codes for a 21 kDa protein, which 
has a C-terminal transmembrane domain. Most studies relating to Bax function and 
apoptosis have focused on this splice variant. The amino acid sequence of Bax-a, BH 
domains and the C-terminal transmembrane domain are shown in figure [1.5]. The beta 
mRNA transcript is 657 bp and contains a larger version of exon 6  which contains a 
termination codon. Bax-(3 is a 24 kDa protein that lacks the C-terminus and hence the 
transmembrane anchor. The bax-y mRNA transcript is 126 bp and consists of exons 1 
and 3. The Bax-y protein is only 4.5 kDa and results from premature termination in 
exon 3 due to a translational ffameshift (Ovalti et al., 1993). The bax-5 mRNA is a 433 
bp transcript that is missing exon 3 but retains the same translational frame. The Bax- 6  
protein retains the transmembrane anchor (Apte et al., 1995). The bax-s transcript 
contains an additional exon (exon 5) in addition to the same exons as bax-a whilst bax- 
o  contains the same exons as bax-a except that it contains a 3’ truncated exon 7. 
Figure [1.6] shows 9 different bax transcripts produced from the bax gene. The 
functions of these different splice variants are not known. More recently three other 
splice variants have been identified. Zhou and co-workers (Zhou et al., 1998) identified 
bax-co whilst screening human hippocampal cDNA for brain-specific homologues of 
bax. They found a 28 kDa protein that lacks the C-terminal transmembrane anchor. 
The Bax-co is identical to Bax-a through the region of the protein encoded by exons 1 to 
6 , after exon 6  Bax-co is generated as a result of the splice donor site at the 3’end of 
exon 6  joining to a site 49 bases pairs 5’ to the Bax-a acceptor site on exon 7. Bax-K
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contains an insert between exons 1 and 2 , and an initiation at an alternative start site in 
exon 2 produces a protein that lacks the N-terminal ART domain that regulates pro- 
apoptotic function, and deletion of this region produces a protein with increased 
apoptotic activity (Jin et al., 2001). Cartron and co-workers (Cartron et al., 2002) 
identified a form of Bax designated Bax-v|/. Bax-\j/ is a N-terminal truncated form of 
Bax that results from a partial deletion of exon 1 of the bax gene. Bax-\|/ has also been 
found to be present in normal tissues. This form of the protein localises to 
mitochondria and was found to be a more powerful inducer of apoptosis than Bax-a. 
The expression of Bax-v|/ in glioblastomas compared with Bax-a correlated with longer 
survival in patients with brain tumours (Cartron et al., 2002).
The bax promoter region contains 4 motifs with homology to consensus p53-binding 
sites. Co-transfection assays using p53 deficient tumour cell lines showed that bax is a 
primary response gene for p53 and is involved in a p53 regulated pathway for induction 
of apoptosis (Miyashita and Reed, 1995)
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Figure [1.5] Primary sequence of Bax-a. Bax-a consists of 192 amino acids. The 
BH3 domain is shown in red and contains amino acids 59 to 73. This domain is 
essential for oligomerisation with anti-apoptotic Bcl-2 proteins e.g. Bcl-2 and B c1-X l or 
with other Bax molecules. The BH1 and BH2 domains are shown in green and blue 
respectively. The C-terminal transmembrane anchor inserts into the outer 
mitochondrial membrane (shown in purple).
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Figure [1.6] Splice variants of bax. The bax gene contains 6 different exons from 
which 9 different transcripts can be produced. Exons are numbered within the boxes 
and the domains of Bax-a are shown within the above boxes. The dotted line indicates 
the length of the translated region (diagram taken from Clerk et al., 2003)
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11.7.1] Translocation and homo-oligomerisation o f Bax during apoptosis
During apoptosis Bax translocates from the cytosol to the mitochondria where it plays a 
major role in the permeabilisation of the OMM (Wolter et al., 1997, Zhang et al., 1998). 
The addition of Bax to isolated mitochondria is sufficient to release apoptogenic 
proteins such as cytochrome c from the IMS (Kluck et al., 1997, Jurgensmeier et al., 
1998, von Ahsen et al., 2000) (see section [1.7.3] for the release of apoptogenic 
proteins from the IMS). Bax has a C-terminal hydrophobic anchor domain that can 
insert into the OMM. Insertion of this C-terminal domain into the OMM is 
accompanied by conformational changes within the Bax protein that expose the N- 
terminal region and the BH3 domain (Wolter et al., 1997, Goping et al., 1998, Desagher 
et al., 1999). These changes are thought to lead to dimerisation, possibly mediated by 
the exposed BH3 domain (Wang et al., 1998, Antonsson et al., 2001). Higher Bax 
oligomers have also been described. In particular, Bax complexes (4-mers and 12 
mers) were isolated from apoptotic cells (Antonsson et al., 2001, Gross et al., 1998). 
More recently very large Bax aggregates, containing thousands of Bax molecules have 
been detected in close proximity to mitochondria during apoptosis (Nechushtan et al., 
2001, Capano & Crompton, 2002). Capano & Crompton (Capano & Crompton, 2002) 
showed that the translocation of Bax, with green fluorescent protein (GFP) present at 
the N-terminus of Bax, was biphasic. When apoptosis was initially induced by the 
addition of staurosporine to GFP-Bax transfected cardiomyocytes, there was little 
evidence of Bax association with mitochondria. After one to three hours incubation 
with staurosporine the association of GFP-Bax with mitochondria was clearly
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discernible. GFP-Bax aggregates were visible after four to five hours of incubation 
with staurosporine and after seven to nine hours the mitochondria began to break up 
and disappear. The function of these large Bax aggregates is not clear. In the same 
study it was shown that cardiomyocytes were transfected with both GFP-Bax and 
cytochrome c with a red fluorescent protein tag (RFP). Before the induction of 
apoptosis with staurosporine, the RFP-Bax was localised to the IMS. After two hours 
of exposure to staurosporine the RFP-cytochrome c distribution became more diffuse 
indicating that RFP-cytochrome c was released from the IMS into the cytosol. At this 
stage it was found that RFP-cytochrome c release from the IMS was complete. It was 
concluded that cytochrome c release occurs in the first phase of GFP-Bax translocation 
to mitochondria when only a small proportion of the GFP-Bax is co-localised with the 
mitochondria. Therefore these results indicate that the formation of large Bax 
aggregates occurs after cytochrome c release from the IMS and this higher Bax 
structure is not required for the permeabilisation of the OMM to pro-apoptotic proteins 
in the IMS.
[1.7.2] Bax and detergent-induced conformational changes and oligomerisation
In vitro studies using recombinant Bax and isolated mitochondria have shown that it is 
the Bax oligomers, (4- 12mers) which are biologically active rather than the monomeric 
form in that only detergent-oligomerised Bax was able to induce cytochrome c release 
from isolated mitochondria whereas monomeric Bax could not (Antonsson et al., 2000). 
The conformational changes leading to the exposure of the N-terminal region and BH3
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domain that take place when the C-terminal hydrophobic domain of Bax inserts into the 
OMM during apoptosis and which are necessary for oligomerisation to take place can be 
induced in vitro by the incubating Bax with nonionic detergents (Hsu & Youle, 1997). 
The degree to which the N-terminal region exposure and oligomerisation takes place is 
dependent upon the detergent used. Nonidet P-40 and Triton-XlOO both strongly induced 
heterodimerisation of Bax with Bc1-Xl and homodimerisation in Bax present in protein 
extracts derived from non-apoptotic thymocytes. Whereas Tween 20 induced 
heterodimerisation with Bc1-Xl but not homodimerisation. The nonionic detergent 
CHAPS was unable to induce conformational changes leading to Bax oligomerisation 
(Hsu & Youle, 1998).
[1.7.3] Bax and the release o f apoptogenic proteins from the IMS
Bax mediates the release of apoptogenic proteins from the IMS. The first to be 
recognised was cytochrome c (Lui et al., 1996). Addition of Bax to isolated 
mitochondria is sufficient to induce the release of cytochrome c. (Eskes et al., 1998, 
Jurgenmeier et al., 1998, Luo et al., 1998 and Desagher et al., 1999). Cytochrome c 
release is almost a universal feature of apoptotic cell death. However, in some cases, it 
is a very late event, for example, apoptosis induced by death receptors bypassing the 
mitochondrial pathway (Scaffidi et al, 1998). In this case cell death is almost 
insensitive to protection by Bc1-Xl. Goldstein and co-workers (Goldstein et al., 2000) 
transfected HeLa cells with a recombinant plasmid containing cytochrome c-GFP. 
They found that the release of cytochrome c-GFP from the IMS always precedes the
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exposure of phosphatidylserine and loss of plasma membrane integrity that are 
characteristics that appear in the later stages of apoptotic cell death. Cytochrome c- 
GFP release was found to be complete after 5 minutes and was shown to be
independent of the type and strength of the stimulus and was also shown to be
temperature independent over the range 24°C-37°C. Released cytochrome c binds to 
the cytosolic adaptor protein apoptosis activating protease activating factor-1 (Apaf-1) 
and dATP together they activate pro-caspase-9. Apaf-1 contains multiple domains that 
facilitate protein-protein interactions including a N-terminal CARD, a nucleotide- 
binding domain and a series of 12 or 13 WD-40 repeats at the C-terminus. The binding 
of cytochrome c to the WD-40 domain increases the affinity of Apaf-1 for dATP/ATP, 
and the binding of dATP/ATP promotes the oligomerisation of Apaf-1 into a high- 
molecular weight complex, the apoptosome (Jiang & Wang, 2000). Interactions 
between Apaf-1, cytochrome c, and pro-caspase-9 are not transient and this complex 
forms the active enzyme. The apoptosome is a large complex (700 kDa) and may 
involve other proteins e.g. heat shock protein-70 (Cain et al., 1999, Cain et al., 2000,
Beere et al., 2000). Caspase-9 activates effector caspases e.g. caspase-3 and this
cleaves ICAD that results in chromatin degradation (Zou et al., 1999). Procaspase-2, 3 
and 9 are also released from the IMS (Zou et al., 1999, Susin et al., 1999a) During 
apoptosis a variety of pro-apoptotic proteins are released from the IMS in addition to 
cytochrome c. Smac /Diablo (Du et al., 2000, Verhagen et al., 2000) and HtrA2/Omi 
(Suzuki et al., 2001, Hegde et al., 2002, Verhagen et al., 2002) both potentiate caspase 
activation by binding to inhibitors of apoptosis proteins (IAPs) and blocking their 
caspase inhibitory activity. Apoptosis inducing factor (AIF) (Susin et al., 1999b) and
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endonuclease G (Endo G) (Li et al., 2001) are also released from the IMS. During 
apoptosis both AIF and Endo G translocate from the IMS to the nucleus. AIF induces 
chromatin condensation and large-scale DNA fragmentation (50 kbp) (Susin et al., 
1999b). Endo G catalyses both high molecular weight DNA cleavage and 
oligonucleosomal DNA breakdown in a sequential manner. In addition Endo G 
cooperates with exonuclease and DNase I to facilitate DNA processing (Widlak et al., 
2001). Whether pro-apoptotic Bcl-2 proteins release all apoptogenic factors from the 
IMS and the temporal sequence of their release remain unclear. Recently it was 
reported that Bax-mediated mitochondrial permeabilisation does not directly induce 
AIF release and that AIF release occurs downstream of cytochrome c release (Amoult 
et al., 2002). A subsequent study by the same group showed that OMM 
permeabilisation induced by Bax resulted in the release of cytochrome c, Smac/Diablo 
and HtrA2/Omi but subsequent caspase activation is required to induce translocation of 
Endo G and AIF into the cytosol from the IMS (Amoult et al., 2003).
[1.8] Molecular mechanisms of OMM permeabilisation by Bax
[1,8.1] Bax only models for OMM permeabilisation
The mechanism by which Bax induces permeabilisation of the OMM has been the 
focus of much research and still remains controversial. One hypothesis put forward is 
that Bax is able to form channels in the OMM through which pro-apoptotic proteins can 
pass. NMR studies have shown that Bc1-Xl and Bax are structurally similar to the
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diptheria toxin and the bacterial colicins (Muchmore et al., 1996, Suzuki et al., 2000). 
These observations have inspired several studies showing that these proteins exhibit ion 
channel activities in synthetic bilayers. In most cases, the channel activities were 
recorded at a non-physiological pH and it was questionable as to whether these 
channels would be large enough to allow the passage of cytochrome c (Minn et al., 
1997, Antonsson et al., 1997). However, Bax tetramers were shown to form a channel 
large enough to allow the release of cytochrome c from liposomes (Saito et al., 2000). 
In addition, Bax was isolated as high molecular weight oligomers (96 kDa and 260 
kDa) from mitochondrial membranes of apoptotic HeLa cells and it was prosposed that 
Bax oligomers might constitute the structural entirety of the cytochrome c-conducting 
channel in the OMM (Antonsson et al., 2001). Other studies had implicated the OMM 
protein the voltage-dependent anion channel (VDAC) in the Bax-induced 
permeabilisation of the OMM, however in this study VDAC did not co-elute with the 
Bax oligomers from the OMM of apoptotic cells. More recently, it was shown that Bid, 
Bax and lipids cooperate to form openings in the OMM through which apoptogenic 
proteins can pass into the cytosol (Kuwana et al., 2002). In this study the apoptotic 
process of protein release from the IMS and its control by Bax/Bid was reconstituted 
using isolated OMM and protein-free liposomes. The results showed that Bax and Bid 
interact directly with the OMM. VDAC which has been implicated in Bax-induced 
permeabilisation of the OMM (see section [1.8.2]) and other mitochondrial membrane 
proteins are not required for permeabilisation of the OMM to take place. 
Permeabilisation of liposomes by Bax was found to be dependent on the amount of the 
lipid cardiolipin. Previous studies have shown that cardiolipin is also required for the
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membrane targeting of Bid (Lutter et al., 2000). Other studies have shown that the 
ability of detergent-oligomerised Bax to produce pores in lipid membranes was affected 
by the addition of lipids that can alter the intrinsic curvature of the membrane whereas 
the lipids had little effect on Bax binding or insertion into the membrane (Basanez et 
al., 2002). Kuwana and co-workers suggested that cardiolipin might increase the local 
stress curvature of the OMM sensitising it to Bax-induced pore formation (Kuwana et 
al., 2003).
[1.8,2] Bax regulates OMM permeabilisation through its interaction with VDAC
Voltage-dependent anion channels (VDACs) are pore-forming proteins found in the 
OMM of all eukaryotes (Schein et al., 1976). These protein, vary in size from 30-32 
kDa, are capable of forming channels with a diameter of 2.5-3nm in planar 
phospholipid bilayers (Granville & Gottlieb, 2003). VDACs play a role in the 
regulated flux of metabolites across the OMM. The gating of the channel depends upon 
the transmembrane potential. VDACs are “open” at low transmembrane potentials, 
with a preference for anions such as phosphate, chloride, and adenine nucleotides. At 
higher transmembrane potentials, VDACs are in a “closed” conformation and are 
slightly more selective for cation (Manella et al., 1992). Two isoforms of VDAC have 
been identified in rats and humans (Blachly-Dyson et al., 1993). Previous studies have 
shown that it is the more abundant isoform VDAC-1 that interacts with ANT to form 
contact sites (see section [1.8.4]) between the IMM and the OMM (Brdiczka et al.,
1998). However, more recently it has been shown that the low abundance isoform
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VDAC-2 inhibits the activation of the pro-apoptotic Bcl-2 protein Bak. VDAC-2 
interacts specifically with inactive monomeric Bak. Cells deficient in VDAC-2 but not 
VDAC-1 exhibited enhanced Bak oligomerisation and were more susceptible to 
apoptotic cell death (Cheng et al., 2003).
Another hypothesis put forward is that Bax induces OMM permeabilisation through its 
interaction with the OMM protein VDAC. Shimizu and co-workers demonstrated that 
the addition of recombinant Bax to VDAC liposomes enhanced sucrose uptake but 
uptake of sucrose into liposomes incorporating Bax without VDAC was low indicating 
that the Bax-enhanced sucrose uptake by VDAC liposomes was mediated not by a 
putative Bax channel but by the effect of Bax on VDAC (Shimizu et al., 1999). Further 
work by the same group showed that Bax and VDAC are capable of forming a large 
pore that was permeable to cytochrome c (Shimizu et al., 2000). However, this pore 
was not wide enough to allow the efflux of proteins larger than cytochrome c. The anti- 
apoptotic protein Bcl-XL can also interact directly with VDAC (Shimizu et al., 1999). 
Studies have shown that Bax and Bc1-Xl function antagonistically to each other, Bcl-XL 
closes VDACs whereas Bax opens them (Shimizu et al., 2000).
An alternative hypothesis concerning the role of VDAC in OMM permeabilisation was 
put forward by Vander Heiden and co-workers (Vander Heiden et al., 1999) in which 
VDAC closure causes a defect in ATP/ADP exchange, inhibition of the Fi Fo-ATPase, 
hyperpolerisation of the IMM followed by a loss of OMM integrity and cytochrome c 
release. The change in mitochondrial membrane potential may result from a failure of
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the VDAC in the OMM bound to ANT in the EMM (see section [1.8.4] for 
intermembrane junctional complexes) to mediate ATP/ADP exchange. Contrary to 
Shimizu and co-workers, Vander Heiden found that Bc1-2/Bc1-Xl expression prevented 
VDAC closure and the subsequent build up of ATP and creatine phosphate in the IMS 
leading to secondary mitochondrial dysfunction and cytochrome c release (Vander 
Heiden et al., 1999). Furthermore Bc1-Xl permitted growth factor-deprived cells to 
maintain sufficient mitochondrial ATP/ADP exchange to sustain coupled respiration 
and that mitochondrial adenylate transport was under active regulation.
More recently, it was shown that Bid and not Bax regulates VDACs (Rostovtseva et al., 
2004). This study contradicts previous work by Shimizu and co-workers that 
demonstrated Bid induces cytochrome c release but not as a result a direct interaction 
with VDAC (Shimizu et al., 1999, Shimizu et al., 2001). Rostovtsera and co-workers 
(Rostovtseva et al., 2004) studied the effects of Bax and Bid on the properties of 
VDACs reconstituted into planar phospholipid membranes. Full-length recombinant 
Bax in the monomeric and detergent-induced oligomeric forms were used. 
Recombinant Bid was activated by cleavage with caspase-8 . They showed that the 
addition of Bax had no effect on VDAC and it was concluded that Bax does not induce 
cytochrome c release by acting on VDAC. In contrast they showed that cleaved Bid 
induces the closure of VDACs and it was proposed that the Bid-induced reduction of 
the permeability of VDACs might interfere with metabolite exchange between 
mitochondria and cytosol leading to an accumulation of products of mitochondrial
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activity within the IMS, generation of an osmotic gradient, and matrix swelling 
followed by the rupture of the OMM.
[1,8,3] Bax interacts with ANT to induce cytochrome c release
ANT is a homodimer consisting of 32 kDa subunits in the IMM. One of its functions is 
to catalyse the one to one exchange of cytosolic ADP against matrix ATP across the 
IMM (Fiore et al., 1998 and references therein). Immunological and molecular biological 
techniques have shown there are three isoforms in humans and two in rat (Doemer et al.,
1997). A study of the distribution of the isoforms in rat showed that ANT-1 is found 
predominantly in the skeletal muscle, heart and brain whereas ANT-2 is found 
predominantly in the kidney, spleen and liver (Domer et al., 1999). In a recent study by 
Brdiczka and co-workers ANT isoforms were found to have different distributions in the 
IMM and have different affinities for the matrix protein cyclophilin D (Cyp D) (see 
section [1.8.5] for the MPT-pore) (Vyssokikh et al., 2001). They found that the cristae 
contained ANT-2 only and both isoforms were found in the peripheral inner membrane. 
In addition, ANT-1 was found to have a higher affinity for Cyp D.
Previous studies have also implicated ANT in the release of apoptogenic proteins from 
the IMS. Bax and ANT coimmunoprecipitated from tissue extracts derived from rat 
brain, mouse liver and human HT-29 colon cancer cells (Marzo et al., 1998b). Other 
work shows that Bax and ANT interact to form a non-specific pore and Bcl-2 
suppresses pore-formation (Brenner et al., 2000, Jacotot et al., 2001). In addition Bax
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and Bcl-2 also influence the enzymatic activity of ANT as an ADP/ATP antiporter 
(Belzacq et al., 2003). Recent data has shown that a-helices -5 and - 6  of Bax were 
shown to mediate the insertion of Bax into the OMM (Heimlich et al., 2004) and 
therefore it is possible that Bax inserted into the OMM may interact directly with ANT 
in the IMM.
[1.8,4] Bax interacts with intermembrane junctional complexes to bring about 
permeabilisation o f the OMM
Regions of contact between the OMM and IMM were first observed using electron 
microscopy (Hackenbrock, 1968). When mitochondria are suspended in hypertonic 
media the matrix space enclosed by the EMM shrinks in size and pulls away from the 
OMM, but regions of contact between the OMM and EMM remain. It is estimated that 
isolated rat liver mitochondria, for example, contain about 1 0 0  intermembrane contact 
sites per mitochondrion (Reichert & Neupert, 2002). Contact sites are formed by 
interactions between IMM and OMM proteins and participate in various functions. 
These include the translocation of newly synthsised proteins into mitochondria, 
mitochondrial fission/fusion events, metabolic transfer, and interaction with Bcl-2 
proteins during apoptosis. Certain contact sites are held together quite strongly and 
resist sonication and mitochondrial subfractionation. In this way membrane fractions 
of intermediate density between the inner and outer membranes have been isolated on 
density gradients. The composition of these intermediate-density fractions is thought to 
reflect the composition of certain types of contact sites. VDAC and ANT have been
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shown to be components of contact sites (Brdiczka, 1991). Other proteins that have 
been localised to these regions include hexokinase (Kottke et al., 1988), creatine kinase 
(Papadopoulos et al., 1999, West et al., 2001), the peripheral benzodiazapine receptor 
(PBR) which regulates the transfer of cholesterol from the OMM to the IMM, Cyp D in 
the matrix binds ANT in the contact sites and can form the mitochondrial permeability 
transition pore (MPT) complex (Crompton et al., 1998) (see section [1.8.4]) and Bcl-2 
proteins (De Jong et al., 1994, Crompton et al., 2002). In addition contact sites have 
been shown to contain a high proportion of cardiolipin (Ardail et al., 1990). Whether 
all components reside in the same contact site is not known. Perhaps the two 
membrane components, VDAC (OMM) and ANT (IMM) establish a junctional 
complex holding the membranes together and the proteins associate with the complex 
depending on the function to be executed. Recent studies have shown that the binding 
of hexokinase II to VDAC present in contact sites can inhibit Bax-induced cytochrome 
c release and apoptosis (Pastorino et al., 2002). How exactly this is achieved is not 
clear. However, hexokinase II is thought to bind VDAC as a tetramer (Xie & Wilson, 
1990), which would have a molecular weight of 400 kDa. Therefore, it may sterically 
hinder Bax binding to VDAC. How mitochondrial contact sites play a role in the 
permeabilisation of the OMM is not clear. Hexokinase II binding stablises contact sites 
(Pastorino & Hoek, 2003) and Bax binding displaces hexokinase II promoting 
disruption of the contact site complex and facilitating the release of intermembrane pro- 
apoptotic factors, e.g. cytochrome c, through a VDAC-associated channel.
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[1,8.5] Bax interacts with the MPT-pore to induce permeabilisation o f the OMM
Another way in which intermembrane contact sites may play a role in the Bax-induced 
permeabilisation of the OMM is via the formation of the MPT-pore. In the late 1970s 
certain permeability properties of the IMM induced by the presence of Ca2+ were 
proposed to be due to the presence of a transmembrane channel or pore (Hunter & 
Haworth, 1979). Further studies have shown that high inorganic phosphate and high 
matrix calcium levels cause the free permeation of low molecular weight solutes (below 
1500 Da) across the IMM (Al Nasser and Crompton, 1986). In reconstituted systems,
9 -4-Ca alone is sufficient to deform purified ANT into a non-specific pore. This occurs 
reversibly. However, the time required for pore formation and its reversal (minutes) 
(Brustovetsky & Klingenberg, 1996, Brustrovetsky et al., 2002) is considerably slower 
than Ca2+-induced pore opening and its reversal in intact mitochondria (seconds) 
(Crompton & Costi, 1988). This data together with the finding that the Cyp D ligand, 
cyclosporin A (CSA), inhibits MPT-pore opening in intact mitochondria (Crompton et 
al., 1988) provided evidence for Cyp D as a component of the MPT-pore. The 
components of the pore have now been elucidated. Woodfield and co-workers 
demonstrated that ANT and Cyp D play a role in MPT (Woodfield et al., 1998). In 
another study by Crompton and co-workers, VDAC was also implicated in MPT 
(Crompton et al., 1998). It was found that GST-Cyp D attached to a glutathione- 
agarose matrix specifically retained VDAC and ANT. Therefore, a model was 
proposed where Cyp D recruits ANT in the inner membrane, which binds VDAC in the 
outer membrane at the contact sites between the two membranes (Crompton et al.,
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1998). Cyp D, like other cellular cyclophilin isoforms, is a peptidyl-prolyl cis/trans 
isomerase (PPIase) that catalyses the interconversion of cis and trans isomers of bonds 
preceding proline in a peptide chain. The Cyp D isoform is a 21 kDa nuclear encoded 
protein that contains a N-terminal presequence that targets the protein to the 
mitochondria (Bergsma et al., 1991). Later it was shown that Cyp D is present in the 
mitochondrial matrix (Johnson et al., 1999). It is thought agents which trigger MPT- 
pore opening do so by causing Cyp D to bind to ANT, for example, oxidative stress 
(Halestrap et al., 1997) and Ca2+ (Halestrap and Davidson, 1990). The physiological 
role of pore remains unclear. It is thought that the MPT-pore plays a role in the 
pathogenesis of ischaemic/reperfusion type injury (reviewed in Crompton, 1999). 
MPT-pore opening has been detected in vivo during myocardial reperfusion injury 
associated with tissue Ca2+ overload and oxidative stress (Griffiths & Halestrap, 1995) 
and oxidant stress (hydroperoxide) induced injury in hepatocytes (Nieminen et al., 
1995). The MPT- pore inhibitor CSA was shown to provide protection against 
hydroperoxide-induced injury in heart and liver cells (Pastorino et al., 1993, Nazareth et 
al., 1991, Griffiths & Halestrap, 1993). In cell death involving cardiomyocytes, e.g. 
myocardial infarction in humans, both necrosis and apoptosis have been observed 
(Veinot et al., 1997). Apoptosis was considered the predominant form of cell death in 
the border zone between noninfarcted areas and the more severely compromised tissue 
(Veinot et al., 1997).
With regard to the role of the PT-pore in Bax-induced permeabilisation of the OMM, 
the results from various studies have been contradictory. It was hypothesised that Bax
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may interact with the MPT-pore to induce pore-opening that would lead to expansion of 
the mitochondrial matrix and subsequent rupture of the OMM (Loeffler & Kroemer, 
2000). The MPT-pore inhibitor CSA has also been shown to inhibit apoptosis in a 
variety of cells under a range of stimuli. However, Cyp D is one of several cyclophilin 
isoforms which bind CSA with similar affinities e.g. cyclophilin-A (cytosol), 
cyclophilin-B (endoplasmic reticulum). The selective suppression of Cyp A using 
antisense RNA in a neuronal cell line mimicks the capacity of CSA to block apoptosis 
induced by staurosporine, NO and other stimuli (Capano et al., 2002b). In other studies 
using isolated mitochondria the target for CSA can only be Cyp D since this is the only 
cyclophilin that is present in mitochondria (Connem & Halestrap, 1992, Crompton, 
2003). Bax-induced cytochrome c release from isolated mitochondria, in the presence 
of Ca2+ was suppressed by CSA (Narita et al., 1998) but in the absence of calcium it 
was not (von Ahsen et al., 2000). A more recent report has shown that t-Bid-induced 
cytochrome c release from isolated mitochondria was inhibited by CSA (Scorrano et 
al., 2002). Electron microscopy studies revealed that the narrow tubular junctions 
connecting the lumen of the cristae with the intermembrane space opened up under the 
influence of tBid facilitating the cytochrome c diffusion out of the lumen to the outer 
membrane. This study showed that the cytochrome c associated with the IMM would 
need to pass through these junctions to gain access to the OMM, from where it would 
be released into the cytosol. Other studies using isolated mitochondria have shown 
MPT is not involved in the Bax-induced permeabilisation of the OMM. Doran & 
Halestrap (Doran & Halestrap, 2000) reported that Bax dimers were present in Percoll- 
purified rat liver mitochondria and can induce the release of cytochrome c from the
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mitochondria. They showed this process occurs rapidly and without the concomitant 
loss of adenylate kinase indicating that a specific mechanism is involved and therefore 
rupture of the OMM does not occur. They found that dextran which maintains contact 
sites between the OMM and the IMM inhibited cytochrome c release suggesting that 
contact sites may play a role in the regulation of cytochrome c release. In addition their 
results showed that the MPT-pore inhibitor, CSA, did not prevent the release of 
cytochrome c and it was concluded that MPT was not involved in cytochrome c release. 
Another study showed that the addition of Bax to rat heart mitochondria lead to the 
uncoupling and inhibition of respiration without MPT occurring (Appaix et al., 2002). 
The effects of full-length and C-terminally truncated Bax on respiration rate, membrane 
potential, MgATPase activity and the kinetics of the regulation of respiration were 
studied in isolated rat heart mitochondria and permeabilised cardiomyocytes. It was 
concluded that full-length Bax affects the OMM and the IMM in three different ways. 
The first is by causing the opening of pores in the OMM. The second is by inhibiting 
some segments of the respiratory chain and the third by uncoupling the IMM by 
increasing proton leak without opening of the MPT-pore. Their results showed that the 
MPT-pore inhibitor CSA prevented none of these Bax-induced effects.
Different mechanisms for the release of apoptogenic proteins from the EMS may 
operate depending on the pathology involved. The MPT-pore may be a more relevant 
mechanism in conditions such as ischaemia/reperfusion injury when there are rises in 
intracellular Ca2+ levels and reactive oxygen species (ROS), which activate MPT. 
However, the question remains unanswered as to whether the rupture of the OMM and
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release of apoptogenic proteins is mediated by Bax binding to MPT-pores or whether 
induction of the MPT by Ca is sufficient to cause lysis of the OMM and the release of 
proteins from the IMS. In neurodegenerative disorders such as strokes, the glutamate 
receptors are overstimulated leading to prolonged increases in cytosolic Ca2+which can 
lead to the release of cytochrome c (Sugawara et al., 1999). A later study showed that 
this calcium-induced cytochrome c release from CNS mitochondria was the result of 
MPT and rupture of the OMM (Bustrovetsky et al., 2002). However, this study did not 
investigate whether or not Bax or any other Bcl-2 protein played a role in the 
permeabilisation of the OMM. In another study Cao and co-workers (Cao et al., 2001) 
demonstrated that Bax translocates from the cytosol to the mitochondria in rat neurons 
after transient cerebral ischaemia. This study showed that the ANT ligand, bongkrekic 
acid, prevented the co-immunoprecipitation of Bax and ANT and Bax triggered pro- 
caspase-9 release from the IMS of isolated brain mitochondria. These results clearly 
showed that Bax participated in apoptosis in ischaemic rat neurons but the role the 
MPT might play in this process was not investigated.
[1.8.6] Bax-induced permeabilisation o f the OMM and mitochondrial fission/fusion
Mitochondria are capable of forming interconnected networks which are regulated by a 
dynamic balance of organelle fusion and fission (Mozdy & Shaw, 2003; Scott et al., 
2003). Recent studies have suggested that these processes are involved in the 
regulation of apoptosis. In mammalian cells in the early stages apoptosis the 
mitochondrial network is destroyed (Frank et al., 2001; Karbowski & Youle, 2003). 
The precise mechanism by which apoptotic fragmentation of the mitochondria occurs is
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not known, however, it is thought to be dependent on the activation or fission (Frank et 
al., 2001; Breckenridge et al., 2003) or an inhibition of fusion (Karbowski et al., 2004) 
or perhaps a combination of both. During apoptosis Bax and Bak translocate to the 
mitochondria and co-localise with proteins involved in mitochondrial dynamics (Frank 
et al., 2001; Breckenridge et al., 2003), for example, Drp 1 (Smirnova et al., 1998) 
which is a dynamin-related GTPase involved in fission and Mfh which is involved in 
fusion (Ishihara et al., 2003, Santel & Fuller, 2001). One explanation as to how the 
mitochondrial fusion/fission balance affects apoptosis is that fission and fusion events 
alter the mitochondrial lipid composition that can influence apoptosis. It has been 
reported that cardiolipin is required for Bax mediated permeabilisation of liposomes 
(Kuwana et al., 2002) and for the functioning of tBid (Lutter et al., 2000). Changes in 
mitochondrial dynamics may alter the cardiolipin content of the OMM making it more 
susceptible to Bax-induced permeabilisation.
[1.9] Apoptosis and ischaemia in cardiomyocytes
Cardiomyocytes are contractile cells of the heart that are terminally differentiated. 
Although recently it was shown that a subpopulation of cardiomyocytes might re-enter 
the cell cycle (Anversa et al., 2002), it is unlikely that this is sufficient to compensate 
for any substantial loss of these cells. Therefore cardiomyocyte cell death as a result of 
ischaemic/reperfusion injury, for example, has a significant impact on cardiac function. 
One of the main insults that are thought to lead to cell death is oxidative stress. 
Reactive oxygen species (ROS) are produced in the ischaemic heart (Vanden Hoek et
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al., 1997, Becker et al., 1999) and these are substantially increased following 
reperfusion (Ferrari et al., 1998). In vivo ROS can be produced by inflammatory cells 
(Duilio et al., 2001) but in cardiomyocytes subjected to simulated ischaemia 
mitochondria are the main source (Becker et al., 1999). Recently a correlation between 
increased ROS production and cardiomyocyte apoptosis has been reported (Qin et al.,
2003). Ischaemic/reperfusion injury can result in cell death by either necrosis or 
apoptosis. In addition, cardiomyocyte cell death sharing features of apoptosis and 
necrosis has been reported (Leist & Jaattela, 2001). The opening of MPT-pores is a key 
event in ischaemic/reperfusion injury (reviewed in Halestrap et al., 2004) and can lead 
to necrotic cell death or apoptosis. Under normal physiological conditions MPT-pores 
are closed and the IMM is permeable to a few selected metabolites and ions. However 
under pathological conditions which give rise to increased intramitochondrial calcium 
and ROS, the MPT-pores open and this has two major consequences. Firstly, although 
small molecular weight solutes move freely across the IMM, proteins are retained 
within the matrix and as a result exert a colloidal osmotic pressure that causes 
mitochondria to swell. The unfolding of the cristae allows the matrix to expand without 
rupture of the IMM, the OMM breaks and this will lead to the release of proteins from 
the IMS. Secondly the IMM becomes freely permeable to protons. This uncouples 
oxidative phosphorylation, causing the proton-translocating ATPase to reverse direction 
and actively hydrolyse ATP. Under such conditions, intracellular ATP concentrations 
rapidly decline, leading to the disruption of ionic and metabolic homeostasis and the 
activation degradative enzymes such as phospholipases, nuclease, and proteases. These 
changes cause irreversible damage and lead to necrotic cell death (Halestrap et al.,
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2004). However, if the pathological insult is less severe and MPT-pore opening is 
transient, ATP levels may be maintained and the cells may recover. Another outcome, 
apoptotic cell death may occur if MTP-pore opening occurs in some of the 
mitochondria within a cell but not others so that ATP levels are maintained but rupture 
of the OMM occurs resulting in the release of apoptogenic proteins from the IMS. The 
role that Bax plays in apoptosis occurring under these conditions has not been fully 
investigated. Previous in vitro studies by Pastorino and co-workers showed that Bax 
was capable of inducing MPT in isolated mitochondria in the presence of calcium 
(Pastorino et al., 1999). Therefore it is possible that Bax and Ca2+ may act 
synergistically to induce the release of apoptogenic proteins from the IMS in 
ischaemic/anoxic-induced apoptosis.
The work in this thesis is aimed at determining which mitochondrial membrane 
proteins interact with Bax during apoptosis. In particular in vitro studies with GST-Bax 
were used to determine whether or not Bax could interact with reconstituted 
components of the MPT-pore complex, VDAC, ANT and Cyp D. Only then could the 
MPT-pore complex be implicated as a mechanism for Bax-induced permeabilisation of 
the OMM. Rat cardiomyocytes were transfected with GFP-Bax and treated with 
sodium cyanide to induce simulated ischaemia. A time-course of GFP-Bax 
translocation from the cytosol to the mitochondria was observed in single 
cardiomyocytes using fluorescence microscopy. Other work presented in this thesis 
focuses on a novel method used in an attempt to identify the mitochondrial calcium 
uniporter protein responsible for the transport of Ca across the IMM.
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The specific aims of each of the results chapters are:
Chapter 3:
To obtain pure recombinant GST or His6-tagged full-length Bax, C-terminally truncated 
Bax (BaxAc) and Bc1-Xl
Chapter 4:
To show that the GST-tagged Bax proteins were biologically active by inducing 
cytochrome c release from isolated mitochondria.
To examine Bax interaction with the mitochondrial membrane proteins VDAC and 
ANT in vitro.
To find out if Bax-VDAC-ANT interactions were affected by the removal of the 
hydrophobic C-terminus of Bax.
To examine the effects of different detergents on VDAC/ANT binding to Bax 
To examine the effects of Bc1-Xl, atractyloside and bongkrekate on VDAC/ANT 
binding to Bax
Chapter 5
To examine GFP-Bax translocation from the cytosol to mitochondria in single primary 
rat cardiomyocytes during apoptosis induced by sodium cyanide using fluorescence 
microscopy
To determine whether VDAC, ANT and Cyp D co-immunoprecipitate with GFP-Bax 
localised to mitochondria in rat cardiomyocytes treated with sodium cyanide
Chapter 6
To identify the calcium uniporter in rat liver mitochondria
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Chapter 2: Materials and Methods
[2.1] Materials
The Hanks balanced salt solution used in the preparation of the rat cardiomyocytes was 
obtained from Gibco-BRL and the M l99 medium used for the culture of the rat 
cardiomyocytes was produced by Sigma. Plasmids pQE-31 and pQE-60 contained 
human bax and 3’ truncated baxAc (which lacks the nucleotide sequences coding for the 
C-terminal 22 amino acids) respectively. Bax was ligated into the Bam HI and Sac I  
sites. BaxAc was ligated into the Nco I  and Bgl II sites. Human bcl-XL was ligated into 
the Bam HI and Bgl II  sites of pQE-60. The full-length recombinant Bax protein 
contains the hexahisitidine tag at the N-terminus. BaxAc and Bcl-XL contain the tag at 
the C-terminus. These plasmids were obtained from Dr. John Ward, Department of 
Biochemistry and Molecular Biology, UCL. The GFP-Bax construct was a gift from 
Michela Capano in this laboratory (Capano & Crompton, 2002). Full-length bax cDNA 
was ligated into the Hindlll and EcoRl restriction sites of pEGFP-C3. The pGEX-3X 
plasmid containing cyp D (rat) cDNA was produced by Dr. Sukaina Viiji in this 
laboratory (Crompton et al., 1998). The cyp D lacked the pre-sequence encoding the 
mitochondrial targeting sequence and was ligated into the BamHI and EcoRI.
The nucleotide triphosphates (dNTP), primers and pfu polymerase were obtained from 
Pharmacia Biotech, and the DMSO, ethidium bromide and markers for agarose gel 
electrophoresis (phage X digested with Pst I) were from Sigma. The pGEX-3X was 
from Amersham Pharmacia. Restriction enzymes and the T4 ligase were from New
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England Biolabs. The pQE-31 and pQE-60 plasmids were produced by Qiagen and the 
pEGF-C3 plasmid was obtained from Clonetech.
Lipofectamine 2000 reagent was obtained from Life Technologies, Paisley, Scotland. 
The Nonidet-P40, agarose-glutathione (GSH), reduced GSH, protease inhibitor cocktail 
and imidazole were obtained from Sigma. Columns used for GST-Bax purification 
were from Pierce. The nitrilotriacetic acid (NTA) column (5ml) and the anion- 
exchange column, Mono Q HR 5/5 (1ml), were obtained from Amersham Pharmacia. 
The BCA protein assay reagents were supplied by Pierce. SDS-PAGE was carried out 
using the SE 250-Mighty Small II Slab Gel Electrophoresis unit, Hoeffer Scientific 
Instruments, San Francisco. Nitrocellulose sheets were obtained from Schleicher and 
Schuell, Dassel, Germany. Enhanced chemiluminescence reagents (ECL) were 
obtained from Amersham Pharmacia and X-ray film from Fujifilm. Anti-human 
antibodies to Bax (monoclonal)(6A7), Bcl-XL (polyclonal) and cytochrome c 
(monoclonal) (clone 7H8.2C12) were obtained from Pharmingen, CA. Anti-human 
monoclonal VDAC antibody clone 31HL was obtained from Calbiochem. Anti-rat 
polyclonal antibody was raised against the peptide YDEIKKYV, corresponding to the 
C-terminus of rat ANT-1. The polyclonal anti-Cyp D antibody was raised against the 
peptide CSDGGARGANSSSQNP, corresponding to the amino acids 1-16 after 
cleavage of the mitochondrial targeting sequence. Both of these antibodies were 
produced by Dr. Veronica Doyle in the laboratory. The secondary antibodies were both 
polyclonal. An anti-mouse IgG conjugated with horse-radish peroxidase was used to 
detect the primary monoclonal antibodies and this was from Calbiochem. An anti­
rabbit IgG conjugated with horse-radish peroxidase was used to detect the primary
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polyclonal antibodies ANT and CypD. Anti-GFP monoclonal antibody (clone 1E4) was 
obtained from MBL laboratories, Nagoya, Japan. Factor Xa used to cleave GST-Bax 
was obtained from Amersham Biosciences. MitoTracker red used for fluorescence 
microscopy was supplied by Molecular Probes. The atractyloside was obtained from 
Sigma and the bongkrekic acid from Calbiochem.
[2.2] Cell culture and transfection
Primary cultures of cardiomyocytes were prepared from 14 day-old Sprague-Dawley 
rats and seeded on to laminin-coated glass coverslips according to the method used by 
Doyle et al. (Doyle et al., 1999). Briefly, rats were sacrificed by cervical dislocation 
and their hearts removed, chopped finely and incubated with 5ml of Hanks balanced salt 
solution containing 0.8mg/ml collagenase II, 20pg/ml DNase II, 20units/ml penicillin, 
2 0 pg/ml streptomyocin, ImM taurine, 40pM CaCh for 15 minutes at 35°C. The 
procedure was repeated 3 times, each time with fresh medium. After gentle 
centrifugation, cells (approximately 107) were resuspended in M l99 culture medium 
containing 2 0 units/ml penicillin, 2 0 pg/ml streptomyocin, 2 pg/ml vitamin B12, and 1 0 % 
v/v fetal calf serum. The cells were then subsequently seeded onto laminin-treated glass 
coverslips at a density of 5xl05 cells/ 0.5ml and incubated in an atmosphere of CO2/ air 
(1:19) at 37°C. After 3 hours, lpM cytosine arabinoside was added to limit the growth 
of fibroblasts (Tanaka et al., 1994). Cells were transfected with pEGFP-C3-bax after 2 
days of culture, replacing the medium with fresh culture media after 5 hours incubation. 
Optimum transfection was obtained with lpg of plasmid DNA and 3 pi of
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Lipofectamine per coverslip. Cells were used for fluorescence microcopy 1-2 days after 
transfection.
[2.3] Subcloning bax and baxAc into pGEX
[2,3.1] PCR to obtain bax and baxAc
PCR was used to amplify bax and baxAc present in the pQE-31 and pQE-60 plasmid, 
respectively. Each 50pl reaction contained: 2ng of template DNA, lOpmol of each 
primer, lpmol of dNTP, 5pi of lOx buffer, 2.5 units of pfu polymerase and 5% w/v 
DMSO. The complete reaction mix minus polymerase was preheated to 99°C for 3 
minutes before addition of the polymerase and subjection to the following PCR 
protocol: denaturation for 1 minute at 95°C, annealing for 1 minute at 65°C and 
elongation for 1 minute 30 seconds at 72°C. This cycle was repeated 28 times followed 
by a final elongation step at 72°C for 5 minutes. The primers were designed to be 
complementary to the 5’ and the 3’ termini of bax and baxAc. The forward primers 
contained a Sma 1/ Xma I  site and the reverse primer an EcoRI site to enable the PCR 
product to be ligated into the pGEX-3X vector.
The primer sequences used were:
bax forward primer- 5’-TGACCCCGGGATGGACGGGTCCGGGGAGCA 3’ 
baxAc reverse primer-5’- TGACGAATTCTTACTGCCAAGTGGGGCGTCCAA 3’ 
bax reverse primer-5’- CGCTCAGAATTCTCAGCCCATCTTCTTCCACATG 3’
The restriction sites within the primers are shown in bold.
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[2,3,2] Ligation into pGEX-3X
The plasmid vector pGEX-3X contained the gst (glutathione-s-transferase) gene 
between the transcriptional start site and a multiple cloning site, enabling a gst gene 
fusion to be created after ligation with the PCR product. The PCR products and pGEX- 
3X were digested with Eco RI and Xma I. The latter is an isoschizomer of Sma I  
producing “sticky ends”, which increases the efficiency of the ligation reaction 
compared to a blunt end ligation if Sma I  was used. The digest (20pl) contained: PCR 
product and pGEX-3X (3:1), Xma I  buffer, 20 units of Xma I  and 20 units of Eco RI. 
Digests were incubated at 37°C for 2 hours. The digested pGEX-3X (10% Of each 
digest) was analysed by agarose gel electrophoresis. Gels contained TAE buffer 
(lOOmM Tris-acetate, lOmM EDTA, pH 8.0) and ethidium bromide (lpg/ml) was added 
to molten gels to allow the DNA to be visualised under uv light. Samples were 
prepared for electrophoresis by the addition of lOx sample loading buffer containing 5% 
glycerol, lOOmM Na2 EDTA, 1% w/v SDS and 0.1% bromophenol blue. The DNA was 
approximately quantified by comparison with known amounts of phage X DNA cut with 
Pst I. Digests were denatured with phenol/chloroform (1:1). The upper phase was 
collected and 0.5pi of glycogen solution was added to facilitate pellet identification. 
Ethanol (3 volumes) was added and the tubes were stored at -60°C for 30 minutes to 
precipitate the DNA. The DNA and the glycogen were subsequently pelleted at 10 000 
rpm for 15 minutes, before removal of the ethanol and washing in 70 % ethanol with 
final suspension in 4pl of water. The DNA was ligated by addition of 1 pi of lOx buffer, 
lpl of T4 ligase (10 units) and 4pl of water and incubated at 16°C overnight.
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[2.3.3] Transforming E. coli with recombinant bax - pGEX-3Xplasmids
The ligation mix derived as described above (7pl) was used to transform E.coli XL-blue 
competent cells. A 300pl aliquot of these cells was thawed on ice, the ligation mix was 
added and the cells were kept on ice for 40 minutes. This was followed by a 10-minute 
incubation at 37°C for 1 hour Luria Bertani (LB) broth (1ml) was mixed with the cells 
and the incubation extended for a further 1 hour. The cells were plated on LB-agar 
plates containing lOOpg/ml ampicillin and grown overnight.
[2.3.4] Screening transformants
The plasmid DNA from the positive transformants was prepared using a Qiagen 
miniprep kit followed by digestion with the restriction enzymes Xma I  and Eco RI to cut 
out the bax inserts. The digested DNA was analysed by agarose gel electrophoresis. 
Recombinant plasmids were sequenced to check for errors that may have occurred 
during the amplification of bax.
[2.4] Expression of recombinant proteins
[2.4.1] Expression o f GST-Bax and GST-BaxAc
For expression of GST-BaxAc, a single colony was inoculated into 10 ml of LB 
medium containing 100pg/ml of ampicillin and was left to grow at 37°C overnight. 
This was subsequently used to inoculate 100ml of fresh LB medium, 1 OOpg/ml 
ampicillin. The cells were grown to an OD6oonm of 0.8 and induced with 0.2mM IPTG 
and grown for a further 3 hours before harvesting. For GST-Bax expression, a single
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colony was inoculated into 100ml of Terrific broth (TB) containing lOOpg/ml of 
ampicillin. This medium contained: 12g peptone, 24g yeast extract, 4ml glycerol, 0.17M 
K2PO4 and 0.72M KH2PO4 . The culture was grown at 37°C overnight and expression 
was induced by the addition of lOpM EPTG with cells being cultured for 24 hours at 
22°C before harvesting. To obtain the recombinant protein, cells were resuspended in 
buffer (20ml) containing 50mM HEPES, 50mM NaCl, 0.5mM EDTA, 5mM DTT, 10pl/ 
ml protease inhibitor cocktail, ImM PMSF, 1% Nonidet P-40 detergent, pH 7.3. Cells 
were lysed in this solution by intermittent sonication (20 secs on/ 20 secs off) for a total 
of 6 minutes. The lysate was then centrifuged at 10000 rpm for 5 minutes to pellet the 
bacterial membranes.
[2.4.2] Expression o f GST-Cyp D and GST
A single colony of XL-blue E. coli transformed with pGEX-3X-cy/? D was inoculated 
into 10ml of LB medium containing lOOpg/ml of ampicillin and was left to grow at 
37°C overnight. Fresh LB medium (10ml) containing 100pg/ml of ampicillin was 
inoculated with 1ml of the overnight culture. Cells were grown to an OD6oonm of 0.6 and 
GST-Cyp D expression was induced with 0.4mM IPTG and then grown for a further 3 
hours before harvesting. The expression of GST was performed in the same way using 
XL-blue cells transformed with pGEX-3X.
[2.4.3] Expression o f hexahistidine-tagged Bax, BaxAc and Bcl-Xi
Expression was carried out as described for the GST-Bax proteins except 1 litre of 
culture was used instead of 100ml and the cells were induced with ImM IPTG.
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[2.4.4] Purification o f GST-tagged proteins
The GST-tagged proteins were purified using a column (0.5ml) consisting of an 
agarose-bead matrix that had been chemically cross-linked to glutathione after expoxy- 
activation via sulphur atoms and a 12-atom spacer. The bacterial cell lysate was applied 
to a column pre-equilibrated with sonication buffer followed by washing with 5 column- 
volumes of the same buffer. The GST-tagged protein was eluted with 0.5ml of 50mM 
HEPES, 50mM GSH, 50mM NaCl.
[2.4.5] Cleavage o f  GST-Bax
The pGEX-3X plasmid (see figure [3.6]) encodes a factor Xa protease recognition site 
between gst and multiple cloning sites. This enables the cleavage of the fusion protein 
in a single digestion step. The factor Xa solution was prepared using cold water (4°C) 
to give a final concentration of lU/pl. The cleavage of the fusion protein was 
performed whilst GST-Bax was bound to the glutathione-agarose matrix. The matrix 
was washed with 10 bed volumes of factor Xa cleavage buffer containing 50mM Tris- 
HC1, pH 7.5, 150mM NaCl, ImM CaC^. For each ml of glutathione-agarose 50pl of 
factor Xa solution was added to 950pl of cleavage buffer. The glutathione-agarose was 
incubated with the factor Xa for 24 hours at 4°C with gentle agitation. Bax was 
obtained in the supernatant from the glutathione-agarose by centrifugation at 5000 rpm 
for 5 minutes.
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[2,4,6] Purification o f hexahistidine-taggedBaxAc and BcUXL
A pre-packed (5ml) NT A column attached to an FPLC system was chelated with Ni2+ 
ions (NiCb solution, 200mM) to produce an affinity matrix that bound the 
hexahistidine-tag. The bacterial lysate containing BaxAc-His6 or His6-Bcl-XL was 
applied to the column. After washing with 5 volumes (25ml) of buffer containing 
50mM HEPES, 50mM NaCl, pH 7.3, 0.5% Nonidet-P-40, bacterial protease inhibitor 
cocktail (lOpl/ml), the bound proteins were eluted with a two-step imidazole gradient: 
50-150mM over 8ml then 0.15 to 1M over the next 8ml. The eluate from the Ni2+-NTA 
column containing BaxAc-His6 was diluted 25x in buffer containing 50mM MES, 
50mM NaCl, pH 6.0 and applied to a Mono Q HR 5/5 FPLC anion-exchange column 
equilibrated with the same buffer. A NaCl gradient (50-500mM) was used to elute the 
bound proteins. Fractions containing the BaxAc-His6 protein were either dialysed 
against 50mM HEPES, lOOmM NaCl, 30% glycerol w/v, pH 7.3 or were concentrated 
in centricon 30 tubes and diluted with the above buffer. These samples were stored at -
‘j,
60°C. The eluate from the Ni -NTA column containing His6-Bcl-XL was diluted 25x in 
buffer containing 50mM HEPES, 50mM NaCl, pH 7.3 and applied to the Mono Q 
column equilibrated with the same buffer. A NaCl gradient (50-500mM) was used to 
elute the bound proteins. The fractions containing Bc1-Xl were stored in 30% glycerol 
at -60°C
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[2.5] Separation of proteins by Sodium Dodecyl Sulphate- 
Polyacrylamide Gel Electophoresis (SDS-PAGE)
[2.5.1] Reagents for SDS-PAGE
The reagents for SDS-PAGE were prepared as follows: acrylamide solution was made 
by dissolving 48g of acrylamide, 1.5g of N, N’-methylene-bis-acrylamide in water to 
give a final volume of 100ml. The gel buffer contained: 5M Tris-HCl, 0.3% w/v SDS, 
pH 8.45. Anode buffer contained 200mM Tris-HCl, pH 8.9 and cathode buffer 
contained lOOmM Tris, 68mM tricine, 1% w/v SDS, pH 8.2.
The reagents were added together as shown in table [2.1] to make the resolving and 
stacking gels.
Table [2.1] Reagents for SDS-PAGE
Volume (ml)
Stacking gel 
1 %
Resolving gel 
15%
Acrylamide 1 9
Gel buffer 10 10
Glycerol - 3
Water 8.4 7.7
Gels were polymerised by the addition of 30pl 1% w/v APS and 3pi TEMED.
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[2.5.2] Preparation ofprotein samples for loading
Samples were heated at 95°C for 5 minutes in the ratio 3:1 with sample buffer 
containing 0.125mM Tris-HCl pH 6.8, 2mM EDTA, 6% SDS, 20% glycerol, 0.025% 
bromophenol blue and 5% P-mercaptoethanol.
[2.5.3] Electrophoresis
Electrophoresis was carried out at 20mA (current limiting) until the dye front moved 
into the resolving gel and then 40mA until the dye front had reached the bottom of the 
gel.
[2.5.4] Coomassie staining
Gels were fixed for 30 minutes in 50% v/v methanol, 10% v/v glacial acetic acid and 
were stained in a solution containing 0.02% w/v Coomassie-Brilliant Blue in 10% v/v 
glacial acetic acid for 2 hours. The gels were destained in four successive washes of 
destaining solution containing 10% glacial acetic acid and 40% v/v methanol over 4 
hours.
[2.5.5] Silver staining
The gels were fixed as described above. Gels were subsequently soaked in water for at 
least 1 hour with 3 changes of water. The silver stain was prepared from 21ml of NaOH 
(0.36% w/v), 1.4ml of NH4OH (30%), 4ml of AgN03 (20%) and 100ml of water. Gels
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were soaked in this solution for 15 minutes and then rinsed in water. The proteins were 
visualised with developing solution containing: citric acid (0.005% w/v) and 
formaldehyde (0.019% v/v). Gels were placed in acetic acid (1% v/v) to stop further 
colour development.
[2.6] Western blotting
[2.6.1] Transfer ofproteins from a gel onto nitrocellulose
The gels and nitrocellulose membranes were placed between 6 sheets of Whatmann 
filter paper soaked in transfer buffer containing: 144mM Tris, 117mM glycine, 
methanol (20% v/v) and SDS (0.1%w/v), pH 9.2. The transfer of proteins from the gel 
to the nitrocellulose was carried out by a Biorad wet transfer unit at 100V for 1 hour 30 
minutes at room temperature.
[2.6.2] Probing the nitrocellulose membranes with antibodies
The nitrocellose membranes were blocked with non-fat dried milk (Marvel, 8% w/v) in 
phosphate buffered saline (PBS) and Tween 20 (0.1%v/v) for 1 hour at room 
temperature. Membranes were then washed in PBS, Tween 20 (0.1% v/v) for 15 
minutes and twice for 5 minutes at room temperature. The antibodies were diluted in 
PBS containing non-fat dried milk (3% w/v), Tween 20 (0.1% v/v) to give the following 
concentrations: Bax- 0.66jig/ml, Bc1-Xl- 0.7pg/ml, cytochrome c- 0.5pg/ml, VDAC- 
lpg/ml. ANT and Cyp D antibodies were diluted 5000x and 3000x, respectively. The 
anti-mouse IgG was diluted to give a final concentration of 0.5pg/ml and the anti-rabbit 
IgG to 0.67pg/ml. The membranes were probed with the primary antibody for 1 hour at
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room temperature and were washed for 15 minutes followed by two 5 minute washes 
before the addition of the secondary antibody for 1 hour at room temperature. After 
final washing the blots were developed using ECL reagents and X-ray film. As an 
alternative to X-ray film a Fuji-LAS 100 phosphoimaging system was sometimes used.
[2.6.3] Assay for cytochrome c release
Rat heart mitochondria were isolated as described in section [2.7.1] and resuspended in 
respiratory buffer containing ImM glutamate and ImM malate. GST-BaxAc, in buffer 
containing 50mM HEPES, lOOmM NaCl, 0.5mM EDTA, 5mM DTT, 10pl/ ml protease 
inhibitor cocktail, ImM PMSF, pH7.3, was added at 125nM, 250nM, 500nM and lpM 
to the mitochondria and incubated at 37°C for 15 minutes. The mitochondria were 
pelleted and the supernatant was filtered using a 0.2pM Millipore filter. The proteins in 
the pellets and supernatant were separated by SDS-PAGE and cytochrome c was 
detected by Western blotting.
[2.6.4] BCA Protein assay
GST-BaxAc was quantified using the BCA protein assay using known concentrations of 
BSA standards. Each well of the microtitre plate contained: 25 pi of each standard or 
unknown sample and 200pl of working reagent. The working reagent was prepared by 
mixing 50 parts of BCA reagent A and 1 part of BCA reagent B. The contents of each 
well were mixed and the plate was incubated at 37°C for 30 minutes. The absorbance 
of each well was read at 562nm. A standard curve of absorbance at 562nm against the
65
Chapter 2: Materials and Methods
protein concentration for the BSA standards was used to calculate the concentration of 
the GST-BaxAc.
[2.7] Preparation of rat heart mitochondria and mitochondrial 
membranes
12.7.1] Rat heart mitochondria
Mitochondria were isolated from the hearts of male Sprague-Dawley rats (200-300 g 
body weight) using the following protocol. Rats were sacrificed by cervical dislocation 
and their hearts removed and placed into an ice-cold solution of 210mM mannitol, 
70mM Tris-HCl, ImM EDTA and 0.5mg/ml BSA (bovine serum albumin) (MSTEB) at 
pH 7.2. The hearts were chopped into small pieces with a pair of scissors and 
transferred to a 30 ml centrifuge tube (1 tube for each heart) and homogenised for 
approximately 10 seconds using a Polytron homogeniser. The polytron probe was pre­
cooled to 4°C before use. Samples were centrifuged at 1800 rpm for 5 minutes in a 
refrigerated superspeed centrifuge, Sorvall RC5B (rotor-SS34) at 4°C. Supernatant 
fluids were decanted into new 30ml tubes and centrifuged at 7500 rpm for 8 minutes to 
sediment the mitochondria. The pellets were then washed by resuspending in a small 
volume of ice-cold 210mM mannitol, 70mM sucrose, lOmM Tris-HCl (MST) pH 7.2 
using a glass test-tube filled with crushed ice. The volumes were made up to 30ml with 
ice-cold MST before further centrifugation at 1800rpm for 5 minutes at 4°C. Pellets 
were then washed as before; another centrifugation step carried out at 7500rpm for 8 
minutes at 4°C before the mitochondrial pellets were finally resuspended in MST at 
around 10 mg/ml of protein and kept on ice until ready for use.
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[2.7.2] Quantification o f mitochondrial protein
Protein was estimated by a modified biuret method (Kroger & Klingenberg, 1966). 
BSA was used as a standard. Each cuvette contained: 0.5ml of sample, 0.5ml of water, 
0.2 ml of 4 % sodium cholate, 2 ml of 10% sodium hydroxide and 0.3 ml of 1% copper 
(II) sulphate. The reactions were mixed and left to stand for 10 minutes, after which the 
absorbance of the sample was read against the blank at 540 nm.
[2.7.3] Preparation o f mitochondrial membranes
Lysosomal membrane contamination was removed from isolated mitochondria using 
digitonin. This detergent is a naturally occurring steroid glycoside that binds to and 
extracts cholesterol. At lower concentrations (0.0125mg/mg of mitochondrial protein) it 
selectively removes the lysosomal membranes that contain more cholesterol than the 
mitochondrial membranes. When higher concentrations of digitonin are used (above 
0.2mg/mg of mitochondrial protein) the outer mitochondrial membrane is selectively 
lysed whilst leaving the inner mitochondrial membrane intact. Membrane lysis is not 
only dependent on the concentration of digitonin used but also on the protein 
concentration. At lower protein concentrations (<20mg/ml) the efficiency of outer 
membrane removal is substantially reduced (Boyer et al., 1994).
After protein quantification, mitochondrial suspensions were diluted to 2mg/ml in MST 
and digitonin was added (0.06mg/mg of mitochondrial protein) before the suspensions 
were incubated on ice for 15 minutes. Mitochondria were centrifuged at 8000 rpm for 
10 minutes and were resuspended in buffer containing: 50mM HEPES, lOOmM NaCl,
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ImM PMSF, 0.5mM DTT, ImM leupeptin, ImM antipain, ImM pepstatin, pH 7.3. 
Sonication was used to lyse the mitochondria and was carried out intermittently (lOsecs 
on /10 secs off) for a total of 6 minutes. The mitochondrial membranes were pelleted in 
a Beckman 7L ultracentrifuge (70 Ti rotor) at 40 000 rpm for 30 minutes and the pellets 
stored at -60 °C until use.
[2.7.4] Detergent extraction o f membrane proteins from the mitochondrial 
membranes
Proteins in the mitochondrial membranes were extracted using CHAPS or Nonidet P-40 
detergent. A mitochondrial membrane pellet containing approximately 20-3Omg of 
protein was added to 2ml of buffer containing: 50mM HEPES, lOOmM NaCl, ImM 
ATP, ImM MgCb, ImM PMSF, 6% w/v CHAPS and 5mM final concentration of a 
broad range protease inhibitor cocktail. The membrane pellet was placed in a hand-held 
glass homogeniser and homogenised for 5 minutes and then left on ice 45 minutes. The 
extract was then centrifuged at 10 OOOrpm for 15 minutes and the pellet discarded. 
Atractyloside (50|o,M), bongkrekic acid (50jjM) or His-Bcl-Xi/Bax (125ng) was added 
to 50pl of the solubilised mitochondrial membrane proteins (0.25mg of mitochondrial 
membrane proteins) before addition to the immobilised fusion protein (section [2.7.5]).
[2.7.5] Addition o f the mitochondrial membrane extract to GST-Bax, GST-BaxAc and 
GST-Cyp D
The fusion proteins were immobilised on the agarose-GSH matrix as described in 
section [2.4.3]. Matrix (50|o.l), which consisted of agarose-GSH-GST-Bax or truncated
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Bax or Cyp D instead of full-length Bax, was placed in Eppendorf tubes with the 50pl 
of supernatant described above. The matrix was washed with 600pl of wash buffer 
containing: 50mM NaCl, lOmM HEPES, 25% glycerol, ImM EGTA, 8pM ADP, 8pM 
ATP, 8mM DTT and 0.5mM MgCb and this was repeated 5 times. Proteins that bound 
the agarose-GSH were eluted with 50pl of 50mM GSH, 50mM NaCl, pH 7.3 and were 
analysed by SDS-PAGE and Western blotting.
[2.8] Immunoprecipitation
GFP-Bax was immunoprecipitated from cell extracts using an anti-GFP monoclonal 
antibody coupled to Sepharose beads. The coupling was carried out by incubating 30pg 
of antibody with 30mg of CNBr-activated Sepharose 4B in 0.5M NaH2P0 4  and 1M 
NaCl, and left overnight in lOOmM ethanolamine, pH 7.5 at 4°C. Cell extracts for 
immunoprecipitation were prepared by scraping the cells from the coverslips into lysis 
medium containing: lOmM HEPES, lOOmM NaCl, ImM EGTA, ImM MgCb, ImM 
KH2PO4, 6% w/v CHAPS, ImM PMSF, pH 7.4 and 2 jig/ml of each of the protease 
inhibitors aprotinin, pepstatin, leupeptin and antipain. Extracts were centrifuged at 
12000 rpm for 5 minutes and each supernatant was gently shaken with 50pl of anti- 
GFP-antibody-coupled Sepharose for 2 hours at 4°C. The supernatant from each 
incubation was retained and the sepharose beads were washed 6 times in lysis buffer. 
The beads were then extracted with SDS sample loading buffer at 90°C for 3 minutes. 
The immunoprecipitated proteins were analysed by SDS-PAGE and Western blotting to 
detect whether VDAC was present. Blots were subsequently stripped and then re­
probed to detect if ANT and Cyp D were present in the immunoprecipitated extract.
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The nitrocellulose membranes were incubated at 50°C for 30 minutes in stripping buffer 
containing lOOmM 2-mercaptoethanol, 2% w/v SDS, 62.5mM Tris-HCl, pH 6.7and 
then washed in PBS-Tween twice for 20 minutes. After blocking for 1 hour in non-fat 
dried milk (Marvel) 5% w/v the membranes were probed with anti-ANT or anti-Cyp D 
antibody (see section [2 .6 .2 ]).
[2.9] Fluorescence imaging
Cells on coverslips were incubated in lOOmM NaCl, 4mM KC1, 24mM HEPES, ImM 
MgSC>4 , ImM CaCl2 , ImM KH2PO4 , pH 7.4. Mitochondria were sometimes visualised 
with MitoTracker red before the induction of apoptosis with ImM NaCN. For dual 
imaging, loading with MitoTracker Red was kept as low as possible i.e. lOng/ml, 10 
minutes at room temperature. Images were obtained with an Olympus 1X-70, 
fluorescence microscope (Micromax 140IE; Princeton Instruments) fitted with a cooled 
CCD camera and an excitation filter wheel (Sutter) with band-pass filters for the 
excitation of GFP (490nm) and the excitation of MitoTracker Red (570nm). 
Fluorescent light was collected via a poly chromic beamsplitter (51006 bs; Chroma) and 
a two-band-pass emission filter in the filter cube (530nm, 635nm; Chroma). The 
appropriate emission band was then selected by band-pass filters in a simple slider in 
the emission light path. Data was analysed by Metamorph Software (Universal 
Imaging) which allowed calculation of mean and S.D of the pixel intensities within 
individual cardiomyocytes.
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[2.10] Ru 360 and the mitochondrial calcium uniporter
[2.10.1] Preparation ofRu360 from Ruthenium red
Ru 360 has the formula [CH3(NH3)4Ru-0-Ru(NH3)4CH3]3+ and was prepared from a 
commercial preparation of ruthenium red by ion-exchange chromatography using CM- 
cellulose. Ruthenium red (500mg) was dissolved in 200ml of lOOmM ammonium 
formate, pH 5.5, and applied to a 50ml CM-cellulose column pre-equilibrated with the 
same buffer. The ruthenium red was fractionated using an ammonium formate gradient 
(0.1M-1M). Ru360 was detected from its absorption maximum at 360nm (Ying et al., 
1991). Following elution, Ru 360 was lyophilised and stored at -20°C. It was diluted in 
lOmM HEPES, 50mM KC1, pH7.3 before use.
[2.10.2] Ru 360 inhibition o f  Ca influx into mitochondria
Mitochondria were prepared as described in section [2.6]. Calcium uptake was 
measured using a Dual-wavelength Perkin-Elmer, model 356 spectrophotometer, 
operating at 375-385nm according to Goldstone et al (Goldstone et al., 1987). 
Mitochondria (2-3mg of protein) were added to 3ml of standard reaction mixture 
containing 120mM KC1, 0.5mM KH2PO4, ImM MgCl2 , 10pM CaCI2 and 1 jug of 
rotenone/mg protein with 60pM arsenazo III as a Ca2+ indicator. Ru 360 was added as 
indicated. The mitochondria were energised by the addition of 6mM succinate and 
20jjM ATP to initiate Ca2+ uptake.
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[2.10.3] Conjugating SAED and DAPPAC
S AED-Sulfosuccinimidyl 2-(7-azido-4-methylcoumarin-acetamido) ethyl-1,3- 
dithiopropionate (Pierce, Rockford, Illinois) is a heterobifunctional, amine reactive, 
water soluble, cleavable, photoreactive crosslinker. It also has the fluorescent molecule 
(AMCA) incorporated into its structure. This cross-linker has two functional groups: 1) 
a sulpho-N-hydroxysuccinimide ester which provides an activated carboxyl group for 
conjugation to the primary amino group of DAPPAC and, 2) a photoactive azido group 
forming a highly reactive nitrene on illumination. The linker between the two groups 
contains a cleavable disulphide bond. It has a maximum uv absorbance at 327nm and 
an extinction coefficient of 18 200M _1cm'!. The structure of SAED is shown below in 
figure [2.1]:
SAED 
MW 621.6 
Spacer Ann Length 22.5 A
Figure [2.1] Structure of SAED
DAPPAC is a cobaltammine complex ion that was synthesised by Crompton and 
Andreeva (Crompton and Andreeva, 1994). SAED and DAPPAC were conjugated 
together in the dark.
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Figure [2.2] Conjugation of SAED and DAPPAC
The reaction resulted in the substitution of the sulpho- NHS group by DAPPAC. 
DAPPAC (lOmg) and SAED (4.2mg) were each dissolved in 50mM phosphate buffer, 
pH 7.3, mixed, and incubated for 4 hours in the dark, after which conjugation was 
judged to be largely complete. Excess SAED was removed by addition of lOOmM (3- 
alanine and incubated for a further 4 hours. The conjugate was then stored in aliquots at 
-20°C.
Mitochondrial membranes were prepared as described in section [2.7].
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[2.10.4] Photolabelling mitochondrial membranes with SAED-conjugated DAPPAC
The mitochondrial membranes (50mg protein) were thawed on ice and resuspended in 
5ml of 150mM NaCl, lOmM Tris-HCl, pH 7.2 and divided into three. One of the 
aliquots was untreated. The other two were treated with lnmol and with lOnmol of 
Ru360. All three were then reacted with lpM SAED-conjugated DAPPAC under long 
uv illumination. After 5 minutes the mitochondrial membranes were sedimented at 40 
OOOrpm for 30 minutes in a Beckman 7L Beckman centrifuge. The supernatants were 
discarded and the pellets were stored at -60°C.
[2.10.5] Extraction o f proteins from mitochondrial membrane proteins using CHAPS
The mitochondrial membrane pellets were extracted using a hand-held homogeniser in 
50mM HEPES, lOOmM NaCl, ImM MgCh, ImM PMSF, 5mM final concentration of a 
broad-range inhibitor cocktail and 6%w/v CHAPS. 2ml of this medium was used to 
extract 30mg of mitochondrial protein. The homogenate was left on ice for 45 minutes 
and then the membrane extract was centrifuged in an Eppendorf centrifuge at lOOOOrpm 
for 10 minutes.
[2.10.6] Separation o f mitochondrial membrane proteins using ion-exchange 
chromatography
The mitochondrial membrane extracts [7.5] were fractionated by FPLC (Pharmacia). 
The extracts were applied to a Mono Q HR 5/5 anion-exchange column and pre­
equilibrated with the 50mM Tris-HCl, lOOmM NaCl, pH 8.0. Proteins were eluted
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using a NaCl gradient 100mM-500mM. The pass-through from the MonoQ was applied 
to a Mono S, cation-exchange column. The same buffer was used and a NaCl gradient 
was used as before. The fluorescence of the collected fractions was measured using a 
Perkin-Elmer fluorimeter.
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Chapter 3: Results
Expression of Bax, C-terminally truncated Bax and BcI-Xl as 
Fusion Proteins in E.coIi
[3.1] Expression of hexahistidine-tagged Bax and hexahistidine- 
tagged C-terminally truncated Bax tagged proteins
Pure Bax protein was required in order to study its interaction with mitochondria. The 
simplest way to achieve this was to express Bax with a tag at either the C or N-terminus 
of the protein to enable purification using an affinity matrix. Bax fusion proteins could 
be coupled to an agarose affinity matrix to pulldown mitochondrial membrane proteins 
that interact with Bax after its translocation from the cytosol to the mitochondria during 
apoptosis (Wolter et al., 1997). Other groups have produced N-terminally-tagged Bax 
and BaxAc. Workers in Jean-Claude Martinou’s group expressed Bax and BaxAc with 
N-terminal hexahistidine-tags (Lewis et al., 1998). Others have produced GST-Bax 
fusion proteins (Pastorino et al., 1999, von Ahsen et al., 2000). N-terminal tags may 
have been preferred for two reasons. Firstly, when Bax was expressed with a GST-tag 
present at the N-terminus of the fusion protein it was shown to reduce Bax toxicity to 
E.coli (Reed et al., 1999). Secondly, the C-terminus contains the hydrophobic 
membrane anchor that was initially thought to be essential for Bax interaction with 
mitochondria (Wolter et al., 1997). However, later studies showed that the C-terminus 
is not required for the cellular localisation of Bax or its ability to mediate cytochrome c 
release (Priault et al., 1999). E. coli strain M l5 and BL21 cells, containing the
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recombinant plasmids pQE31 and pQE60-containing human bax and baxAc 
respectively, were used to produce the Bax proteins. The baxAc was 3’ truncated and 
the corresponding protein lacked 22 amino acids at the C-terminus. The tag encoded by 
the vectors consists of six histidine residues fused to the termini of the proteins (the N- 
terminus for Bax and the C-terminus for BaxAc). This small 0.7kDa tag was less likely 
to affect the overall structure and function of the protein than a larger tag. This tag 
facilitates purification by chelating with the metal ion affinity matrix Ni2+- NTA- 
agarose (Porath et al., 1975).
[3.1.1] Expression o f His6-Bax
E.coli strain M l5 was co-transformed with plasmids pQE-31-bax, pQE-70- bcl-XL Ac 
(3’ truncated BcI-Xl) and pREP4 containing the lac repressor gene. The full-length Bax 
protein has been shown to be toxic to E.coli (Asoh et al., 1998). Therefore the rationale 
for this system was to keep expression tightly regulated by controlling gene expression 
with the lac repressor encoded by the pREP4 plasmid and at the protein level by the 
BcI-XlAc, which dimerises with Bax to reduce its toxicity (Asoh et al., 1998). The 
expression of Bax and BcI-XlAc was induced by the addition of IPTG, when the cell 
growth reached mid-log phase. The bacterial cells were lysed after 3 hours. BcI-Xl 
expression was detected by Western blotting, however Bax expression was not detected 
in either the pellet or supernatant fractions of the bacterial cell lysate. Various 
conditions were tested to induce the expression of Bax. These were: the optical density 
at which the cells were induced with IPTG (0.4 to 1 OD at 600nm), the length of time 
the cultures were left to grow after induction (1 hour to 5 hours), transformation of the
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plasmids into different strains of E. coli DH5a, BL21 and XL-blue, and the pQE-31 
plasmid alone (containing bax) was used to transform E. coli. . However the Bax 
protein was not detected. A previous study (Asoh et al., 1998) showed that an amount 
of full-length His-Bax as low as 0.01% of the total bacterial protein was sufficient to 
induce death in E. coli. His-Bax expression in E.coli DH5a was demonstrated by 
Montessuit and co-workers (Montessuit et al., 1999). The authors used the pBad 
expression vector. His-bax gene expression was under the control of the ara c promoter 
and expression was induced by the addition of arabinose and large-scale purification of 
His-Bax was facilitated by the use of a 50-litre fermenter to obtain large quantities of E. 
coli expressing the His-Bax protein. In this investigation His-Bax expression was 
carried out on a smaller scale (1 litre) and the His-Bax protein was not detected by 
Western blotting. The same antibody (6A7 monoclonal antibody) that recognises a N- 
terminal epitope of the Bax protein was also used to detect the GST-Bax fusion proteins 
(section [3.2]). The choice of expression system may be important to obtain optimum 
levels of His-Bax expression. Nevertheless it was surprising that His-Bax was not even 
detectable by Western blotting in the present study.
[3,1,2] Expression and purification o f the BaxAc-His6
The truncated Bax protein, BaxAc-His6, lacked 22 amino acids at the C-terminus. The 
absence of this hydrophobic C-terminal domain increased the solubility of the Bax 
protein (Pastorino et al., 1999). Pastorino and co-workers have used a truncated form of 
Bax that lacked 19 amino acids at the C-terminus. (Pastorino et al., 1999). This 
truncated form of the protein was shown to be biologically active in that it could induce
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the release of cytochrome c from isolated mitochondria (Pastorino et al., 1999, Appaix 
et al., 2000).
E. coli (BL21) were transformed with the pQE60 plasmid contained baxAc. In this case 
the hexahistidine tag was present on the C-terminus of the protein. It was found that the 
optimum OD6oonm to induce E.coli cultures with IPTG was 0.8. After induction the 
cells were grown at 37°C for 3 hours. SDS-PAGE was used to separate the proteins in 
the bacterial lysates derived from cells that were uninduced and those induced with 
IPTG. Coomassie staining showed no difference in the proteins produced by the 
induced and uninduced cells. However, the Western blotting confirmed that BaxAc-His6 
was present in the induced sample. Since Bax was poorly expressed, a litre of culture 
was required. The BaxAc-His6 in the bacterial cell lysate was purified using a Ni-NTA 
column followed by a Mono Q anion-exchange column. A protein elution profile from 
the Ni-NTA column and a Western blot, figures [3.1] and [3.2] show which fractions 
contained BaxAc-His6. A two-step gradient (50-150mM, 150-1000mM imidazole) was 
used to elute the proteins that were bound to the column.
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Figure [3.1) Elution profile from the Ni-NTA column. A two-step imidazole 
gradient was used to elute the bound proteins (50-150mM, 150-1000mM). BaxAc-His6 
eluted between 60-70mM imidazole in fractions 31 and 32. The volume of each fraction 
collected was lml. A full-scale deflection (F.S.D) of 0.2A was used until fraction 29. 
After this 0.1 A was used.
The fractions containing BaxAc-His6 were not pure; therefore a second purification step 
involving anion-exchange chromatography (Mono Q) was used. The pH at which the 
anion-exchange chromatography step was performed was varied to find out at which pH 
BaxAc-His6 was retained on the Mono Q column with fewer bacterial proteins. At pH 
6.0 BaxAc-His6 was retained on the anion-exchange column and co-eluted with fewer
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bacterial proteins present. The BaxAc-His6 was eluted with 350 mM NaCl. Figure [3.3] 
shows an elution profile from the Mono Q column.
49 kDa
29 kDa 
20 kDa
7 kDa
Supernatant 31 32 33 34 35 36
Figure [3.2] The content of BaxAc-His6 in fractions eluted from the Ni-NTA 
column. The proteins present in the fractions eluted from the Ni-NTA column (see 
figure [3.1]) were separated by SDS-PAGE and Western blotting was used to determine 
which fractions contained BaxAc-His6 (20pl aliquot of each 1ml fraction). BaxAc-His6 
was eluted in fractions 31 and 32.
Western blotting was used to determine which fractions contained BaxAc-His6. Figure
[3.4] shows that BaxAc-His6 was eluted in fraction 16. The purity of this fraction was
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assessed by SDS-PAGE and silver-staining (Figure [3.5]). The fraction containing 
BaxAc-His6 was dialysed against 20mM HEPES, 50mM NaCl, pH 7.3.
1 2 3 4 5 6  7 8 9 10 1112 13 14 15 16 17 18 19 20
Fraction number
Figure [3.3] Anion-exchange chromatography was used as a second step to purify 
BaxAc-His6 from the bacterial cell lysate. Fractions 31 and 32 eluted from the Ni2+- 
NTA column were diluted 25x in buffer containing 50mM MES, 50mM NaCl, pH 6.0, 
applied to the Mono Q column and then eluted in the same buffer with a salt gradient 
(50-500 mM NaCl). The truncated Bax eluted in fraction 16 with 350mM NaCl. Full- 
scale deflection (F.S.D) of 0.005A was used up to fraction 5 and then 0.002A was used. 
The volume of each fraction collected was 1ml.
Although BaxAc was partially purified, the protein was not stable during dialysis. The 
proteins were separated by SDS-PAGE and the BaxAc-His6 was not detected by
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Western blotting, only smaller degradation products. A third purification step was not 
deemed practical, as the yield would further decrease. In light of this, and the lack of 
stability during the dialysis step, another approach was used.
Figure [3.4] Western blotting showed that BaxAc-His6 was eluted in fraction 16. A
20pl aliquot of each fraction (1ml; figure [3.31) that was eluted from the Mono Q 
column was analysed (the fraction numbers are shown along the bottom of the blot).
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Figure [3.5] Silver-staining was used to determine the purity of BaxAc-His6 in 
fraction 16 that was eluted from the MonoQ column. A 20)il aliquot of each fraction 
(lml; figure [3.3]) was analysed. The fraction numbers are shown along the bottom of 
the gel and the arrow indicates the band corresponding to BaxAc-His6.
[3 .2 ] GST-Bax and  GST-BaxAc
[3.2.1] Subcloning o f Bax and BaxAc into the pGEX-3X vector
The pGEX plasmid contains the glutathione-s-transferase gene (gst) upstream of the 
cloning site (Smith and Johnson, 1988). Therefore the Bax fusion proteins contained
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GST at the N-terminus. The pGEX expression system was chosen because higher levels 
of expression were obtained than with His-tagged Bax. GST is a bacterial protein and 
its presence at the N-terminus of the fusion proteins renders Bax less toxic to E. coli 
(Asoh et al., 1998). Figure [3.6] shows the pGEX plasmid. Gene expression is 
controlled by the tac promoter, a stronger hybrid of the lac and trp promoters. This 
plasmid also contains the lacF gene that produces the lac repressor allowing controlled 
expression in E. coli.
Figure [3.6] The pGEX-3X plasmid was ligated with box and baxAc. The
Smal/Xmal and EcoRl restriction sites were used.
Factor Xa
GAA GOT CGT GGG ATCCCC GGJG.AAT TQA TCG IfiA CRACIJaAC
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PCR was used to obtain the bax and baxAc cDNA and these were ligated in frame with 
the gst gene of the pGEX vector. The presence of the restriction sites in the primer 
sequences produced strong secondary structure (information obtained with primers from 
Amersham-Pharmacia) within the primers and therefore a hotstart PCR protocol was 
used. Figure [3.7] shows the amino acid sequence for Bax and BaxAc, and where the 
primers would bind to the corresponding nucleotide sequence.
1 MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELAL
4 8  DPVPQDASTKKLSECLKRIGDELDSNMELQRMIAAVDTDSPREVFFR 
9 5  VAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALC 
1 4 2  TKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQTV
1 8 9  TIFVAGVLTASLTIWKKMG
The nucleotide sequence for each of the $ primers used is shown below:
Bax forward piiinei: TGAC'C CCGGpATGGACGGGTCCGGGGAGCA 
BaxAc reverse prime i : TGAC GAATT C’TTACTGCCAAGTGGGGCGTCCAA
Bax reverse primer: CGCTCA GAATT CTCAGCCCATC TTCTTCCACATG
Figure [3.7] The amino acid sequence for Bax. The truncated form lacks 22 amino 
acids at the C-terminus of the protein, which are shown in red. The amino acids that are 
underlined show where the primers would bind to the corresponding nucleotide 
sequence. The sequence of each of the three primers used is also shown. These include 
restriction sites (shown in the rectangles) to allow ligation into the same sites in the 
pGEX-3X vector.
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DMSO (5%) was added to the PCR reactions as this prevents the formation of 
secondary structure within the primers. Figure [3.8] shows the effect of DMSO on the 
amount of bax produced by PCR.
0.51kb
1 2 3 4 5
Figure [3.8] Analysis of bax PCR product by agarose gel elctrophoresis. DMSO 
was varied. Lane 1, no DMSO, lane 2, 2.5% DMSO, lane 3, 5% DMSO, lane 4, 10% 
DMSO and lane 5, no template control.
After ligation, E.coli XL-Blue cells were transformed with the recombinant plasmids. 
Digestion of the plasmids with the restriction enzymes Xmal and EcoRl confirmed that 
the bax inserts were present. In figure [3.9] recombinant plasmid DNA cut with Xma I
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and Eco R1 was analysed by agarose gel. The same was carried out for recombinant 
plasmid containing baxAc (not shown).
11 .5kb—  
5.07kb —
2.85kb —
O.Skb —
I I \ I
1 2  3 4 5 6 7
Figure [3.9] Analysis of the recombinant plasmid, digested with Xma I  and EcoRl, 
by agarose gel electrophoresis. Lane 1, uncut recombinant plasmid (pGEX+bax). The 
expected size for the recombinant plasmid is 4.53kb, however, the plasmid is 
supercoiled and has an apparent size of approximately 3kb. Lane 2, pGEX plasmid 
digested with Xma I; lane 3 pGEX plasmid digested with EcoRl; lane 4, pGEX plasmid 
digested with Xma I  and EcoRl. Lane 5, recombinant plasmid digested with Xma I; lane 
6, recombinant plasmid digested with EcoRl. The plasmids cut with a single restriction 
are no longer supercoiled and therefore their migration through the gel is not retarded 
and the plasmids have approximately the expected sizes of 3.98kb for pGEX and 4.53kb 
for the recombinant plasmid. The pGEX plasmid digested Xma I  and Eco RI (lane 4) 
has the size as the plasmid cut with only one enzyme because the cleavage sites for both 
enzymes are located next to each other (see Figure [3.6]). Lane 7, recombinant plasmid 
digested with Xmal and EcoRl. Two bands are present in lane 7; the bax insert migrates 
at 0.55kb and pGEX at 3.98kb. The PCR product was sequenced to check for errors.
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[3.2,2] Expression o f GST-Bax and GST-BaxAc
Expression of GST-BaxAc was induced with 0.4 mM IPTG at an OD6oonm of 0-8. The 
proteins in the supernatant and pellet fractions of the bacterial cell lysate were analysed 
by SDS-PAGE and Western blotting. GST-BaxAc was present in the supernatant 
fraction. Expression of GST-Bax was carried out using the same method that was used 
for GST-BaxAC. However, expression levels for the full-length fusion protein were 
low. The full-length Bax protein is toxic to E.coli. A protocol was designed to allow a 
slow gradual induction of expression of GST-Bax from the tac promoter within the 
pGEX plasmid, using a low concentration of IPTG. The cells were grown for 12 hours 
at 37°C followed by induction with 10pM IPTG and cell growth for a further 24 hours 
at 22°C. Expression at lower temperatures facilitates the correct-folding of the 
recombinant protein and therefore prevents inclusion body formation (Schein, 1991). In 
this investigation, GST-Bax was not detected in the bacterial pellet fraction, indicating 
that inclusion bodies were not present (see figure [3.10]). The proteins in the bacterial 
cell lysates were analysed and GST-Bax was found to be present in the supernatant 
fractions from the uninduced cells as well as those induced by IPTG indicating that 
expression from the tac is not tightly regulated possibly due to the insufficient amounts 
of the lac repressor that binds to the promoter and prevents transcription taking place. 
Two products were detected by the Bax antibody in the induced supernatant fraction 
(figure [3.10]). The larger product corresponded to the GST-Bax (47 kDa) and the 
smaller product (30 kDa) to a C-terminally truncated form of the fusion protein. The 
Bax monoclonal antibody (6A7) recognises the epitope PTSSEQI. These amino acids
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are present at the N-terminus of Bax (amino acids 13-19). One product was detected in 
the uninduced supernatant fraction.
A B
Figure [3.10] Western blot analysis identifies GST-Bax in the supernatant 
fractions of the bacterial cell extracts. A. GST-Bax was detected with the 6A7 anti­
human Bax monoclonal antibody raised against the N-terminal epitope PTSSEQI. 
Equal amounts of supernatant and pellet fractions were used (20pl of each fraction in 
each lane). Lane 1, supernatant fraction from E.coli (XL-blue) transformed with 
pGEX-bax and were induced withlOpM IPTG. Lane 2, pellet fraction from induced 
cells. Lane 3, supernatant from uninduced cells. Lane 4, pellet fraction from uninduced 
cells. B. The proteins in the supernatant fractions were separated by SDS-PAGE and 
visualised by Coomassie-blue stain. Lane 1, supernatant from induced cells. Lane 2, 
supernatant from uninduced cells.
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[3.2.3] Purification o f GST-Bax and GST-BaxA using an agarose-glutathione affinity 
matrix
Bacterial extracts containing GST-Bax (full-length) were prepared by sonication in the 
presence of 1% Nonidet P-40 as detergent to prevent the fusion protein from 
aggregating due to the hydrophobic C-terminus (section [2.3.1]) (Wieckowski et al, 
2001). An agarose-glutathione matrix was used to purify the fusion proteins. In this 
one step a high degree of purity was achieved (figure [3.11]).
50 kD a
35 kD a 
29 kD a 
19 kD a
7 k D a  ------
I I
GST-BaxAc GST-Bax
Figure [3.11] Purification from bacterial cell lysates of GST-Bax fusion proteins 
using agarose-GSH. GST-Bax and GST-BaxAc were eluted from the GSH-matrix 
with 50mM GSH, 50mM NaCl. The proteins in the eluate were separated by SDS- 
PAGE and were visualised by Coomassie-blue staining. The above gel shows two 
bands present just below the 50 kDa marker which are GST-BaxAc (44 kDa) and GST- 
Bax (47 kDa). Other bands are likely to be breakdown products of the fusion protein 
(see text).
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Other bands are visible on the Coomassie-stained gel. As these lower molecular 
weight bands were also detected by Western blotting (figure [3.12]), they are likely to 
be breakdown products of the fusion protein.
Figure [3.12] Detection of the bands contaminating GST-Bax by the anti-Bax 
antibody. The proteins were eluted from the agarose-GSH matrix and then separated 
by SDS-PAGE. GST-Bax fusion proteins and N-terminal breakdown products of the 
fusion proteins were detected using the 6A7 anti-human Bax monoclonal antibody 
which recognises amino acids 13-19 of Bax.
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[3.3] His6-BcI-Xl
[3.3.1] Expression o f hexahistidine-tagged BcI-Xl
The pQE-31 plasmid containing bcl-XL was obtained from Dr. John Ward, Department 
of Biochemistry and Molecular Biology, UCL. The expression of His6-Bcl-XL was 
more straightforward than for the Bax proteins because His6-Bcl-XL is not toxic to 
bacteria. E.coli XL-blue cells were transformed with the recombinant pQE-31 plasmid. 
Expression of the His6-Bcl-XL was induced by the addition of ImM IPTG to the 
bacterial cell cultures at an OD6oonm of 0.8. The bacteria were grown for up to three 
hours after induction of His6-Bcl-XL expression by IPTG. Bacterial cell lysates 
containing His6-Bcl-XL were prepared by sonication in the presence of Nonidet P-40. 
The pellet and supernatant fractions from the bacterial lysates were analysed by SDS- 
PAGE followed by Coomassie-blue staining (figure [3.13]). His6-Bcl-XL was found in 
the supernatant fractions and was not found in the pellets indicating that the product 
was soluble.
[3.3.2] Purification o f hexahistidine-tagged BcI-Xl
The purification of the His6-Bcl-XL protein involved a two-step process. The first was 
an affinity purification step on the Ni -NTA column and the second step involved the 
further separation of the proteins by anion-exchange chromatography on a Mono Q HR 
5/5 column attached to a FPLC system. The protein elution profile from the second 
purification step, the Mono Q anion-exchange column, is shown in figure [3.14],
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Figure [3.13] Expression of His6-Bcl-XL. Four-10ml cultures of E. coli transformed 
with the recombinant the pQE-31 plasmid containing His^-Bcl-Xi were harvested at the 
times indicated above after induction with 0.4mM IPTG. The cultures were sedimented 
by centrifugation and then resuspended in sonication buffer containing 50mM HEPES, 
50mM NaCl, 0.5mM EDTA, 5mM DTT, lOpl/ml protease inhibitor cocktail, ImM 
PMSF, 1% Nonidet P-40, pH 7.3. Proteins in the supernatant (S) and pellet (P) 
fractions of the bacterial cell lysate were separated by SDS-PAGE visualised by 
Coomassie-blue staining. 20pl of the supernatant and pellet were loaded onto the gel 
(20pl of 1.5ml of S and P resuspended in loading buffer).
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Figure [3.14] Elution profile from the Mono Q anion-exchange column. His6-Bcl- 
XL eluted in fractions 14, 15 and 16. Full-scale deflection (F.S.D) of 0.1 A was used 
The volume of each fraction collected was lml.
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The His6-Bcl-XL protein was detected in the fractions eluted from the Ni2+-NTA 
column and the Mono Q anion-exchange by dot blotting. His6-Bcl-XL was present in 
fractions 14, 15 and 16 shown in the protein elution profile in figure [3.14]. The His6- 
Bc1-Xl eluted from the Mono Q column at a salt concentration of approximately 
370mM. The fractions containing the His6-Bcl-XL were analysed SDS-PAGE followed 
by Coomassie-staining. A dot blot and a Coomassie-stained gel of the fractions 15 and 
16 containing His-Bcl-XL are shown in figure [3.15]. The fractions from the Mono Q 
column were stored in 30% glycerol at -60°C.
[3.4] Discussion
In mammalian and yeast cells Bax oligomerisation and its targeting to the 
mitochondrial membranes during apoptosis are essential for Bax to exert its cytotoxic 
affects (Zha et al., 1996, Wolter et al., 1997). E.coli cells transformed with a 
prokaryotic expression vector carrying human bax cDNA were shown to grow poorly 
on solid and in liquid media (Asoh et al., 1998). Bacterial cells lack mitochondria, 
however, a trace amount of Bax protein (0.01% of the total cellular protein) is sufficient 
to kill E. coli. Bax expression in bacteria is also associated with physiological changes. 
These include increases in monosaturated fatty acids, O2 consumption, superoxide 
production, nicked DNA and the frequency of mutations. Co-expression of BcI-Xl
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Figure [3.15] His6-Bcl-XL was detected in the fractions from the anion-exhange 
column by dot-blotting and analysed by SDS-PAGE followed by Coomassie-blue 
staining. 20pl of each 1ml fraction obtained from the Mono Q anion-exchange was 
loaded onto the blot and the gel.
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with Bax was shown to have an inhibitory affect on Bax-induced cytotoxicity. In this 
investigation full-length His-Bax expression was not detected even when co-expressed 
Bc1-Xl. Full-length Bax and BaxAc were expressed as GST-fusion proteins and were 
coupled to agarose-GSH to produce Bax affinity matrices. These were used to 
investigate the interaction of Bax with mitochondrial membrane proteins (Chapter 4) 
that may play a role in the permeabilisation of the OMM during apoptosis and cause the 
release of apoptogenic proteins from the IMS. The purified His6-Bc1-Xl was added 
together with rat heart mitochondrial membrane extracts to GST-Bax to investigate its 
inhibitory affect on Bax interaction with mitochondrial membrane proteins.
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Chapter 4: Results
Interactions of Bax and BaxAc with a junctional 
mitochondrial membrane complex
[4.1] Interaction of Bax fusion proteins with VDAC and ANT
Previous studies indicated that the MPT-pore played a central role in apoptosis by 
facilitating the release of apoptogenic proteins (e.g. cytochrome c) from the IMS. The 
proposed mechanism involved the opening of the MPT-pore and the subsequent 
swelling of the matrix leading to the rupture of the OMM. Disruption of the 
mitochondrial inner membrane potential (Aij/m) was shown to be an early biochemical 
alteration that occurs in apoptotic cells (Deckwerth & Johnson, 1993, Vayssiere et al., 
1994, Zamzami et al., 1995, Petit et al., 1995). The MPT-pore was shown to consist of 
ANT in the inner mitochondrial membrane and Cyp D in the matrix (Woodfield et al., 
1998). Previous studies in our laboratory using GST-Cyp D demonstrated that the 
MPT-pore consists of CyP D in the matrix, ANT in the inner membrane and VDAC in 
the outer membrane (Crompton et al., 1998). Pharmacological and functional studies 
indicated that the reduction in Av|/m during apoptosis was due to the opening of the 
MPT-pore rather than non-specific mitochondrial membrane damage (Marchetti et al.,
1996). Marchetti and co-workers investigated glucocorticoid-induced apoptosis in 
thymocytes. The ANT ligand and MPT-pore inhibitor bongkrekic acid was shown to 
inhibit apoptotic changes including AT'm dissipation, depletion of non-oxidised
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glutathione, and generation of reactive oxygen species and exposure of 
phosphatidylserine on the outer surface of the plasma membrane. In another study, 
hexokinase-associated protein complexes containing the MPT-pore components ANT, 
Cyp D and possibly VDAC, in addition to Bax and some unidentified proteins, were 
purified from rat brain and were incorporated into liposomes. These complexes were 
shown to have MPT-pore activity in liposomes (Marzo et al., 1998a, Zamzami et al., 
1998). The function of the reconstituted MPT-pore complexes was explored using 
ligands of the components of the pore. The ANT ligands atractyloside, ter- 
butylhydroperoxide, Ca and diamide, which all promote MPT-pore opening were 
found to induce the release of the fluorochrome DiOC6 (622 Da) entrapped in 
liposomes while bongkrekic acid, which inhibits MPT, prevented DiOC6 release. The 
Cyp D ligands, cyclosporin A (CSA) and N-methyl-Val-4-cyclosporin (mCSA), the 
non-immunosupressive Cyp D ligand which does not interact with calcineurin, both of 
which prevented MPT-pore opening in isolated mitochondria (Zamzami et al., 1996, 
Zorrati & Szabo, 1995) also prevented DiOC6 release from liposomes. Bax was 
immunodepleted from the MPT-pore complexes prior to reconstitution into liposomes 
loaded with DiOC6. Bax-deficient MPT-pore liposomes failed to release DiOC6 upon 
exposure to the ANT ligand atractyloside (Marzo et al., 1998a). In addition, Bax or 
atractyloside were shown to induce A'Pm dissipation and apoptotic nuclear changes 
when microinjected into rat fibroblasts (Marzo et al., 1998b). These changes were 
inhibited by bongkrekic acid and both CSA and mCSA. Bax co-immunoprecipitated 
with ANT and a physical interaction between human ANT-2 and Bax was 
demonstrated using a yeast two-hybrid system (Marzo et al., 1998b). Further evidence 
for the role of the MPT-pore in apoptosis was provided using a cell-free system to study
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neuronal apoptosis (Ellerby et al., 1997). Atractyloside and the wasp toxin mastoparan, 
which also promotes MPT-pore opening (Pfeiffer et al., 1995), were shown to promote 
neural apoptosis, which was dependent on the presence of mitochondria. The 
activation of apoptosis was measured by fodrin cleavage. Studies using isolated 
mitochondria provided further evidence for the role of the MPT-pore in Bax-dependent 
cytochrome c release. Narita and co-workers (Narita et al., 1998) showed that the 
addition of recombinant Bax to isolated mitochondria resulted in loss of A\|/, 
mitochondrial swelling and cytochrome c release. These changes were dependent on 
Ca2+ and were prevented by CSA and bongkrekic acid. Other work (Jurgensmeier et 
al., 1998) also showed that Bax induced cytochrome c release from isolated 
mitochondria. This study showed that it was Ca2+ and not Bax that caused 
mitochondrial swelling which suggested that Bax did not directly induce MPT. 
However, other data from this study demonstrated that Bax induced cytochrome c 
release from isolated mitochondria was inhibited by CSA in the absence of Ca2+. MPT- 
pore opening, as a mechanism for cytochrome c release was controversial since other 
groups provided evidence for Bax-induced cytochrome c release that did not require 
MPT-pore opening. Eskes and co-workers (Eskes et al., 1998) showed that Bax- 
induced cytochrome c release from isolated mitochondria was independent of the MPT- 
pore. In contrast to studies by other groups (Pastorino et al., 1999, Narita et al., 1998, 
Jurgenmeier et al., 1998) Eskes and co-workers found that Bax-induced cytochrome c 
release from isolated mitochondria was not prevented by bongkrekic acid or CSA. 
Furthermore Mg ions, which inhibit MPT-pore opening, were required for 
cytochrome c release. Other groups have proposed models of Bax-induced cytochrome 
c release that involve Bax forming pores in the OMM through which cytochrome c can
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pass through to the cytosol. NMR structure analysis showed that Bax and Bc1-Xl were 
structurally similar to the pore-forming subunit of the diphtheria toxin (Suzuki et al., 
2000, Muchmore et al., 1996) and are capable of forming channels in synthetic lipid 
bilayers following oligomerisation (Reed, 1997). Bax channels were shown to be pH- 
sensitive, voltage-gated channels which are slightly selective for anions at a 
physiological pH (Antonsson et al., 1997, Schlesinger et al., 1997, Schendel et al.,
1997). In addition more recent studies have shown that oligomerised Bax, not 
monomeric Bax, was able to release fluorescein entrapped in liposomes (Antonsson et 
al., 2000) and this did not require the presence of mitochondrial membrane proteins. 
This suggested that Bax alone was sufficient for cytochrome c release.
The aim of this work was to determine if Bax targeted VDAC-ANT intermembrane 
junctional complexes (contact sites) and whether it was possible to reconstitute a Bax- 
VDAC-ANT-Cyp D complex. Only then could the MPT-pore be directly implicated in 
outer membrane lysis and a mechanism for cytochrome c release.
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In order to find out if Bax interacted with VDAC and ANT, GST-Bax and the C- 
terminally truncated form, GST-Bax Ac, were expressed as described in [3.2]. The 
recombinant GST-Bax proteins were immobilised onto agarose-GSH matrices. Pull­
down experiments were performed in which a detergent extract of rat heart 
mitochondrial membranes, containing VDAC and ANT, was applied to the 
immobilised GST-Bax.
[4,1,1] Detection o f  VDAC and ANT in detergent extracts o f rat heart mitochondria
Detergent extracts of rat heart mitochondrial membranes were used as a source of 
VDAC and ANT. This mitochondrial membrane extract was prepared as described 
previously in [2,7.4]. Before examining VDAC and ANT interactions with GST-Bax 
fusion proteins it was important to confirm that the anti-VDAC and the anti-ANT 
antibodies used in this investigation were specific for VDAC and ANT respectively. 
Therefore, proteins in the mitochondrial membrane extract were separated by SDS- 
PAGE and Western blotting was used to specifically detect VDAC (30 kDa) and ANT 
(32 kDa) present in the extract (figure [4.1]).
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Figure [4.1] Specificity of the anti-VDAC and ANT antibodies used. A Proteins in 
the mitochondrial membrane extract were separated by SDS-PAGE and visualised by 
Coomassie-blue stain. B Western blotting showed that the anti-ANT and anti-VDAC 
antibodies specifically detected ANT and VDAC respectively. The ANT antibody used 
was polyclonal raised against the YDEIKKYV peptide corresponding to the C-terminus 
of rat ANT-1 (this laboratory). The VDAC antibody used was monoclonal 31HL clone 
(calbiochem) and is specific for the N-terminal region of VDAC.
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[4.1.2] Protein sequence alignments to compare human and rat Bax
The GST-Bax fusion proteins used in this investigation contained human Bax whilst the 
mitochondrial membrane proteins were derived from rat heart mitochondria. Therefore 
it was important to address whether or not this was likely to affect Bax-VDAC-ANT 
interactions. A protein alignment for human and rat Bax-a was performed to show that 
the primary sequences were highly conserved between humans and rats.
10 20  30 40  50
MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPV
MDGSGEQLGGGGPTS SEQFMKTGAFLLQGFIQDRAERMAGETPELTLEQP 
10 20  30  40  50
60 70 80 90 100
PQDASTKKLSECLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMF
PQDASTKKL S EC LRRIGDELDNNMELQRMIADVDTDS PREVFFRVAADMF 
60 70 80 90 100
1 1 0  12 0  130  14 0  150
SDGNFNWGRWALFYFASKLVLKALCTKVPELIRTIMGWTLDFLRERLLG
ADGNFNWGRWALFYFASKLVLKALCTKVPELIRTIMGWTLDFLRERLLV 
110  12 0  130  14 0  150
1 6 0  170  1 8 0  190
WIQDQGGWDGLLSYFGTPTWQTVTIFVAGVLTASLTIWKKMG
WIQDQGGWEGLLSYFGTPTWQTVTIFVAGVLTASLTIWKKMG 
160  17 0  180  190
Figure [4.2] Alignment of the amino acid sequences of human and rat Bax-a. The
sequence alignment was carried out using the HGMP matcher alignment program. The 
human sequence is shown at the top. Rat and human Bax are 91% identical (two dots 
represents sequence identity whereas one dot shows the amino acids are similar).
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[4.1.3] GST-BaxAc induces cytochrome c release from isolated mitochondria
Previously other groups showed that BaxAc induced cytochrome c release from isolated 
mitochondria (Pastorino et al., 1998, Narita et al., 1998). At the beginning of this work 
it was important to establish whether or not the fusion proteins retained Bax activity 
despite the presence of the large GST-tag (26 kDa) at the N-termini of the proteins. 
Therefore GST-Bax Ac was assayed to assess its ability to induce cytochrome c release 
from isolated rat heart mitochondria. GST-Bax Ac rather than GST-Bax was used in this 
assay because detergent (Nonidet-P40) required for GST-Bax solubilisation would lead 
to OMM lysis in the absence of GST-Bax. Rat heart mitochondria were isolated and 
then resuspended in respiratory buffer (section [2.6.3]). GST-BaxAc (0-1 pM) was 
added to the mitochondria. The mitochondria were then pelleted and the supernatant 
filtered (0.2pm pore size). Proteins in the pellet and supernatant fractions were 
separated by SDS-PAGE and cytochrome c was detected by Western blotting. The 
results showed that GST-BaxAc induced cytochrome c release from the isolated 
mitochondria (figure [4.3]). In the controls, respiratory buffer only (lane 1) and GST 
(lane 2), no cytochrome c was present in the supernatant implying little or no 
cytochrome c release from the mitochondria. This result suggests that the 
mitochondrial outer membranes were intact and GST-BaxAc specifically induced 
cytochrome c release. Increasing the concentration of GST-BaxAc added resulted in 
more cytochrome c release (up to 500nM of GST-BaxAc).
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Mitochondria
Figure [4.3] GST-BaxAc induces cytochrome c release from isolated mitochondria.
Isolated rat heart mitochondria suspended in respiratory buffer containing lmM glutamate 
and lmM malate were incubated with GST-BaxAc for 15 minutes at 37°C (section
[2.6.3]). Proteins in the supernatant and mitochondrial fractions were separated by SDS- 
PAGE (2pg of protein in each lane) The presence of cytochrome c in the supernatant and 
mitochondria was detected by Western blotting using a monoclonal anti-cytochrome c 
antibody. The supernatant blot shows that more cytochrome c was released with 
increasing concentrations of GST-BaxAc, up to 500nM GST-BaxAc. Lane 1, no 
additions, lane 2, GST alone (500nM) was added. Lanes 3, 4, 5 and 6, 125nM, 250nM, 
500nM and lpM of GST-BaxAc were added respectively. This result was obtained in 
three independent experiments.
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[4.1,4] GST-BaxAc and GST-Bax tightly bind to VDAC/ANT
In order to find out if mitochondrial membrane proteins, in particular VDAC and ANT, 
bind to Bax the fusion proteins were immobilised on an agarose-GSH matrix. 
Mitochondrial membrane extract was added to agarose-glutathione-GST-Bax or 
agarose-GST-BaxAc. The matrix was washed 3 or 5 times and bound proteins were 
eluted with GSH. Agarose-glutathione-GST was used as a control matrix. The proteins 
in the eluates were separated by SDS-PAGE and visualised by Coomassie-staining 
(Figure [4.4]).
These data showed two proteins (approximately 34 kDa and 30 kDa) that co-elute with 
GST-BaxAc after 3 washes (lane 5) and 5 washes (lane 8) and do not co-elute with GST 
(lanes 4, 6 and 7). However, the same bands were also detected by the anti-Bax 
antibody (figure [3.15]) and, therefore, are most probably breakdown products of the 
fusion proteins (GST-Bax, GST-BaxAc). These bands would obscure any VDAC and 
ANT (32 kDa and 30 kDa, respectively). The presence or otherwise of VDAC and 
ANT was therefore detected using the ANT and VDAC specific antibodies (Figure
[4.1]). Figure [4.5] shows that GST-BaxAc specifically binds VDAC and ANT. Figure 
[4.6] shows that both VDAC and ANT were also present in the eluates from the 
agarose-GSH-GST-Bax matrix. In both cases there was no detectable binding to GST 
alone confirming that VDAC-ANT bound to the Bax/BaxAc moieties of the fusion 
proteins. With BaxAc (Figure [4.5]), similar amounts of VDAC and ANT were retained
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after 3 and 5 washes as shown on the blot (lanes 2 and 5), this confirmed that VDAC 
and ANT were retained tightly. Similar results were obtained with Bax.
50 kDa ---- ^ * - _ r C T  T?avAf
35 kDa —
^ ---V Jl-D d A L lt
tflgMH A
Imm
26 kDa — mm gst
18 kDa -  **
6 kDa — w
1 2 3 4 5 6 7 8
Lane 1 2 3 4 5 6 7 8
Agarose-GSH-GST + - - + - + + -
Agarose-GSH-GST-Bax Ac - + - - + - - +
Mitochondrial membrane extract - - + + + + + +
Agarose-GSH - - + - - + + -
Number o f  washes 5 5 3 3 3 2 5 5
Figure [4.4] Separation of proteins eluted from the GST and GST-BaxAc matrices 
by SDS-PAGE. The bound proteins were visualised by Coomassie-staining. A protein 
extract (300pl, 3mg of protein) derived from mitochondrial membranes was added to 
the agarose-GSH matrices (50pl of matrix). The extract was removed and the matrices 
were washed 3 or 5 times with 600pl of buffer containing 50mM NaCl, lOmM HEPES, 
25% glycerol, lmM EGTA, 8pM ADP, 8pM ATP, 8mM DTT and 0.5mM MgCl2. The 
bound proteins were eluted with 50mM NaCl, 50mM glutathione. (The same result 
was obtained in three independent experiments)
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35 kDa
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B
35 kDa —I
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1 2 3 4 5 6 7
Lane 1 2 3 4 5 6 7
Agarose-GSH-GST + - - + - + -
Agarose-GSH-GST-Bax Ac - + - - + - +
Mitochondrial membrane extract + + + + + - -
Agarose-GSH - - + - - - -
Number o f washes 5 5 3 3 3 5 5
Figure [4.5] VDAC and ANT specifically bind to GST-BaxAc. A and B Western 
blotting was used to detect VDAC and ANT, respectively. Both proteins co-eluted with 
GST-BaxAc from the agarose-GSH. (The same result was obtained in three 
independent experiments)
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35 k D a  
20 k D a
7 k D a
Figure (4.6] The agarose-GSH-GST-Bax matrix binds VDAC and ANT. Western 
blotting was used to detect VDAC and ANT. Lane 1, eluates from the GST-Bax 
matrix. Lane 2, eluates from the GST matrix. In each case the agarose-GSH matrices 
were washed 5 times before the proteins were eluted with 50mM glutathione, 50mM 
NaCl. (The same result was obtained in three independent experiments)
[4.1.5] The effects o f detergents on VDAC/ANT binding to GST-Bax
In experiments shown in this chapter Nonidet-P40 was used during the preparation of 
GST-Bax and the mitochondrial membrane extract containing VDAC and ANT. 
However, different detergents were known to influence the conformation of Bax and its 
oligomeric state. Moreover oligomeric Bax and not monomeric Bax appeared to be the 
active form of Bax required for cytochrome c release (Antonsson et al., 2000).
VDAC ANT
35 k D a  
20 k D a
7 k D a
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Evidence for detergent-induced conformational changes was obtained using anti-Bax 
antibodies (Hsu & Youle, 1997, Hsu & Youle, 1998). An antibody (6A7) to an N- 
terminal epitope between amino acids 12 and 24 of Bax did not immunoprecipitate the 
soluble monomeric form of Bax obtained from cytosolic extracts of murine thymocytes 
indicating that this epitope was normally buried within the protein. In the presence of 
non-ionic detergent (Nonidet P-40 and Triton-X 100) the epitope was accessible to the 
6A7 antibody and Bax was immunoprecipitated using the 6A7 antibody and was 
detected by Western blotting with another antibody (5B7). In addition these detergents 
were capable of inducing homodimerisation and dimerisation with other Bcl-2 proteins, 
for example Bc1-Xl. Another non-ionic detergent Tween-20 also induced 
heterodimerisation with Bc1-Xl but not homodimerisation or accessibility to the 6A7 
antibody. The zwitterionic detergent CHAPS did not promote Bax dimer formation or 
6A7 epitope exposure. The oligomeric forms of recombinant Bax and not the 
monomeric form were shown to form channels in liposomes and trigger cytochrome c 
release from isolated mitochondria (Antonsson et al., 2000). With regards to this 
investigation the detergent-induced conformational changes in Bax may have altered 
GST-Bax binding to VDAC-ANT. The GST-Bax/GST-BaxAc was attached to an 
agarose-GSH matrix therefore it was not clear whether oligomerisation would take 
place under these conditions. Nevertheless the binding of VDAC-ANT to GST-Bax in 
the presence of Nonidet P-40, Tween-20 and CHAPS were compared. Figure [4.7] 
shows that the choice of detergent used had no effect on VDAC-ANT binding to GST- 
Bax. Since binding occurred in the presence of CHAPS this result suggests that no 
conformational change and exposure of the 6A7 epitope was required for Bax binding 
to VDAC-ANT.
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Figure [4.7] The effect of different detergents on binding of VDAC and ANT to 
GST-Bax. The detergents indicated were present during the purification of the fusion 
proteins, the solubilisation of the mitochondrial membrane extracts and were present in 
the buffers during the pulldowns. Lane 1, 0.5% Nonidet-P40 was used during 
purification of GST-Bax. Lane 2, 0.5 % CHAPS was used and lane 3, 0.5% Tween-20. 
Lanes 4 and 5, 2% Nonidet P-40 and 2% CHAPS were used respectively. (Similar 
results were obtained in three independent experiments)
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[4,1.6] The effects o f BcI-Xl, atractyloside and bongkrekic acid on VDAC/ANT 
binding to GST-Bax
The results show that ANT co-elutes with VDAC from a GST-Bax affinity matrix. 
Both of these mitochondrial membrane proteins are key components of mitochondrial 
intermembrane contact sites that can recruit other proteins from the cytosol e.g. 
hexokinase and from the matrix e.g. Cyp D (section [1.8]). Subsequent studies were 
undertaken to evaluate the effects of the ANT ligands bongkrekic acid and atractyloside 
on ANT and VDAC binding to GST-Bax. Bongkrekic acid and atractyloside are both 
competitive inhibitors of ANT. Bongkrekic acid binds to the matrix side of ANT and 
traps it in the m-conformation with the binding site facing the matrix. Atractyloside 
binds to the cytosolic side of ANT and traps it in the c-conformation. Both of these 
inhibitors bind to hydrophilic loops in ANT that are exposed to the matrix side of ANT 
(bongkrekic acid) and the cytosolic side (atractyloside) (Brandolin et al., 1985, Muller 
et al., 1996, Dianoux et al., 2000). Bongkrekic acid was shown to protect cells from 
apoptosis (Marchetti et al., 1996 a, b) including apoptosis induced by transient 
ischaemia in rat neuronal cells (Cao et al., 2001). In isolated mitochondria bongkrekic 
acid prevents Bax-induced cytochrome c release, Bax-induced dissipation of AT'm and 
nuclear apoptotic changes in rat fibroblasts (Narita et al., 1998, Marzo et al., 1998b) 
and the release of pro-caspase-9 (Cao et al., 2001). Atractyloside was shown to have the 
opposite effect to bongkrekic acid in that it promoted AT'm dissipation, nuclear 
apoptotic changes (Marzo et al., 1998b) and Bax-ANT channel activity in liposomes 
(Marzo et al, 1998a, Brenner et al., 2000). In the present study mitochondrial 
membrane extracts were treated with atractyloside, bongkrekic acid or B cI-Xl and then
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added to GST-Bax immobilised on GSH-agarose. The proteins were eluted from the 
agarose-GSH-GST-Bax, equal amounts of total protein were separated by SDS-PAGE 
and VDAC and ANT were detected by Western blotting. The blots were developed and 
quantified using a Fuji-LAS-100 phosph/fluoro-imaging system (figures [4.8] and 
[4.9]). In figure [4.9] the results show that bongkrekic acid increased the amount of 
ANT and VDAC retained by GST-Bax. The presence of atractyloside considerably 
reduced the amount of ANT retained by GST-Bax and only slightly reduced the amount 
of VDAC bound to GST-Bax. Figure [4.9] B shows that atractyloside increases the 
amount of VDAC relative to ANT that is bound to GST-Bax by six-fold and 
bongkrekic acid by two-fold. These results suggest that atractyloside and bongkrekic 
acid exert their effects by altering the relative amounts of VDAC and ANT bound to 
Bax. Data from another study has shown that the anti-apoptotic protein B cI-X l 
interacts with VDAC (Shimizu et al., 1999) and that reduction in Bax binding to VDAC 
was due to competitive inhibition of Bcl-XL to VDAC. Bcl-XL can also bind to and 
form heterodimers with Bax (Oltvai et al., 1993). Minn and co-workers have shown 
that B cI-X l regulates apoptosis by both heterodimerisation dependent and independent 
mechanisms (Minn et al., 1999). Figure [4.9] shows that B cI-X l reduces the amount of 
VDAC and ANT bound to GST-Bax and has little effect on the ratio of VDAC to ANT 
that interacts with the fusion protein.
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ANT
35 kDa 
29 kDa
C 2 B
VDAC
35 kDa —
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B
Figure [4.8] The effects of BcI-X l, atractyloside and bongkrekic acid on the 
amount of VDAC and ANT that binds to GST-Bax. 50pl of agarose-GST-Bax slurry 
was used for each pulldown. Ci and C2, controls, mitochondrial membrane extract only, 
A, mitochondrial extract and atractyloside (50pM), B, mitochondrial membrane extract 
and bongkrekic acid (50pM) and X , mitochondrial membrane extract and B cI -X l 
(0.125ng). (Similar results were obtained in three independent experiments)
116
Chapter 4: Results
A
Addition to 
mitochondrial 
membrane extract
Relative density of the 
ANT band on the blot
Relative density of the 
VDAC band on the blot
Control 1 122.36 146.00
Control 2 119.00 157.00
B cI -X l 57.14 60.62
Atractyloside 24.25 140.60
Bongkrekic acid 338.20 770.00
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Figure [4.9] Quantifying of the effects of atractyloside, bongkrekic acid and Bcl-XL 
on the interactions of VDAC and ANT with GST-Bax. A shows the relative band 
densities of VDAC and ANT on the Western blots shown in figure [4.8]. B shows the 
variation in the ratio of VDAC-ANT bound to GST-Bax after the mitochondrial 
membranes were treated with BcI-Xl, atractyloside and bongkrekic acid.
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[4.2] Bax and the Permeability Transition Pore Complex
Under pathological conditions, for example during ischaemia/reperfusion injury that 
results in increases in mitochondrial matrix calcium levels, the MPT pore complex can 
form a large pore in the LMM that results in mitochondrial swelling. MPT-pore 
opening requires Cyp D since opening is blocked by the Cyp D ligand, Cyclosporin A 
(CSA) (Crompton et al., 1988). MPT-pore opening may play a role in apoptotic cell 
death. In particular it was proposed that MPT-pore mediated mitochondrial swelling 
may provide a mechanism for outer membrane lysis and release of intermembrane 
space proteins to the cytosol (Loeffler & Kroemer, 2000) although this mechanism is 
diputed (section [4.1]). Since Bax interacts with VDAC and ANT in vitro (figures [4.4] 
and [4.5]) it was relevant to investigate if a Bax-VDAC-ANT-Cyp D complex could be 
isolated.
[4.2.1] GST-Cyp D binds VDAC and ANT
The MPT pore components can be reconstituted in vitro (Crompton et al., 1998). ANT 
and VDAC binding to GST-Cyp D is shown in figure [4.10]. Only one band can be 
seen on the gel at 30 kDa, this is because ANT and VDAC have similar molecular 
weights of 32k Da and 30 kDa respectively. Western blotting was used to confirm both 
proteins were present (figure [4.11]).
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Figure [4.10] Agarose-GST-Cyp D selectively retained a 30kDa protein from 
mitochondrial membrane extract. Mitochondrial membrane extract was added to 
50pl of agarose-GSH-GST and agarose-GSH-GST-Cyp D. The matrices were washed 
with 600pl of buffer containing 50mM NaCl, lOmM HEPES, 25% glycerol, lmM 
EGTA, 8jjM  ADP, 8pM ATP, 8mM DTT and 0.5mM MgCh and the bound proteins 
were eluted with 50mM NaCl, 50 mM glutathione. The eluted proteins were separated 
by SDS-PAGE and visualised by Coomassie-blue stain. Lane 1, agarose-GST, lane 2, 
GST-Cyp D, lane 3, mitochondrial membrane extract.
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Figure [4.11] VDAC and ANT bind to GST-Cyp D and not GST alone. Western 
blotting was used to confirm that VDAC and ANT were present in the elutes from the 
GST-Cyp D matrix. Lane 1, VDAC and ANT co-eluted with GST-Cyp D. Lane 2, 
VDAC and ANT did not co-elute with GST.
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[4.2.2] Bax and Bcl-XL interact with VDAC-ANT-GST-Cyp D
To determine whether or not Bax was capable of binding to the MPT-pore complex, 
recombinant Bax produced from the cleavage of GST-Bax (section [2.4.5]) was added 
to the solubilised mitochondrial membrane extract and then the extract was applied to 
the GST-Cyp D affinity matrix. The proteins in the eluates were separated by SDS- 
PAGE and Western blotting was used to detect Bax binding (figure [4.12]). The 
results showed that Bax was retained by the GST-Cyp D matrix in the presence of 
VDAC-ANT (lane 1) and did not bind to the GST-Cyp D alone (lane 2) or when 
VDAC-ANT and Bax were added to the GST matrix (lane 4) indicating that the Bax- 
VDAC-ANT-Cyp D interaction was specific. Lane 5 contains recombinant Bax (21 
kDa). Other bands can also be seen which are probably breakdown products of Bax 
generated when GST-Bax was cleaved with factor Xa. None of the breakdown 
products bound to GST-Cyp D-ANT-VDAC. Figure [4.13] shows that VDAC and 
ANT were present in the eluates from the GST-Cyp D matrix (lanes 1 and 3 in figure 
[4.12]) confirming that they co-elute with Bax (lane 1 figure [4.12]). Purified B cI-X l 
(section [3.3]) was added to the solubilised mitochondrial membrane extract and the 
extract was applied to the GST-Cyp D matrix to find out if B cI-X l interacts with 
components of the MPT-pore. Western blotting was used to detect B cI-X l in the 
eluates from the agarose-GSH-GST-Cyp D. Figure [4.14] (lane 1) shows that B cI-X l 
was specifically retained by GST-Cyp D in the presence of the mitochondrial extract 
and VDAC and ANT were also detected in the eluate (not shown). B cI-X l was not 
retained by GST-Cyp D alone (lane 2) or by GST in the presence of the mitochondrial 
membrane extract (lane 3).
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Lane 1 2 3 4 5
Agarose-GSH-GST - - - + -
Agarose-GSH-GST-Cyp D + + + - -
Mitochondrial membrane extract + - + + -
Bax + + - + +
Figure [4.12] Bax co-elutes with VDAC and ANT from the GST-Cyp D matrix.
Mitochondrial membrane extract (0.25mg protein in 50jil) together with purified Bax 
(125ng) were added to the agarose-GSH-GST and agarose-GSH-GST-Cyp D matrices. 
The extract was removed and the matrices were washed 5 times before the bound 
proteins were eluted with 50mM NaCl, 50mM glutathione. The proteins in the eluates 
from the GST-Cyp D and GST matrices were separated by SDS-PAGE and the 
presence of Bax was detected by Western blotting with the 6A7 anti-Bax monoclonal 
antibody. (The same result was obtained in three independent experiments)
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VDAC
Figure [4.13] VDAC and ANT were present in the eluate from the GST-Cyp D 
matrix. The presence of VDAC and ANT in the eluates from the GST-Cyp D matrix 
was detected by Western blotting using the monoclonal anti-VDAC antibody and the 
polyclonal anti-ANT antibody. Lane 1, eluate from the GST-Cyp D matrix with no 
Bax added. Lane 2, eluate from GST-Cyp D the matrix with Bax present. (The same 
result was obtained in three independent experiments)
123
Chapter 4: Results
35 kDa 
21 kD;i
7 kDa
Lane 1 2 3 4
Agarose-GSH-GST - - + -
Agarose-GSH-GST-Cyp D + + - -
Mitochondrial membrane extract + - + -
His-Bcl-XL + + + +
Figure [4.14] His6-Bcl-XL co-elutes with VDAC and ANT from the GST-Cyp D 
matrix. Mitochondrial membrane extract (0.25mg of protein in 50pl) together with 
His-Bcl-XL (125ng) were added to agarose-GSH-GST or the agarose-GSH-GST-Cyp 
D. The extract was removed and the agarose matrices were washed 5 times before the 
bound proteins were eluted with 50mM NaCl, 50mM glutathione. The proteins in the 
eluates from the GST-Cyp D and GST matrices were separated by SDS-PAGE and the 
presence of Bcl-XL was detected by Western blotting with the anti-Bcl-XL monoclonal 
antibody. (The same result was obtained in three independent experiments)
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[4.2.3] Cyp D interacts with ANT-VDAC-GST-Bax
To confirm the results obtained in section [4.2.2], purified Cyp D was added to 
solubilised mitochondrial membrane extracts and then the extract was applied to the 
GST-Bax matrix. The proteins in the eluates from the matrix were separated by SDS- 
PAGE and Western blotting was used to detect Cyp D binding (figure [4.15]). The 
results showed that Cyp D was retained by the GST-Bax matrix in the presence of 
VDAC and ANT (lane 3) and did not bind to GST-Bax alone (lane 2) or to GST in the 
presence of the mitochondrial membrane extract (lane 1) indicating the VDAC-ANT- 
Cyp D complex binds specifically to the Bax moietie (lane 1).
[4.3] Discussion
The results in this chapter show that both GST-Bax and the C-terminally truncated 
GST-Bax Ac interact with VDAC (OMM) and ANT (IMM) present in rat mitochondrial 
membranes in the absence of Cyp D which was not present in the mitochondrial 
membrane preparations (determined by Western blotting data not shown). The GST- 
Bax proteins used in this investigation retained Bax activity which was determined by 
adding GST-BaxAc to isolated rat heart mitochondria and detecting cytochrome c 
release by Western blotting as described in previous studies using recombinant Bax Ac 
(Eskes et al., 1998, Jurgenmeier et al., 1998, Pastorino et al., 1999). The results 
presented in this chapter show increasing the concentration of GST-BaxAc (lacks 22 
amino acids at the C-terminus) resulted in more cytochrome c release up to 500nM of
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Lane i 2 3 4
Agarose-GSH-GST + - - -
Agarose-GSH-GST-Bax - + + +
Mitochondrial membrane extract + - + +
c ypD + + + -
Figure [4.15] CyP D is specifically retained by GST-Bax in the presence of VDAC 
and ANT. Mitochondrial membrane extract (0.25mg of protein) together with Cyp D 
(50ng) were added to agarose-GSH-GST or agarose-GSH-GST-Bax. The extract was 
removed and agarose matrices were washed 5 times before the bound proteins were 
eluted with 50mM NaCl, 50mM glutathione. The proteins in the eluates were separated 
by SDS-PAGE and the presence of Cyp D was detected with an anti-Cyp D raised 
against the peptide CSDGGARGANSSSQNP, corresponding to the amino acids 1-16 
after cleavage of the mitochondrial targeting sequence of Cyp D. (The results are same 
result was obtained in two independent experiments)
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GST-BaxAc. These results are similar to previously published data using C-terminally 
truncated Bax (lacks 19 amino acids at the C-terminus) in which Bax induced 
cytochrome c release in a concentration dependent manner up to lpM (Pastorino et al., 
1999). Other studies have shown that detergents can influence the conformation of Bax 
and its oligomeric state (Hsu & Youle, 1997, Hsu & Youle, 1998). Moreover 
oligomeric and not monomeric Bax appeared to be the active form of Bax (Antonsson 
et al., 2000, Antonsson et al., 2001). The work presented in this chapter shows the 
choice of detergent used had no effect on VDAC and ANT binding to GST-Bax. 
However GST-Bax was attached to an agarose-GSH matrix and therefore it was not 
clear whether conformational changes and oligomerisation would take place under 
these conditions. Atractyloside and bongkrekic acid are ANT ligands. Other studies 
have shown that bongkrekic acid protects cells from apoptosis (Marchetti et al., 1996 a, 
b, Cao et al., 2001). The current study demonstrates that bongkrekic acid increased the 
amount of both VDAC and ANT retained by GST-Bax whilst atractyloside, which 
promotes apoptosis by potentiating Bax action on mitochondria (Pastorino et al., 1999), 
decreased the amount of ANT retained by GST-Bax and slightly reduced the amount of 
VDAC retained. These results suggest that the stoichiometry of the VDAC and ANT 
intermembrane complexes may be important in the promotion of apoptosis by 
atractyloside and the protection by bongkrekic acid. To further investigate the 
significance of VDAC-ANT stoichiometry in the atractyloside promotion and 
bongkrekic acid inhibition of the release of apoptogenic proteins from the IMS, isolated 
mitochondria incubated with Bax in the presence of atractyloside or bongkrekic acid 
could be treated with reagents to cross-link Bax and VDAC-ANT in the intermembrane
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contact sites. Western blotting could be used to examine the relative amounts of 
VDAC and ANT present. Although bongkrekic acid inhibits apoptosis, its primary 
action is to inhibit the export of ATP from the mitochondria to the cytosol and therefore 
would be of little therapeutic value especially in the heart, which is dependent on 
oxidative phosphorylation and the export of ATP from the mitochondria to the cytosol 
to drive contractions.
In order to investigate whether or not Bax was capable of interacting with components 
of the MPT-pore GST-Bax was cleaved with factor Xa and this was added to GST-Cyp 
D together with the mitochondrial membrane extract containing VDAC and ANT. The 
results show that Bax was retained by GST-Cyp D in the presence of VDAC and ANT. 
Cyp D co-eluted with VDAC and ANT from the GST-Bax matrix. These results 
demonstrate that Bax is capable of direct interaction with the components of the MPT- 
pore supporting the hypothesis put forward by Kroemer’s group that Bax interacts with 
the MPT-pore to mediate the release of apoptogenic proteins from IMS. The results in 
this chapter also show that His6-Bcl-XL interacts with the MPT-pore and its antagonistic 
effect against Bax may involve the inhibition of Bax binding to the MPT-pore. 
Recently De Giorgi and co-workers (De Giorgi et al., 2002) investigated whether MPT- 
pore opening in live cells was sufficient to activate apoptosis. MPT was induced in live 
cells using tetramethyl-rhodamine methyl ester (TMRM) whose positive charge causes 
it to be accumulated within the mitochondria. Using a cell line stably transfected with 
GFP-cytochrome c they showed that cytochrome c release from the IMS occurred 4 
hours after MPT-pore opening and dissipation of A\|/m. Triple wavelength imaging was 
performed to visualise the mitochondrial matrix compartment, the distribution of Bax
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and cytochrome c. Their results showed that after MPT-pore opening but before any 
visible sign of Bax redistribution from the cytosol to the mitochondria no cytochrome c 
release was detected. Cytochrome c was still present in the IMS after Bax localisation 
to mitochondria and was only released after large (lOOnm) Bax clusters were formed on 
the outer OMM. They therefore concluded MPT-pore opening and A\|/m dissipation 
signals Bax translocation to mitochondria and it is the subsequent 
clustering/multimerisation and Bax channel formation that results in cytochrome c 
release. The involvement of the MPT-pore in the release of apoptogenic proteins from 
the IMS still remains controversial. The dissipation of A\j/m is not detected in all cell 
types during apoptosis indicating that this is not a universal mechanism for cytochrome 
c release. For example, during fenretinide-induced apoptosis in neuroblastoma cell 
lines cytochrome c release was detected with no significant AxFm dissipation (Lovat et 
al., 2000). Other studies show that AT'™ dissipation does occur however this was not a 
result of MPT-pore opening. When apoptosis was induced in human leukaemia cell 
lines with the immunosuppressive, anti-tumour, anti-viral drug didemnin B, AT'm 
dissipation occurred but was not inhibited by either CSA or bongkrekic acid and was 
inhibited by the broad-range caspase inhibitor z-VAD-ftnk (Grubb et al., 2001). 
Another study showed that the addition of Bax to isolated rat heart mitochondria 
resulted in the opening of large pores in the OMM, the inhibition of the respiratory 
chain and the uncoupling of the IMM by increasing proton leakage without the opening 
of the MPT-pore as indicated by a lack of sensitivity to CSA (Appaix et al., 2002).
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This current study demonstrates that GST-Bax is capable of interacting with VDAC 
and ANT without the presence of Cyp D. Other work has shown that contact sites 
between the inner and outer mitochondrial membranes formed the interaction of VDAC 
and ANT may be responsible for cytochrome c release. Doran and Halestrap (Doran & 
Halestrap, 2000) showed that Bax dimers were present in Percoll-purified isolated rat 
liver mitochondria and cytochrome c was released independently of adenylate kinase 
implying outer mitochondrial membrane rupture did not take place. They showed that 
cytochrome c release was not inhibited by CSA indicating that the MPT-pore was not 
involved. Other proteins bind to VDAC-ANT contact sites e.g. hexokinase and this was 
shown to inhibit Bax-induced cytochrome c release and apoptosis (Pastorino et al., 
2002), by competing with Bax for binding at the mitochondrial surface. The cell-free 
GST pulldown system described in this chapter could be used to investigate which 
other proteins associate with the contact sites, e.g. creatine kinase and the 
benzodiazepine receptor, can interact simultaneously with VDAC, ANT and Bax. The 
experiments could also be performed using other Bcl-2 proteins to determine if they 
compete with Bax for binding to VDAC and ANT.
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Anoxia-induced translocation of GFP-Bax from the cytosol 
to mitochondria in rat cardiomyocytes
[5.1] Bax translocation to mitochondria
Apoptosis in cardiomyocytes has been reported in a variety of cardiovascular 
pathologies including ischaemia/reperfiision injury (MacLellan & Schneider, 1997, 
Haunstetter & Izumo, 1998). Apoptotic and necrotic cell death both occur during 
ischaemic injury in the myocardium (Kajstura et al., 1996, Fliss & Gattinger, 1996, 
Veinot et al., 1997). However, apoptosis was shown to be the earliest form of cell death 
in ischaemic myocardium in both animal models and humans. Although apoptosis and 
necrosis are the two accepted and clearly defined forms of cell death, there are 
increasing reports of cell death which share features of both apoptosis and necrosis 
(Leist & Jaattela, 2001), raising the question whether they are discrete forms of cell 
death or if there is a range of responses utlising the same machinery. Whether 
apoptosis or necrosis is initiated in ischaemic cardiomyocytes is thought to be 
dependent on the presence or absence of ATP. If ATP is present then cells die by 
apoptosis since energy is required for the execution of apoptosis (Tatsumi et al., 2003, 
Shiraishi et al., 2001, Nicotera et al., 1998). However, glucose uptake and glycolysis 
reduced hypoxia induced apoptosis in neonatal rat cardiomyocytes (Malhotra & 
Brosius, 1999). Whether hypoxia/anoxia alone is sufficient to induce apoptosis or if it 
requires a combination of hypoxia and reperfusion leading to acidosis is disputed.
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Webster and co-workers (Webster et al., 1999) have demonstrated that in an in vivo 
model, acidosis and reperfiision but not hypoxia alone induced apoptosis. In another 
study chronic hypoxia was shown to induce apoptosis in rat hearts and in isolated rat 
cardiomyocytes (Jung et al., 2001). More recently the molecular mechanisms of 
hypoxia-induced apoptosis in tumour cells were investigated and these results showed 
cell-death occurred via the intrinsic apoptotic (mitochondrial) pathway (Weinmann et 
al., 2004). There are two pathways that lead to cell death. The extrinsic pathway 
requires the triggering of the cell surface death receptors by specific ligands and allows 
the cell to respond to the immediate environment. Cells can also die via the intrinsic 
pathway, which is driven by organelles such as the ER and the mitochondria, in 
response to changes in the internal environment. Both of these pathways have been 
implicated in apoptosis occurring in myocardial diseases with the mitochondrial 
pathway playing a role in the acute and chronic phases of myocardial disease and death 
receptors may play a more significant in the longer term (Clerk et al., 2003).
During hypoxia-induced apoptosis in cardiomyocytes the level of Bax expression was 
significantly increased in hypoxic rat hearts compared with normoxic hearts (Jung et al., 
2001) implying that Bax plays an important role in the hypoxia-induced apoptotic 
pathway. In many cell types, including cardiomyocytes, Bax is located predominantly 
in the cytosol but translocates to mitochondria at an early stage in apoptosis (Wolter et 
al., 1997, Zhang et al., 1998, Capano & Crompton, 2002). Bax present in the cytosol of 
non-apoptotic cells has the N-terminal domain buried within the protein (Hsu & Youle,
1997) and this prevents its targeting to mitochondria (Cartron et al., 2003). However, 
previously it was shown that regulated targeting of Bax to mitochondria and its
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insertion into the mitochondrial membranes involved the C-terminal hydrophobic 
domain and was accompanied by conformational changes that expose the N-terminal 
region and the BH3 domain (Wolter et al., 1997, Goping et al., 1998, Desagher et al., 
1999). These changes were shown to be responsible for dimerisation mediated by the 
exposed BH3 domain (Wang et al., 1999, Antonsson et al., 1991). In contrast other 
groups have shown that deletion of the C-terminus of Bax did not abolish mitochondrial 
targeting and therefore proposed that the C-terminus is not a mitochondrial targeting 
signal (Tremblais et al., 1999). More recently Bax-induced cytochrome c release from 
mitochondria was shown to be dependent on a-helices -5 and -6  (Heimlich et al., 
2004). These a-helices share structural similarities to the pore-forming domains of 
certain bacterial toxins (Chou et al., 1999, Me Donnell et al., 1999, Sattler et al., 1997). 
This study showed that Bax lacking a functional BH3 domain was capable of inducing 
cytochrome c release, however, deletion of helices -5 and -6 prevented insertion of Bax 
into mitochondrial membranes and greatly decreased the cytochrome c releasing 
activity. The ability of Bax to induce the release of apoptogenic proteins from the IMS 
is thought to be dependent on its oligomeric state. In particular, Bax complexes (4-mers 
and 12-mers) were isolated from apoptotic cells (Antonsson et al., 2001, Gross et al.,
1998). Larger Bax aggregates containing thousands of Bax molecules have been 
detected close to mitochondria during apoptosis (Nuchushtan et al., 2001). However 
the role of these Bax aggregates in the permeabilisation of the OMM or other apoptotic 
functions is not known. Previous studies in our laboratory have shown that endogenous 
Bax was present throughout the cytosol in primary rat cardiomyocytes (Capano & 
Crompton, 2002). Induction of apoptosis by staurosporine lead to a punctate 
distribution of Bax. Further experiments with cardiomyocytes transfected with GFP-
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Bax and using MitoTracker red, which accumulates electrophoretically into 
mitochondria in response to high inner membrane potential, revealed that the GFP-Bax 
co-localised with the MitoTracker red. Therefore it was concluded that the punctate 
distribution of Bax during apoptosis was due to its localisation to mitochondria.
In this investigation primary rat cardiomyocytes were transfected with GFP-Bax (green 
fluorescent protein present at the N-terminal of Bax, section [2.2]). GFP-Bax constructs 
have been used in a number of studies to examine Bax translocation from the cytosol to 
the mitochondria during apoptosis (Wolter et al., 1997, Neschushtan et al., 2001, 
Capano & Crompton, 2002). GFP-Bax has the same cellular distribution as endogenous 
Bax, i.e. in the cytosol of healthy cells, despite the presence of the large GFP-tag (30 
kDa) at the N-terminus. The cells were treated with sodium cyanide (ImM) to block 
mitochondrial electron transport and no glucose was present in the medium in order to 
impose simulated ischaemia. The aim of this work was to find out if Bax translocation 
from the cytosol to mitochondria occurred under ischaemic conditions in 
cardiomyocytes. Another aim was to determine if Bax was capable of interacting with 
the VDAC-ANT junctional intermembrane contact sites and if Cyp D was present 
which would provide strong support for the role of the MPT-pore in Bax induced 
permeabilisation of the OMM.
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[5.1.1] GFP-Bax translocation to mitochondria after incubation with cyanide
In this investigation anoxia-induced apoptosis in rat cardiomyocytes was initiated by the 
addition of sodium cyanide (ImM). Cardiomyocytes transfected with GFP-Bax 
(section [2.2]) were observed by fluorescent microscopy before the addition of cyanide 
and at half hour intervals after the addition of cyanide. Figure [5.1] shows images 
obtained over a 4 hour time-period of a single cardiomyocyte transfected with GFP-Bax 
following the addition of sodium cyanide. In figure [5.1] A, time-zero before treatment 
with cyanide, GFP-Bax had a diffuse distribution throughout the cytoplasm and the 
nucleus with a few denser regions of GFP-Bax present in the cytoplasm. Over a 4 hour 
time-period the distribution of GFP-Bax became less diffuse and the denser regions of 
GFP-Bax in the cytoplasm became more apparent. This punctate distribution of GFP- 
Bax is observed after 2.5 hours after treatment with sodium cyanide (figure [5.1] C). 
Figure [5.2] A shows an enlarged region of the cell at time zero and figure [5.2] B after 
4 hours incubation with cyanide. It clearly shows the punctate GFP-Bax distribution in 
the cytoplasm. After 4-6 hours the mitochondria began to break up and disappear 
(results not shown).
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Figure [5.1 ] Cyanide-induced translocation of GFP-Bax. A cardiomyocyte 
transfected with GFP-Bax was imaged at the indicated times after the addition of 
sodium cyanide. Cells were removed from the incubator (37°C) and the cell culture 
medium was removed and replaced with 1ml of buffer containing 24mM HEPES, 4mM 
KC1, lOOmM NaCl, ImM MgS04, ImM CaCl2, ImM KH2P04, pH 7.4 (for each cover 
slip). The imaging of the cells was carried out at room temperature. Sodium cyanide 
was added to the incubation medium. A At time-zero, before the addition of sodium 
cyanide. Scale bar represents 10pm. B After 1.5 hours. C After 2.5 hours. D After 3 
hours. E After 3.5 hours. F After 4 hours.
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0 hours 4 hours after addition of
sodium cyanide
Figure [5.2] Enlargement of an area of a cardiomyocyte transfected with GFP-Bax 
before and four hours after the addition of sodium cyanide. A An enlargement of 
the area shown in the rectangle of 15.1] A showing a cardiomyocyte at time-zero before 
the addition of sodium cyanide. B The same area was selected in [5.1] F that shows the 
same cardiomyocyte 4 hours after the addition of sodium cyanide. Scale bar represents 
2.5pm
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[5.1.2] Analysis o f GFP-Bax translocation
Changes in GFP-Bax distribution were quantified in two ways; from the standard 
deviation (S.D.) in pixel intensities and from the line analysis of the pixel intensities. 
The images shown in [5.1] A-F were analysed using Metamorph Software to calculate 
the S.D. of the pixel intensities. Three different areas of the cell were selected and the 
S.D. of the pixel intensities was measured for the same areas within each image (figure
[5.3]). Before the addition of cyanide the S.D. values were low but increased as the 
GFP-Bax distribution became less diffuse. In a previous study GFP-Bax translocation 
was followed after cardiomyocytes were incubated with staurosporine. Three distinct 
phases of GFP-Bax sequestration were observed (Capano & Crompton, 2002). The 
two phases observed in figure [5.3] were also seen i.e. the initial diffuse distribution of 
GFP-Bax followed by its localisation to mitochondria. The third phase characterised 
was associated with the formation of large Bax aggregates on mitochondria. The Bax 
aggregates were first observed by Nechushstan and co-workers in HeLa cells 
undergoing apoptosis after treatment with staurosporine (Nechushstan et al., 2001). 
When the cardiomyocytes were incubated with cyanide the third phase with GFP-Bax 
aggregates present on mitochondria was rarely seen. At later time points there was a 
loss of mitochondrial integrity and GFP-Bax could not be seen.
In figure [5.4] the pixel intensities were analysed along a line drawn through the 
cytoplasm after different times after treatment with sodium cyanide. The analysis 
shows that at time-zero, before the addition of cyanide, the intensity of the adjacent 
pixels along the line had a similar intensity that was consistent with the observed 
diffuse distribution of GFP-Bax in the cytoplasm (figure [5.4] A, C). After 4 hours
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incubation with sodium cyanide the pixel intensity of adjacent pixels varied which is 
consistent the observed punctate GFP-Bax distribution (figure [5.4] B, D).
Time (hours]
Figure [5.3] Analysis of S.D. of pixel intensities for each time-point. Three different 
areas with the same dimensions were selected for each of the images (A) to (F) shown 
in figure [5.1] and the Metamorph software was used to determine the S.D. for each of 
the selected regions as to obtain a quantitative measure of the changes in the 
intracellular distribution of GFP-Bax from time-zero before the addition of sodium 
cyanide up to 4 hours after treatment with cyanide.
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Figure [5.4] Line analysis of pixel intensities. A Cardiomyocyte at time-zero 
before the addition of sodium cyanide. B After 4 hours incubation with sodium 
cyanide. The pixel intensities along the same line shown are given in C (time- 
zero) and D (after 4 hours).
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The analysis of the S.D. of pixel intensities was also performed to compare the GFP- 
Bax sequestration in different cells. Figure [5.5] shows the mean S.D. from three 
different areas (with the same dimensions) of three different cells after treatment with 
sodium cyanide for up to 6 hours. One of the cells shown is the same as figure [5.1] 
(pink squares). These results are similar to those shown in figure [5.3]. The same two 
GFP-Bax sequestration phases were observed when the areas of the single 
cardiomyocytes were examined over the 4-hour time-course. In phase 1, the S.D. 
remains low up until 2 hours corresponding to a diffuse GFP-Bax distribution and in 
phase 2 there was an increase in the S.D. associated with the more punctate distribution 
of GFP-Bax. The results obtained for the cell represented in blue in figure [5.5] show 
that after 4.5 hours there was a further increase in the S.D and this was observed up to 
5.5 hours after treatment with sodium cyanide. After 5.5 hours the cell could no longer 
be seen using the fluorescent microscope. For most of the cells the punctate GFP-Bax 
distribution was observed up to 4 hours after the addition of cyanide after which the 
cells began to break up and disappear. Figure [5.6] shows the images obtained for the 
cell represented in blue in figure [5.5]. After 5 hours, following the addition of cyanide, 
ethidium homodimer-1 (EthD-1) was added to the cells to determine if they were still 
viable. EthD is excluded by the intact plasma membrane of live cells but enters cells 
with damaged membranes and undergoes a 40-fold enhancement of fluorescence upon 
binding nucleic acids, thereby producing a bright red fluorescence in dead cells.
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Figure [5.5] Analysis of mean S.D. of pixel intensities for each time-point for three 
different cells. Each colour (yellow, blue and pink) represents a different cell. The 
pink line shows the mean data for the cell shown in figure [5.1]. Three areas (with the 
same dimensions) of each cell were analysed for each time-point after the addition of 
sodium cyanide and the mean value for the S.D. was calculated.
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E
Figure [5.6] Cell viability after treatment with sodium cyanide. A cardiomyocyte 
transfected with GFP-Bax was imaged at the indicated times after addition of cyanide. 
A At time-zero. B After 2 hours. C After 3 hours. D After 5 hours. E After 5 hours 
the cells were stained with EthD-1. The nuclei of dead cells stain bright red. F Overlay 
of the images of GFP-Bax and EthD-1.
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Previously, Wolter and co-workers (Wolter et al., 1997) reported that GFP-Bax 
translocated to mitochondria in staurosporine-induced apoptosis in Cos-7 cells; 
however, GFP-Bax also accumulated at other sites that did not stain for mitochondria. 
More recently it was shown that Bax also targets the ER where it affects Ca2+ retention 
(Pan et al., 2001, Oakes et al., 2003). In this investigation the mitochondrial stain 
MitoTracker red was used to determine if the punctate GFP-Bax distribution after 
incubation with cyanide was due to GFP-Bax localisation with mitochondria. The 
MitoTracker red was added immediately before the induction of apoptosis. This stain 
accumulates electrophoretically into mitochondria in response to the high inner 
membrane potential. Mitochondrial uptake of the MitoTracker became impaired after 
more than 3 hours treatment with cyanide, possibly reflecting the reported decrease in 
inner membrane potential at this time (Shiraishi et al., 2001). In addition the cyanide 
used in this investigation inhibits the mitochondrial electron transport chain that would 
subsequently lead to a decrease in the inner membrane potential. Figure [5.7] A shows 
cells transfected with GFP-Bax three hours after the addition of cyanide. The same 
cells are shown in figure [5.7] B where the mitochondria were visualised with 
MitoTracker red. The two images were overlayed in figure [5.7] C. An enlargement an 
area of the cell shown in figure [5.7] is shown in figure [5.8]. The overlayed images 
show that the punctate distribution of GFP-Bax is due to its localisation to 
mitochondria. However, ER tracker would be required to determine whether or not 
GFP-Bax translocates to the ER.
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A GFP-Bax B MitoTracker C Overlay
Figure [5.7] Localisation of GFP-Bax to mitochondria. A Cardiomyocytes 
transfected with GFP-Bax. B Cardiomyocytes stained with MitoTracker red. C 
Overlay of images A and C.
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A GFP-Bax B MitoTracker red C Overlay
Figure [5.8] Enlargement of an area o f the cardiomyocyte shown in figure [5.~]
3 hours after treatment with sodium cvanide
[5 .2] GFP-Bax co -im m unoprecip ita tes w ith  VDAC and  ANT
Immunoprecipitations were performed to find out if Bax targets VDAC-ANT 
intermembrane contact sites in rat cardiomyocytes. Cell extracts were prepared from 
GFP-Bax and GFP transfected cardiomyocytes (section [2.8]). These extracts were 
incubated with anti-GFP monoclonal antibody coupled to sepharose beads. The 
immunoprecipitated proteins were extracted in SDS-PAGE sample buffer and analysed 
by Western blotting. Figure [5.9] A shows that VDAC co-immunoprecipitates with 
GFP-Bax 1.5 hours and 3 hours after cells were treated with cyanide. In addition only a 
very small amount of VDAC co-immunoprecipitated with GFP-Bax at time-zero, before 
the addition of cyanide. VDAC did not co-immunoprecipate with GFP 3 hours after the
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cells were treated with cyanide. In two separate experiments, with different cells, 
immunoprecipitations were carried out at time-zero and 2 hours after incubation with 
cyanide (figure [5.9] B). Again GFP-Bax co-immunoprecipitated with VDAC after 2 
hours but not at time-zero. The blot shown in figure [5.9] B was stripped and then 
probed with an anti-ANT polyclonal antibody. ANT also co-immunoprecipitates with 
GFP-Bax 2 hours after the cells were treated with cyanide and not at time-zero (figure 
[5.9] C). These data indicate that Bax not only interacts with VDAC, but also VDAC- 
ANT complexes. As demonstrated in chapter 4, VDAC-ANT complexes can recruit 
Cyp D from the mitochondrial matrix to produce a complex that forms the PT pore 
under pathological conditions (Crompton et al., 1998). Therefore Western blotting was 
used to detect Cyp D in the immunoprecipitates, however, none was detected.
[5.3] Discussion
In this investigation rat cardiomyocytes transfected with GFP-Bax were treated with 
cyanide to induce apoptosis and GFP-Bax translocation was examined in single rat 
cardiomyocytes. Initially the GFP-Bax displayed a diffuse distribution throughout the 
cytosol and 1.5 hours after treatment with cyanide a more punctate GFP-Bax 
distribution was observed. The mitochondrial stain MitoTracker red was used to show 
that GFP-Bax localised to mitochondria. In Chapter 4 the results showed that GST-Bax 
interacted with VDAC and ANT in mitochondrial membrane extracts derived from rat 
hearts. When purified Cyp D was added, together with the mitochondrial membrane 
extract, it was also retained by the GST-Bax matrix indicating that Bax interacted with
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Figure [5.9] GFP-Bax co-immunoprecipitates with VDAC and ANT after 
translocation to mitochondria. A GFP-Bax transfected cells were treated with ImM 
sodium cyanide for the time indicated. Anti-GFP antibody coupled to sepharose beads 
was used to immunoprecipitate GFP-Bax or GFP from extracts of the transfected cells 
(as indicated above each lane; whether cells were tranfected with either GFP alone or 
with GFP-Bax). Western blotting was used to determine if VDAC was present in the 
immunoprecipitate (IP). B In two other experiments, using different cells, Western 
blotting was used to detect VDAC in the IPs before treatment with cyanide and two 
hours after treatment with cyanide. C The blot shown in B was stripped and Western 
blotting was used to determine if ANT was present in the GFP-Bax IPs.
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components of the MPT-pore. Therefore immunoprecipitations were performed using 
cell extracts derived from cardiomyocytes transfected with GFP-Bax and treated with 
cyanide to determine if Bax interacts with VDAC-ANT after translocation to 
mitochondria. The results showed that GFP-Bax co-immunoprecipitated with VDAC 
and ANT but Cyp D was not detected.
A previous study showed that periods of prolonged hypoxia were sufficient to induce 
apoptosis in cardiomyocytes (Jung et al., 2001, Matsui et al., 1999) whilst other groups 
showed that reperfusion in addition to ischaemia was required to induce apoptosis 
(Webster et al., 1999). The discrepancy between these studies may be explained by 
different experimental conditions. Webster et al. used insulin-supplemented medium. 
Insulin has been shown to prevent apoptosis through activation of Akt a 
serine/threonine kinase, which is a downstream effector of growth factor mediated cell 
survival (Hermann et al., 2000). In the work presented in this chapter cardiomyocytes 
were subjected to simulated ischaemia. Treatment of the cells with cyanide inhibited 
the electron-transport chain to induce anoxia and no glucose was present in the medium 
to simulate ischaemia. Jung and co-workers compared the levels of Bax expression in 
hypoxic and normoxic rat hearts and in cultured cardiomyocytes. Their data showed 
that Bax expression levels were increased in hypoxic rat hearts but not in cultured 
hypoxic cardiomyocytes. Jung and co-workers suggest this difference may be due to a 
daily 10-minute period of re-oxygenation in room air while the rats were fed and the 
cages were changed. Whether or not hypoxia increases Bax expression may not be 
critical since Bax is present in the cytosol of non-apoptotic cardiomyocytes and 
transient transfection with GFP-Bax does not result in apoptosis. Bax action is
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dependent on apoptotic stimuli that results in conformational changes that expose the 
N-terminal region of Bax, the oligomeric state of Bax (Antonsson et al., 2001) and 
translocation to mitochondrial membranes (Wolter et al., 1997, Capano & Crompton,
2002). Evidence for the central role of mitochondria in hypoxia-induced apoptosis was 
provided in a recent study by Weinmann and co-workers (Weinmann et al., 2004). 
Their results showed that a lack of caspase-8 or FADD, that are important mediators of 
the extrinsic pathway which is activated by ligation of receptors on the plasma 
membrane and in which mitochondria do not play a central role, had no affect on the 
time-course or rate of hypoxia induced apoptosis in Jurkat T-lymphoma cells. In 
contrast, overexpression of Bcl-2 or expression of a dominant negative caspase-9 
mutant, both known to interfere with mitochondrial apoptotic signalling, significantly 
inhibited hypoxia-induced apoptosis. Therefore it was concluded that hypoxia-induced 
apoptosis occurs via the intrinsic apoptotic pathway.
In this study EthD-1 was used to determine cell viability after treatment with cyanide, 
however, this did not show whether the cells were apoptotic or necrotic. The relative 
levels of apoptotic and necrotic cell death could be measured in a number of ways. 
Phoshatidylserine is exposed on the surface of apoptotic cells. Annexin V binds to 
phosphatidylserine with high affinity and this can be conjugated with fluorescein in 
order to detect apoptotic cells using flow cytometry (van Engeland et al., 1998). In 
addition the cationic dye PI could be used together with fluorescein-annexin since PI is 
excluded by intact plasma membranes. Therefore it would be possible to determine if 
the cells were unaffected, non-apoptotic cells (annexin V negative/PI negative), early 
apoptotic cells (annexin V positive/PI negative), and late apoptotic or necrotic cells (PI
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positive). Other ways in which apoptotic cells can be identified is by detecting DNA 
strand breaks, for example using terminal deoxynucleotide transferase-mediated dUTP- 
biotin nick-end labeling (TUNEL) (Gavrieli et al., 1992). The incorporation of 
biotinylated bases into damaged DNA allows their subsequent detection by anti-biotin 
antibodies.
The mechanism of Bax-induced permeabilisation of the OMM remains unresolved. 
Tsujimoto’s group has proposed that VDAC forms a pore through which apoptogenic 
proteins are released from the IMS into the cytosol (Shimizu et al., 1999, Shimizu et al., 
2000). The VDAC pore was opened by Bax and closed by Bc1-Xl. However, other 
studies have demonstrated Bax-only mechanisms of outer membrane permeabilisation. 
These include the assembly of Bax oligomers in the mitochondrial outer membrane to 
form pores (Antonsson et al., 2001, Pavlov et al., 2001, Saito et al., 2000, Korsmeyer et 
al., 2000) and Bax-induced destabilisation of the phospholipid bilayer, leading to 
transient breaks in the outer membrane (Bansnez et al., 1999, Kuwana et al., 2002). 
Another study in our laboratory demonstrated that during staurosporine-induced 
apoptosis Bax translocates from the cytosol to the mitochondria. Immunoprecipitations 
performed after staurosporine-induced apoptosis in cardiomyocytes also showed that 
VDAC and ANT co-immunoprecipitate with GFP-Bax (Capano & Crompton, 2002). In 
the same study GFP-Bax translocation to mitochondria and interaction with VDAC and 
ANT was shown to occur in the same time frame as the release of red-fluorescent 
protein-tagged cytochrome c (RFP-cytochrome c). Previously it was shown that 
apoptosis and necrosis are initiated in the same way during liver damage and both 
involve the MPT-pore but have different outcomes (Lemasters, 1999). The results in
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this chapter show that in neonatal cardiomyocytes transfected with GFP-Bax treated 
with cyanide, to simulate ischaemia, VDAC and ANT co-immunoprecipitate with GFP- 
Bax but not Cyp D suggesting Bax does not interact with the MPT-pore under these 
conditions. However, other work suggests the MPT-pore does play a role in 
cytochrome c release from mitochondria in cardiomyocytes undergoing apoptosis 
induced by ischaemia (Borutaite et al., 2003). Rat hearts were perfused using a 
Langendorff-perfusion system and stop-flow ischaemia was induced for 30-60 minutes. 
Their results showed that ischaemia alone was sufficient to induce apoptosis and 
mitochondrial dysfunction. MPT was implicated in cytochrome c release because pre­
perfusion of hearts with cyclosporin A prevented the release of cytochrome c from 
mitochondria during ischaemia. In this investigation GFP-Bax co-immunoprecipitated 
with ANT in the IMM as well as VDAC. From these findings it is not possible to tell 
whether the co-immunoprecipitation of ANT with VDAC merely reflects the ability of 
VDAC to bind to ANT (Brdiczka, 1991) or whether it points to the formation of a stable 
Bax-VDAC-ANT complex which interacts with Bax. The latter is favoured by other 
lines of research that implicate ANT in apoptosis. The overexpression of ANT-1 leads 
to apoptosis in a number of cell types (Bauer et al., 1999). Bax has also been shown to 
interact with ANT which results in the modulation of ANT antiporter activity, reducing 
ADP/ATP exchange (Belzacq et al., 2003). These findings point to Bax targeting a 
VDAC-ANT mitochondrial intermembrane complex. The role of this complex in the 
permeabilisation of the OMM is not clear. Bax may form a pore with VDAC (Shimizu 
et al., 2000) or the VDAC-ANT complex may function as a receptor for Bax 
localisation to mitochondria and permeabilisation of the OMM may occur via a Bax-
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only model involving destabilisation of the phospholipid structure of the OMM 
(Kuwana et al., 2002).
In order to determine whether or not the MPT pore is involved in the mechanism of 
cyanide-induced apoptosis in cardiomyocytes MPT could be measured. In other studies 
MPT was measured as a loss of mitochondrial membrane potential (AT'm) (Bialik et al., 
1999, Lovat et al., 2000). However, this method would be unsuitable for this current 
study as sodium cyanide inhibits the mitochondrial electron-transport chain leading to a 
loss of ATV Previously the fluorochrome calcein (622Da) was used to measure MPT- 
pore opening in intact cells (Nieminen et al., 1997). Another approach would be to 
treat the cardiomyocytes with ligands of Cyp D that are known to inhibit MPT-pore 
opening, for example CSA or Sanglifehrin A (SfA) (Clarke et al., 2002) before the 
induction of apoptosis with cyanide to determine whether the inhibition of MPT would 
prevent translocation of Bax to mitochondria and apoptosis from occurring. However 
Bax has also been shown to localise to the ER and reduces its ability to retain calcium 
(Pan et al., 2001). Further experimental work could be carried out to determine 
whether or not Bax localises to the ER during cyanide-induced apoptosis. Other Bcl-2 
proteins (Nuchushtan et al., 2001) e.g. Bak translocate to mitochondria and 
permeabilise the OMM leading to the loss of apoptogenic proteins from the IMS. 
Interfering RNA (RNAi) technology could be used to inhibit Bax expression in 
cardiomyocytes to determine whether Bax is essential in the cyanide-induced apoptotic 
mechanism or whether Bak or other pro-apoptotic Bcl-2 proteins are capable of 
mediating apoptosis in the absence of Bax.
154
Chapter 6: Results
Chapter 6: Results
Attempts to identify the mitochondrial calcium uniporter
[6.1] Calcium and apoptosis
Mitochondria are key players in apoptotic signalling (Hengartner, 2000) but other 
organelles, including the ER, have also been implicated (Ferri & Kroemer, 2001). The 
ER can initiate apoptosis when unfolded proteins accumulate within the ER or when 
ER-Golgi transport inhibition results in the so-called ER stress response (Oyadomari et 
al., 2002). It also regulates apoptosis through its role in intracellular Ca2+ signalling.
94 -The ER is the mam intracellular Ca store and is physically and physiologically 
interconnected with mitochondria. This spatial and functional organisation impacts on 
the regulation of mitochondrial function and complex cellular processes (Hajnoczky et 
al., 2003, Hajnoczky et al., 1995, Rizzuto et al., 1998). Mitochondria have been shown 
to modulate and synchronise Ca2+ signalling (Berridge et al., 2000). In addition, stimuli
94 -that produce inositol 1,4,5-triphosphate (IP3) cause the release of Ca from the ER that 
is rapidly taken up by juxtaposed mitochondria (Rizzuto et al., 1993). Ca2+ is also an 
important modulator of the MPT-pore (section [1.8.4]). This non-selective pore in the 
IMM allows the permeabilisation of the EMM to solutes up to 1500 Da (Bemardi, 1999, 
Crompton, 1999) and opens under pathological conditions involving increases in
9 4 -intracellular Ca and Pz e.g. during ischaemia/reperfusion injury in the heart (reviewed 
in Halestrap et al., 2004).
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The MPT-pore has been implicated in both apoptotic and necrotic cell death (Zamzami 
et al., 1996, Scorrano et al., 1999). During apoptosis Bcl-2, Bax and Bak localise to the 
ER as well as mitochondria (Pinton et al., 2001, Wei et al., 2001, Scorrano et al., 2003). 
Bcl-2 has been shown to modulate Ca2+ fluxes during the course of cell death. Several 
groups have shown that overexpression of Bcl-2 leads to a reduction in the resting ER 
Ca2+ concentration and a reduction in the extent of Ca2+ entry into the ER (Pinton et al., 
2000, Foyouzi-Youssefi et al., 2000). Bax and Bak double knockouts were shown to be 
resistant to death induced by thapsigargin (Wei et al., 2001), an irreversible inhibitor of 
the sarco-endoplasmic Ca2+ ATPase (SERCA) responsible for the re-uptake of Ca2+ 
from the cytosol into the ER lumen (Distelhorst et al., 1996). Inhibition of the SERCA
‘j i
pump by thapsigargin caused the passive release of the ER Ca and a rise in cytosolic 
Ca2+. In the absence of extracellular Ca2+, the increase in cytosolic Ca2+ was 
proportional to the ER Ca2+ content. Bax and Bak deficient cells displayed a lower 
cytosolic Ca2+ peak compared to wildtype cells due to the diminished steady Ca2+ levels 
assessed by calcium-sensitive organelle specific fluorescent probes (Scorrano et al.,
2003). Scorrano and co-workers (Scorrano et al., 2003) assessed the relative impact of
“94-reduced ER Ca levels observed in Bax and Bak deficient cells on the regulation of 
apoptosis. The defects in the double knockouts were corrected by targeting Bax 
exclusively to the mitochondria and by overexpressing SERCA. The expression of
j
mitochondrially targeted Bax in the knockouts did not correct levels of ER Ca . 
Double knockout cells were used to determine whether the outcome of different 
apoptotic stimuli was primarily controlled by ER Ca2+ or mitochondrial-based Bax or
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Bak. Apoptosis induced by the BH3-only domain protein tBid (Wei et al., 2000) was 
restored in the knockouts by mitochondrially targeted Bax but not by the 
overexpression of SERCA. However, apoptosis induced by ceramide, arachidonic acid 
or oxidative stress (Pinton et al., 2001, Scorrano et al., 2001, Scorrano et al., 2003) was 
restored by the overexpression of SERCA in the Bax and Bak deficient cells and not by 
mitochondrially targeted Bax. To achieve the same level of apoptotic cell death in Bax 
and Bak deficient cells as the wildtype in response to proapoptotic stimuli such as 
etoposide or staurosporine; both mitochondrially targeted Bax and the overexpression 
of SERCA were required.
[6,1.1] Mitochondrial calcium cycling
Mitochondrial Ca2+ uptake was first described in 1961 by De Luca and Engstrom (De 
Luca & Engstrom, 1961). The mitochondrial calcium uniporter located in the IMM 
passes Ca2+ down the electrochemical gradient maintained across this membrane 
without direct coupling to ATP hydrolysis or the transport of other ions (Gunter &
2*"bGunter, 1994). Calcium exits mitochondria by exchange with sodium on the Na /Ca 
carrier (Crompton et al., 1976). This is shown in Figure [6.1]. Continuous Ca2+cycling 
across the inner membrane occurs and is established by the kinetic properties of the 
uniporter and efflux system(s). Calcium influx via the uniporter is driven by the 
electrochemical gradient, and the rate of this process increases with increasing 
membrane potential but only up to -llOmV (isolated liver mitochondria) (Goldstone et 
al., 1987). Above this value, uniporter activity reaches a plateau. As a result, decreases
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in inner membrane potential to 1 lOmV do not produce losses of mitochondrial Ca2+, at 
least not in isolated mitochondria. This transport cycle enables changes in cytosolic 
[Ca2+] to be relayed into changes in matrix [Ca2+]. Changes within the limits 0.1-10 pM 
are appropriate to regulate the activity of the dehydrogenases involved in controlling the 
rate of intramitochondrial oxidative metabolism (McCormack & Denton, 1990). These 
key enzymes are: pyruvate dehydrogenase, oxoglutarate dehydrogenase and NAD- 
linked isocitrate dehydrogenase. These three enzymes catalyse oxidative 
decarboxylations at control points in mitochondrial oxidative metabolism. By extending 
the messenger role of Ca2+ to the mitochondria, the Ca2+ transport cycle allows 
oxidative metabolism to respond to Ca2+-dependent events in the cytosol (Hansford, 
1991). An obvious example is in the case of cardiac muscle contraction. When heart 
muscle contractions increase, the height and frequency of the cytosolic transients also 
increase leading to an increase in mitochondrial [Ca ] and consequent activation of the 
TCA cycle and oxidative phosphorylation (Denton and McCormack; 1984).
[6.1.2] Mitochondrial Calcium Uniporter
Previously it was unclear as to whether the mitochondrial calcium uniporter was a 
carrier or a channel (Gunter & Pfieffer, 1990). Carriers are characterised by turnover 
numbers that are about 1000-fold lower than ion channels. However, a recent study 
involving the patch-clamping of single mitoplasts (mitochondria with the outer
• • 2“bmembrane removed) isolated from COS-7 cells showed that the umporter is a Ca
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Figure [6.1] Mitochondrial calcium cycle. Calcium enters mitochondria through the 
uniporter and exits through the Na+/Ca2+ antiporter. This process is driven by the proton 
pumps of the respiratory chain. Mitochondrial calcium controls key regulatory 
dehydrogenases in the mitochondrial matrix. Under pathological conditions associated 
with ATP depletion and oxidative stress, mitochondrial Ca2+ triggers PT pore opening, 
(taken from Crompton, 1999)
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selective ion channel (Kirichok et al., 2004). Their results showed that a voltage from -  
160mV (potential across the EMM of energised mitochondria) to +80 mV elicited a
9-4-current that gradually increased as the free Ca concentration at the cytosolic surface of 
the IMM was varied from 20pM to IOOjjM. These concentrations are comparable with 
the Ca2+ concentration in microdomains near the ER/SR or plasma membrane channels, 
sensed by neighbouring mitochondria (Rizzuto et al., 2000, Montero et al., 2000, 
Rizzuto et al., 1993, Neher et al., 1998). The uniporter is activated by ADP, 
aminoglucoside antibiotics and triethylenetetramine (Gunter et al., 1991, and references 
therein) and is inhibited by the lanthanides and Ruthenium Red (Moore, 1971, 
Vasington et al., 1972; Reed and Bygrave, 1974) Ruthenium Red has the formula: 
[(NH3)5Runi-0-(NH3)4RuIV-0-Runi(NH3)5]6+. However, another ruthenium complex 
ion, known as Ru 360 is a more potent uniporter inhibitor and is present as an impurity 
in commercial preparations of Ruthenium Red (Ying et al., 1991) and has the formula 
[CH3(NH3)4Ru-0-Ru(NH3)4CH3]3+. A s  little as 50pmoles Ru 360/mg mitochondrial 
protein is sufficient for 50% inhibition of uniporter activity. Among other ammine 
complexes, Crompton and Andreeva (Crompton & Andreeva, 1994) synthesised 
several cobaltammines. Of these diaminopentanepentamminecobalt (DAPPAC) was 
the most potent inhibitor (Ki 0.14pM; corresponding to 0.14 nmoles/ mg mitochondrial 
protein).
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[6.1.3] Ca2+ Uniporter and Ra M
Gunter and co-workers have postulated the existence of a further Ca2+ uptake system. 
This is known as Ra M. Calcium uptake in nmoles/mg mitochondrial protein was plotted 
against pulse width in seconds. The rates indicated by the slopes of the lines were 
consistent with the rate of uptake by the uniporter. However, when extrapolated the line 
of fit always intersected the ordinate above zero uptake (Sparagna et al., 1994 and 
Sparagna et al., 1995). Gunter and co-workers suggested that this indicates that uptake of 
Ca2+ occurs very rapidly at the beginning of each pulse. Calcium uptake via Ra M was 
shown to be inhibited by uncouplers that dissipate the membrane potential suggesting that 
the thermodynamic driving force for the uptake is the Ca2+ electrochemical gradient. This 
group initially reported Ra M in liver mitochondria but they have also identified it in 
heart. However, Ra M in heart mitochondria was observed to be smaller than in liver 
mitochondria. Ra M has also been shown to be sensitive to inhibition by Ruthenium Red, 
although higher amounts are required to inhibit Ra M than the uniporter. This system is 
unaffected by millimolar mounts of AMP and ADP but is activated by 1 pM spermine 
and millimolar amounts of ATP. In addition, spermine and ATP can act in a synergistic 
manner to further increase Ca2+ uptake by Ra M. Calcium uptake by Ra M is so rapid that 
it cannot be measured directly. Predictions are that Ra M acts at least 300 times more 
rapidly than the uniporter. Others have published data in support of the other uptake 
system (Gallitelli et al., 1999). However, since the mechanism of uptake of both systems 
has not been elucidated it remains to be seen whether Ra M is a separate entity or an 
alternative conformation of the uniporter complex. The uniporter may have two 
conformations; one for rapid Ca uptake and the other the uniporter.
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[6,1,4] Purification o f the Ca2+ uniporter
So far, the calcium uniporter has not been unambiguously purified. This reflects 
difficulties inherent in the purification of a low-abundance hydrophobic protein. 
Mironova and co-workers reported the purification of a low-molecular weight peptide 
(20kDa) from rat liver mitochondria that formed selective channels in lipid bilayers. 
These channels were strongly inhibited by l-4pM Ruthenium Red (Mironova et al., 
1994). In another study, Zazueta and co-workers (Zazueta et al., 1998) used two 
methods to purify the uniporter. Proteins derived from rat kidney submitochondrial 
particles were separated by isoelectric focussing. Two assays were then carried out to 
identify the uniporter. One assay involved the reconstitution of the liquid-phase 
isoelectrofocussed proteins into cytochrome oxidase vesicles (COVs). Transport 
activity was measured as the ability of COVs to support uptake of radiolabelled 45‘Ca2+ 
in the presence of cytochrome c and the electron donor pair ascorbate-TMPD. In 
addition Western blotting was carried out using antibodies raised against mitochondrial 
membrane fractions with maximal Ca transport activity and which had previously 
been shown to inhibit calcium uptake by mitoplasts (Zazueta et al., 1994). The other 
method involved the addition of radiolabelled Ru 360 to submitochondrial particles and 
separation of the labelled proteins by CM-cellulose chromatography. An 18-kDa 
protein was found which bound Ru 360 and when reconstituted into vesicles could 
transport calcium. A 70 kDa protein was also co-purified with the 18-kDa proteins but 
whether this was part of the uniporter complex or an artefact of the purification was
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uncertain. Recent studies from the same group have shown that cardiolipin regulates 
the activity of the 18 kDa protein in liposomes by modifying the structure of the lipid 
bilayer (Zazueta et al., 2003).
[6.2] Novel Approach to identify the Calcium Uniporter in rat liver 
mitochondria
Ru 360 and DAPPAC are both potent inhibitors of the uniporter. In this study attempts 
were made to combine their inhibitory potential in a novel approach for uniporter 
identification. DAPPAC was converted to a fluorescent photoactive derivative 
(DAPPAC-SAED) for sensitive detection of photolabelled proteins. The photolabelling 
of the mitochondrial membranes by DAPPAC-SAED was carried out in the presence 
and absence of Ru 360. The rationale for this approach was to identify a protein whose 
labelling by DAPPAC was blocked by Ru 360. Figure [6.2] outlines the strategy used 
in an attempt to isolate the Ca uniporter from rat liver mitochondria. DAPPAC and 
Ru 360 both inhibit the Ca2+ uniporter, Ru 360 rather more strongly than DAPPAC 
(section [6.1.2]). They are both ammine complexes (of Co and Ru, respectively) and 
would both be expected to occupy the same site on the uniporter and to compete with 
each other for binding. The rationale was that Ru 360 would decrease photolabelling of 
the uniporter by SAED-DAPPAC, enabling uniporter-containing fractions to be 
identified as those in which fluorescent covalent labelling was inhibited by Ru 360.
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[6.3] Isolating the inhibitor Ru 360 from a commercial preparation of 
Ruthenium Red
The inhibitor was purified from a commercial preparation of Ruthenium Red using CM- 
cellulose chromatography (Ying et al., 1991). The Ru 360 eluted as a pale yellow 
fraction with 0.4 M ammonium formate. The Ruthenium Red was eluted as a bright 
pink fraction with 0.8 M ammonium formate. Most of the Ru 360 eluted in fractions 1- 
20 and Ruthenium Red eluted in fractions 78-85 (figure [6.3]). The concentration of Ru 
360 present in fractions 1-20 was calculated using Beer-Lamberts Law using a molar 
extinction coefficient of 2.6 x 104 M'1 cm'1 at 360nm (Ying et al., 1991). Using this 
value, 78 nmoles of Ru 360 was recovered from 1.16 mmoles of Ruthenium Red. 
Figure [6.4] shows that fractions 1-20 have the correct absorption maximum (360nm) 
for Ru 360.
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Ca2+ Uniporter
Separation of the inhibitor Ru 360 from a commercial preparation of 
Ruthenium Red using ion-exchange chromatography
Coupling of DAPPAC to the fluorescent cross-linker SAED
I
Photolabelling of proteins from the inner mitochondrial membrane with 
SAED-DAPPAC in both the presence and absence of Ru 360
Separation of the membrane proteins by ion-exchange chromatography
i
Measurement of the fluorescence of each fraction collected and 
comparing the fractions obtained with and without Ru 360 present in 
order to see which fraction contained the uni porter
Figure [6.2] Outline of the different steps used to try to identify the calcium 
uniporter protein in a mitochondrial membrane extract from rat liver.
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Figure [6.3] Fractionation of Ruthenium Red by ion-exchange chromatography.
The absorbance o f  each fraction eluted from the CM-cellulose column was measured at 
360 nm (blue line) and at 532 nm (pink line). 360 nm and 532 nm are the wavelengths 
at which the maximum absorption occurs for Ru360 and Ruthenium Red respectively 
(Ying et al., 1991). A linear ammonium formate gradient (0.1M-1M) was applied 
between fractions 0 and 100. The volume o f each fraction was 1ml.
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Figure [6.4] The absorption maximum for fraction 1-20 was 360nm. Fractions 1- 
20, which were thought to contain Ru 360, were pooled and the absorption was 
measured at wavelengths of 340-500nm.
[6.4] Inhibition of Ca2+ uptake into rat liver mitochondria by Ru 360
Ca2+ uptake by mitochondria was measured with the Ca2+ indicator arsenazo III in the 
presence of various concentrations of Ru 360 (0-0.012 nmol/mg of mitochondrial 
protein). The results (figure [6.5]) show that 4.2 pmoles Ru 360/mg protein yielded 50% 
inhibition of the uniporter.
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Figure [6.5] Ca2+ uptake by liver mitochondria was measured with the Ca2+ 
indicator arsenazo III in the presence of various concentrations of Ru 360 (0-0.012 
nmol/mg of mitochondrial protein). The assay was carried out as described in section 
[6.13]. All measurements relate to lmg mitochondrial protein, 0.25 mg of mitochondrial 
protein was used for each assay. The error bars show standard deviation
The equation obtained from the graph was re-arranged to find x-the inhibitor 
concentration that gives half the amount of uptake of calcium into the mitochondria ie. 
the 50 % inhibition level.
y = 368.15e"228*42 x
therefore: x = In 368.15 y / -228.42
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When no Ru 360 inhibitor was added 350.59 nmol/mg/min of calcium was taken up by 
the mitochondria.
Therefore, half of this was 175.30 nmol/mg/min and using the above equation the 
amount of Ru 360 that was required to produce this can be calculated:
x = In 368.15 175 30 / -228.42 
x = 5.908 17SJ0 / -228.42 
x = 1.01/ -228.42 
x = 0.0042
Therefore, the 50 % inhibition level was found to be 0.0042 nmol/mg protein. This was 
similar to that published by Ying and co-workers which was 0.0035 nmol/mg protein 
(Ying et al., 1991). It was concluded from the absorption spectrum (figure [6.4]) and 
its inhibitory potency that Ru 360 had been successfully purified.
[6.5] Photolabelling mitochondrial membrane proteins with SAED- 
conjugated DAPPAC
The photo-reactive cross-linker molecule SEAD was linked to DAPPAC, as described in 
section [2.10.3], This conjugation reaction would be expected to produce a molecule 
capable of binding with some specificity to the uniporter. A number of cobaltammines
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including hexamine cobalt (Co(NH3)6, inhibit the uniporter (Crompton & Andreeva, 
1994) with high affinity eg. the Ki for Co(NH3)6 is 1.7pM. Thus the inhibition by 
DAPPAC resides in the cobaltammine portion of the molecule such that addition of 
SAED at the free amino group of DAPPAC, separated from the cobaltammine group by 
a 5-carbon spacer, would be unlikely to abolish its inhibitory capacity. The 
fluorescence from the cross-linking azido group could be detected and therefore it 
would be possible to identify the uniporter in fractions eluted from the ion-exchange 
columns.
Photolabelling of the membrane proteins with SAED-DAPPAC was carried out as 
described in section [2.10.4]. The proteins in the labelled mitochondrial membrane 
extracts were separated on a Mono Q anion-exchange column equilibrated with Tris 
buffer (pH 8.0). The bound proteins were eluted with a NaCl gradient (100-500 mM 
NaCl). The pass through was dialysed against HEPES buffer (pH 7.2) for 14 hours and 
applied to a Mono S cation-exchange column pre-equilibrated with the same buffer. The 
bound proteins were then eluted with a NaCl gradient (100-500mM NaCl).
The fluorescence of SAED-DAPPAC present in each of the fractions collected was 
measured (excitation 340 nm, emission 435 nm). The protein elution profiles from the 
Mono Q and the Mono S columns for each of the mitochondrial membrane pellets ie. 1 
nmol Ru 360, 0.1 nmol Ru 360 and no Ru 360, were compared. In addition, the 
fluorescence value obtained for each fraction was analysed to see if the calcium 
uniporter protein could be identified. The protein elution profiles from the Mono Q 
column together with the fluorescence values for each fraction are shown in figure 
[6.6]. Figure [6.7] shows the results obtained from the Mono S column.
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Figure [6.6] Comparing the protein elution profiles obtained from the Mono Q 
anion-exchange column and the fluorescence of SAED-DAPPAC in each fraction.
A. The mitochondrial membranes were treated with SAED-DAPPAC conjugate in the 
absence and in the presence of 0.1 nmol and 1 nmol Ru 360. The proteins in each 
membrane preparation were separated on a Mono Q anion-exchange column pre­
equilibrated with 50mM Tris-HCl, lOOmM NaCl, ImM PMSF and 6% (w/v) CHAPS, 
pH 8.0 and the bound proteins were eluted with a NaCl gradient (100-500mM). A full- 
scale defection (F.S.D) of 0.01 was used and 1ml fractions were collected. B. The 
fluorescence values for SAED-DAPPAC in each of the eluted fractions was measured 
(excitation 340nm, emission 435nm) (blue- no Ru 360, pink- 0.1 nmol Ru 360 and 
yellow- 1 nmol Ru 360).
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Figure [6.7] Comparing the protein elution profiles obtained from the Mono S 
cation-exchange column and the fluorescence of SAED-DAPPAC in each fraction.
A. The pass-through from the Mono Q column was dialysed for 24 hours against 
buffer containing 50mM HEPES, 25mM NaCl, pH 7.2 and then applied to the Mono S 
column pre-equilibrated with the same buffer and the bound proteins were eluted with a 
NaCl gradient (100-500mM). The Full-scale deflection (F.S.D) was 0.1 and 1ml 
fractions were collected. B. The fluorescence values for SAED-DAPPAC for each of 
the eluted fractions was measured (excitation 340, emission 435) (blue- no Ru 360, 
pink- 0.1 nmols Ru 360 and yellow- 1 nmol Ru 360)
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Figure [6.6] shows the results obtained from the Mono Q anion-exchange column. 
Fractions 8-12 have the highest fluorescence with a peak in fraction 9. The results show 
the fluorescence from SAED-DAPPAC was reduced almost 3-fold for fraction 9 in the 
presence of Ru 360. Therefore, it was possible that this fraction contained the calcium 
uniporter protein. The proteins that did not bind to the Mono Q column were dialysed for 
16 hours and then applied to a Mono S cation-exchange column (figure [6.7]). Fraction 9 
had the highest fluorescence. Again, Ru 360 sensitive labelling was obtained (fractions 6 
and 9).
This was a promising start to this study. Initially, the results showed the maximum 
fluorescence was detected in the 9th fraction eluted from the Mono Q anion-exchange 
column. The fluorescence was reduced in the in the presence of Ru 360. However, this 
result could not be reproduced. Ru 360 did not always decrease this fluorescence peak 
and the fraction in which the maximum fluorescence was observed also changed. These 
results suggest that SAED-DAPPAC was not specifically interacting with the uniporter 
protein. Ru 360 and DAPPAC are both positively charged and may therefore bind to 
other membrane proteins with a negative charge.
[6.6] Discussion
Calcium is an activator of the MPT-pore that has been implicated in necrotic and 
apoptotic cell death (Crompton, 2000). The opening of the MPT-pore occurs when
increases in intracellular Ca are relayed to the mitochondrial matrix by the
7 *4-Ca uniporter located in the IMM. Therefore the calcium uniporter is a potential
• 7 4 * •therapeutic target in the prevention of Ca induced MPT-pore opening e.g in 
ishaemic/reperfusion injury. The mechanism by which the Ca2+ uniporter mediates
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mitochondrial Ca2+ uptake has now been established (Kirichok et al., 2004). However, 
the mitochondrial uniporter protein has not been unambiguously identified and the 
nucleotide and amino acid sequences for the uniporter are not known. This is probably 
a result of the difficulties associated with the purification a low abundance membrane 
protein and, with the reconstitution of protein activity in liposomes since membrane 
protein function may require protein-phospholipid interaction. Recently cardiolipin, 
which is present in the IMM, was shown to inhibit reconstituted mitochondrial calcium 
uniporter activity (Zazueta et al., 2003). However it was not clear as to whether the 
composition of the liposomes reflected the lipid environment of the Ca umporter in 
vivo and therefore whether cardiolipin regulates Ca entry into mitochondria. In 
addition a molecular biology approach could be used to identify the nucleotide 
sequence for the uniporter. A PCR based method could be designed using degenerate 
primers that bind to sequences containing Ca2+ binding motifs e.g E-F hand motif.
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Chapter 7: Discussion
[7.1] Bax interacts with the VDAC-ANT mitochondrial intermembrane 
contact sites: implications for a mechanism for the Bax-induced 
release of apoptogenic proteins from the IMS
During apoptosis, Bax translocates from the cytosol to the mitochondria and induces 
the release of apoptogenic proteins from the IMS (Chapter 1). Bax recruitment to 
mitochondria involves a conformational change at the N-terminus of the protein which 
leads to its translocation from the cytosol to mitochondria (Cartron et al., 2003). The 
mechanisms by which Bax induces the release of proteins from the IMS are not well 
understood. Several hypotheses have been put forward. These include the involvement 
of the MPT-pore (Loeffler & Kroemer, 2000) (see [4.1]), the formation of Bax-VDAC 
pores in the OMM (Shimizu et al., 2000) and Bax-only models for example involving 
Bax-mediated disruption of the phospholipid bilayer structure leading to the in 
introduction of transient holes in the OMM (Kuwana et al., 2002). The identification of 
mitochondrial membrane proteins that interact with Bax would enhance our 
understanding of how Bax participates in the permeabilisation of the OMM. This 
investigation has shown that GST-Bax interacts with VDAC (OMM) and ANT (IMM) 
present in mitochondrial membranes derived from rat heart. In addition VDAC and 
ANT co-immunoprecipitate with GFP-Bax in cell extracts derived from 
cardiomyocytes undergoing apoptosis after cyanide treatment in order to simulate 
ischaemia (Chapter 5). These data provide evidence for the role of VDAC-ANT 
contact sites as mitochondrial receptors for Bax. GST-Bax and the C-terminally
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truncated GST-BaxAc both interact with VDAC and ANT. Previously the C-terminal 
region of Bax was shown to be involved in Bax translocation to mitochondria and 
insertion into the OMM (Wolter et al., 1997, Goping et al., 1998). However other 
studies have demonstrated that the deletion of the C-terminus of Bax did not abolish 
mitochondrial targeting of Bax (Temblais et al., 1999). Although the substitution of the 
C-terminus of Bax with that of Bc1-Xl did not affect its subcellular localisation it was 
shown to abolish its pro-apoptotic function and increased cell survival in a number of 
cell types (Oliver et al., 2000). Other studies have shown that both full-length and 
BaxAc are capable of inducing cytochrome c release (Jurgensmeier et al., 1998, Eskes 
et al., 1998, Goldstein et al., 2000). The differences in the effect of both forms of Bax 
was found to be quantitative, 5pM BaxAc released about 8% of the total mitochondrial 
cytochrome c from isolated mitochondria, whereas 5pM of full-length Bax released 
75% (Appaix et al., 2002).
The rat mitochondrial membrane preparations used in Chapter 4 did not contain either 
Bax or'Cyp D (as assessed by Western blotting, data not shown). Therefore GST-Bax 
and GST-Cyp D pulldowns were performed in the presence of exogenous Cyp D or 
Bax to determine if a Bax-VDAC-ANT-Cyp D complex could be isolated. This would 
indicate that Bax interacts directly with components of the MPT-pore complex. The 
GST-Bax pulldowns contained VDAC, ANT, Cyp D and GST-Cyp D retained VDAC, 
ANT and Bax. This indicates that Bax is capable of direct interaction with the MPT- 
pore complex. Kroemer and co-workers hypothesised that the dissipation of ATfrn 
observed during apoptosis was due to opening of the MPT-pores in the IMM leading to
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mitochondrial swelling, rupture of the OMM and the release of apoptogenic proteins 
from the IMS (see section [4.1]). They showed that isolated hexokinase-associated 
mitochondrial membrane complexes containing ANT, Cyp D and Bax as well as other 
unidentified proteins had MPT-pore activity when reconstituted into liposomes (Marzo 
et al., 1998a). The role of the MPT-pore is disputed and dissipation of A'Pm is not 
observed in all cells undergoing apoptosis (Lovat et al., 2000) or may occur many hours 
before the permeabilisation of the OMM (De Giorgi et al., 2002). Dissipation of AT1 
might also be caused by the effects of Bax on components of the respiratory chain. Bax 
was also shown to increase MgATPase activity by the partial uncoupling of the IMM 
and to inhibit some component(s) of the respiratory chain (Appaix et al., 2002). These 
other effects of Bax might also explain why Bax is toxic to bacteria even though they 
lack mitochondria (Chapter 3). In Chapter 5, immunoprecipitation using sepharose- 
coupled anti-GFP antibodies on cell extracts of apoptotic cardiomyocytes transfected 
with GFP-Bax showed that VDAC and ANT co-immunoprecipitated with GFP-Bax but 
not Cyp D indicating that the MPT-pore complex was not targeted by Bax following 
translocation to the mitochondria. VDAC and ANT mitochondrial intermembrane 
contact sites interact with other proteins including hexokinase, creatine kinase and the 
peripheral benzodiazepine receptor (Reichert & Neupert, 2002, Fritz et al.,2001 Joseph- 
Liauzun et al., 1998). It is not known whether all components reside within the same 
contact site. Bax and Cyp D might be able to bind to VDAC-ANT contact sites 
simultaneously but during apoptosis the contact sites might not recruit Cyp D. 
Hexokinase II binding to contact sites inhibits Bax-induced cytochrome c release and 
apoptosis (Pastorino et al., 2002). Tetramers of hexokinase (400 kDa) bind to VDAC 
and prevent Bax binding by steric hindrance. Despite evidence that the MPT-pore is
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not a universal mechanism for the release of apoptogenic proteins from the IMS the 
Cyp D inhibitor CSA prevented Bax-induced cytochrome c release from isolated 
mitochondria in the presence of Ca2+ (Marzo et al., 1998b) and not in the absence of 
Ca2+(von Ahsen et al., 2000). In another study Bax, in the absence of Ca2+, induced 
cytochrome c release from isolated mitochondria but did not cause mitochondrial 
swelling characteristic of MPT-pore opening (Jurgensmeier et al., 1998). Furthermore 
Bax-induced cytochrome c release was inhibited by CSA indicating that Cyp D was 
involved in this process since it is the only cyclophilin present in mitochondria. The 
dissipation of AT'm during lymphocyte apoptosis was prevented by the MPT-pore 
inhibitors CSA, mCSA (a non-immunosupressive analogue of CSA) and bongkrekic 
acid (Zamzami et al., 1996). However data obtained from apoptotic cells treated with 
CSA are more difficult to interpret since CSA also interacts with the other cellular 
cyclophilin isoforms e.g. cyclophilin A (Cyp A) which is present in the cytosol. In a 
neuronal cell line, the antisense suppression of Cyp A mimics the capacity of CSA to 
block apoptosis induced by staurosporine, NO and other stimuli (Capano et al., 2002). 
The inhibitory effects of CSA suggest that overexpression of Cyp D would induce 
apoptosis however the overexpression of Cyp D suppressed the spontaneous apoptosis 
observed in ANT-1 overexpressing cells (Bauer et al., 1999) and in another study it 
delayed apoptosis induced by staurosporine (Lin & Lechleiter, 2002). More recently, 
Cyp D overexpression in B50 neuronal cells was shown to promote MPT and necrosis 
induced by the NO donor nitroprusside but inhibited apoptosis induced by NO or 
staurosporine (Li et al., 2004). The inconsistencies in these results might be due to Cyp 
D having more than one role and one of these might be CSA sensitive while the other is 
not. For example, Cyp D might interact with mitochondrial peroxiredoxin in a CSA
180
Chapter 7: Discussion
insensitive manner. Peroxiredoxins are involved in protection against oxidative stress 
(Lee et al., 2001) in addition to a CSA sensitive role preventing MPT-pore opening.
Results from the present study indicate that Bax binding to VDAC-ANT was altered by 
the ANT ligands atractyloside (promotes apoptosis) and bongkrekic acid (inhibits 
apoptosis). The addition of atractyloside significantly increased the amount relative of 
VDAC compared to ANT that was retained by GST-Bax. The same amount of VDAC 
was present but there was an 80% reduction in ANT retained compared to control (no 
additions). Bongkrekic acid increased the amount of both VDAC (by 81%) and ANT 
(63%) bound to GST-Bax. These data indicated that the ANT ligands alter the 
composition of the VDAC-ANT complexes which interact with Bax (Figure [7.1]). 
Recently it was shown that hexokinase I containing VDAC-ANT contact sites isolated 
from rat kidney cortex or brain contained cytochrome c (Vyssokikh et al., 2004). The 
cytochrome c distribution was proposed to be located in three sub-mitochondrial 
compartments at the surface of the cristae, bound to the peripheral IMM and associated 
with the contact sites. The contact site associated cytochrome c was thought to 
represent a specific releasable pool in the early period of Bax action (Capano & 
Crompton, 2002) and the presence of cytochrome c at the contact sites was shown to be 
dependent on the VDAC-ANT structure. Atractyloside promotes contact site formation 
(Bucheler et al., 1991, Vyssokikh et al., 2001) and increased the amount of cytochrome 
c associated with the contact sites where as bongkrekic acid had the opposite effect. 
However Vyssokikh and co-workers (Vyssokikh et al., 2004) did not investigate the 
effects of Bax binding to contact sites in the presence of atractyloside or bongkrekic
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acid and therefore what impact the Bax-VDAC-ANT interaction has on the 
composition of the contact sites remained unclear.
The question arises as to the role of VDAC-ANT contact sites in the Bax-induced 
permeabilisation of the OMM. Are the contact sites receptors for Bax localisation to 
mitochondria or do they or individual components participate directly in the 
permeabilisation of the OMM? From the results obtained in Chapters 4 and 5 it is not 
possible to determine if the co-immunoprecipitation of VDAC and ANT merely reflects 
the ability of VDAC and ANT to bind together or whether it points to the formation of 
a Bax-VDAC-ANT complex. Previous studies have shown that VDAC and Bax form 
channels when reconstituted into phospholipid membranes (Shimzu et al., 2000) and 
these channels are permeable to cytochrome c. However a recent study by another 
group found no electrophysiologically detectable interaction between VDAC isolated 
from mammalian mitochondria, and either monomeric or oligomeric Bax (Rostovtseva 
et al., 2004). Contrary to the data obtained in this investigation the authors proposed 
that this is consistent with other data that failed to detect Bax-VDAC interaction by 
immunoprecipitation or cross-linking (Mihhailov et al., 2001). Furthermore these 
authors demonstrated that t-Bid affects the voltage gating of VDAC by inducing 
channel closure. The diameter of VDAC is not wide enough to allow the passage of 
cytochrome c and therefore cannot directly be responsible for the permeabilisation of 
the OMM. Another hypothesis is based on the ability of Bax to close VDAC which 
results in the accumulation of small metabolites in the IMS followed by mitochondrial 
swelling and the loss of OMM integrity (Vander Heiden et al., 2001, Vander Heiden et 
al., 2000). However, a number of studies have shown the absence of mitochondrial
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swelling and the maintenance of integrity of the OMM during apoptosis (Waterhouse et 
al., 2002).
Other data has shown that Bax is capable of direct interaction with ANT in the IMM to 
form a non-specific pore that is inhibited by bongkrekic acid and CSA (Marzo et al., 
1998b). Other evidence obtained using a yeast two-hybrid system demonstrated that 
Bax interacts with amino acids 105-156 of ANT-2. Further studies have shown that 
Bax can also interact with ANT to prevent ATP/ADP exchange across the IMM 
(Belzacq et al., 2003). Following insertion into the OMM, Bax activity might be 
modulated by ANT in the IMM. The amino acid sequence for human ANT-1 and 
ANT-2 are 95% identical. Contrary to data published by Kroemer’s laboratory, 
Bauer’s group (Bauer et al., 1999) demonstrated that overexpression of ANT-1 induces 
apoptosis whereas ANT-2 does not. Both iso forms can exist within the same 
mitochondrion (Vyssokikh et al., 2001) however ANT-2 was found exclusively in the 
cristae and both isoforms were present in the peripheral inner membrane. In addition 
ANT-1 was found to form complexes with VDAC and to have a higher affinity for Cyp 
D than ANT-2. In the present study an anti-ANT polyclonal antibody was used to 
detect ANT, this recognises the C-terminal epitope YDEIKKYV which is common to 
both ANT isoforms. Since VDAC and ANT were detected this suggests the ANT-1 
isoform was present but ANT-2 interaction with GST-Bax cannot be ruled out. Models 
for the role of contact sites in the Bax-induced release of proteins from the IMS are 
summarised in figure [7.1].
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The phospholipid cardiolipin is involved in Bid targeting to lipid membranes (Lutter et 
al., 2001, Lutter et al., 2000) and promoting the formation of large pores in membranes 
by tBid and monomeric Bax (Kuwana et al., 2002). Cardiolipin is found in high 
concentrations throughout the IMM and also at VDAC-ANT contact sites (17-20%) 
(Simbeni et al., 1991, Ardail et al., 1990). In the OMM cardiolipin is present at lower 
concentrations (0.3-4%) (De Kroon et al., 1997). The contact sites might act as 
receptors for Bax following translocation to mitochondria. Bax interacts with 
cardiolipin to induce disruption of the phospholipid bilayer resulting in the formation of 
transient pores through which apoptogenic proteins can pass. One of the functions of 
tBid, which also localises to the contact sites (Lutter et al., 2001), is to promote 
oligomerisation of Bax and Bak. The oligomerised form of Bax is thought to be 
necessary for cytochrome c release to occur (Antonsson et al., 2000). In vitro the 
oligomeric state of Bax can be altered by non-ionic detergents (Hsu & Youle, 1997). 
Zwitterionic detergents such as CHAPS do not promote oligomerisation. The data 
shown in Chapter 4 shows that GST-Bax purified in the presence of CHAPS retained 
VDAC and ANT from rat heart mitochondrial membrane extracts indicating that 
monomeric Bax binds to contact sites and oligomerisation occurs afterwards. Bax also 
forms larger Bax complexes consisting of thousands of Bax molecules (Nechushtan et 
al., 2001). In some cases it was shown the formation of the larger Bax complexes 
preceded cytochrome c release (De Giorgi et al., 2002) and in others it occurred much 
later (Capano & Crompton, 2002). A study by Kuwana and co-workers (Kuwana et al., 
2002) demonstrates that Bax interaction with cardiolipin containing outer mitochondrial 
membrane vesicles (OMVs) is sufficient to permeabilise the OMVs and mimics many 
properties of apoptotic permeabilisation of the OMM. However this model does not
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encompass all aspects of OMM permeabilisation, for example the IMM of 
mitochondria or the membrane of mitoplasts (mitochondria lacking the OMM) are not 
completely permeabilised by tBid/Bax despite the fact that the IMM contains large 
amounts of cardiolipin. Therefore other regulatory components must be present during 
OMM permeabilisation.
Bax and tBid localise to
contact sites containing 
cardiolipin
OMM
ANTIMM /
tBid induces Bax oligomerisation 
and Bax inserts into the OMM
D
ANTIMM
OMM
Bongkrekic acid C and atractyloside D alter the relative amounts of VDAC and ANT that interact with Bax
Figure [7.1] Bax interacts with VDAC and ANT: models for the role of Bax in the 
release of apoptogenic proteins from the IMS. A Bax and tBid localise to the 
VDAC-ANT intermembrane contact sites. B After tBid induced oligomerisation Bax 
might participate in the release of proteins from the IMS by 1 forming Bax channels 
that are regulated by ANT-2 interacting with VDAC to produce Bax-VDAC channels, 3 
interacting with cardiolipin at the contact sites leading to the localised disruption of the 
lipid bilayer resulting in the formation of transient pores. C The ANT ligands 
bongkrekic acid and D atractyloside alters the relative amounts of VDAC and ANT that 
interact with Bax.
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Mitochondrial apoptosis may be mediated through differential apoptotic pathways 
including those involving the ER (Nutt et al., 2002). In this case some apoptotic stimuli 
may lead to the release of Ca2+ from the ER stores, which in turn leads to increases in 
mitochondrial matrix Ca2+ (see section [6.1]), MPT, mitochondrial swelling and 
rupture of the OMM allowing the release of apoptogenic proteins from the IMS. Both 
pro-apoptotic proteins (Bax and Bak) and anti-apoptotic proteins e.g. Bcl-2 localise to 
the ER during apoptosis and either increase or reduce the releasable Ca2+ ER pool 
respectively (Scorrano et al., 2002). The question arises as to the relative contributions 
of the Ca2+ release and direct permeabilisation of the OMM pathways in apoptosis 
induced in various cell types and by different stimuli. Apoptotic messengers such as 
ceramide, arachidonic acid and reactive oxygen species (ROS) rely on the Ca2+ release 
pathway while other stimuli do not (Scorrano et al., 2003, Nutt et al., 2002, Nakamura 
et al., 2000). How exactly Bcl-2 proteins regulate the release of proteins from the IMS 
and the role of mitochondria in different cell types during apoptosis are active areas of 
research, the results from which will hopefully enhance our understanding of this 
process and allow for the development of novel therapies for diseases in which 
apoptosis (or lack of) contributes to the pathology, for example cancers and heart 
disease.
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